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Abstract 
Numerous epidemiological studies indicate that flavonoid intake as part of a 
balanced diet confers beneficial health effects in man, including improved 
cardiovascular function, reduced incidence of cancer and amelioration of 
symptoms associated with inflammatory disorders (Boots  et al., 2008).  A 
recent area of interest that may be fruitful is the study of anti-inflammatory 
effects of flavonoids in combination with statins. 
Porcine coronary artery (PCA) segments were incubated overnight at 37°C in 
PRGL¿HG .UHEV-Henseleit solution with or without 1µg mL-1 
lipopolysaccharides (LPS), with either (0.1±10µM) quercetin, or 10µM 
TXHUFHWLQƍ-suphate and 10µM quercetin-3-glucuronide, or with (0.01-10µM) 
epicatechins, 10µM catecchin and10µM epigallocatechin gallate. (0.03-3µM) 
simvastatins and 10µM pravastatin are also used in this study. In addition, since 
many quercetin-rich foods also contain significant amounts of myricetin, this 
flavonoid has also been examined. 
After 16 to 18 hours, segments were prepared for isometric tension recording 
in Krebs-Henseleit solution. The segments were then exposed to cumulatively 
increasing concentrations of KCl and then U46619. Responses are shown as 
milliNewton or calculated as the concentration causing 50% of the maximum 
effect (-log EC50). For nitrite measurement, segments of the PCA were 
LQFXEDWHGLQ'0(0DW&IRUKRXUVZLWKRUZLWKRXWȝJP/-1 LPS. The 
nitrite content (nmol) of the bathing medium was determined by 
spectrophotometry using the Griess reaction, while inducible nitric oxide 
V\QWKDVH ZDV LGHQWL¿HG LPPXQRKLVWRFKHPLFDOO\ 'LIIHUHQFHV EHWZHHQ PHDQ
values were assessed by ANOVA (post-hoc Dunnett test). 
Prolonged exposure to LPS caused hyporesponsiveness of the PCA associated 
with increase in nitrite production by a mechanism that appears to involve the 
induction of nitric oxide synthase. Nitrite content of the incubation medium 
increased 3 to 10-fold following exposure to LPS and inducible nitric oxide 
synthase was detected in the adventitia. The results indicated that all of the 
tested flavonoids and statins are able to suppress LPS-induced changes in 
vascular responses, nitrite production and expression of inducible nitric oxide 
synthase. While 10µM myricetin was inactive. 
In conclusion I have demonstrated that quercetin, and its principal human 
metabolites and catechins oppose pro-inflammatory events in both endothelial 
cells and vascular smooth muscle cells. Possibly through a mechanism 
involving inhibition of NFkB. Since pre-treatment of the PCA with statins 
reduced LPS-induced changes in vasoconstrictor responses, suppressed the 
induction of nitric oxide synthase caused by LPS and the associated increase in 
nitrite production. It is unlikely that the effect of the statin involves direct 
inhibition of NOS. These findings are consistent with clinical studies 
suggesting that prior use of statins may afford protection against bacterial 
sepsis. 
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Cardiovascular disease (CVD) remains the leading cause of death throughout the 
Western world and the second most common cause worldwide despite enormous 
progress in the prevention and treatment of cardiovascular diseases (Braunwald, 
1997) . By the year 2020, it is estimated that nearly 40% of all deaths worldwide 
will be due to CVD, which is more than twice the percentage of deaths from 
cancer. In the last 30 years, hyperlipidemia has been identified as a major 
modifiable risk factor for CV death (Braunwald, 1997). Treatments aimed to 
modifying plasma cholesterol levels by dietary and pharmacological means. 
Dietary treatment focused on energy restrictions and modifying saturated fat 
intake. Statin drugs have been shown to very significantly reduce cardiovascular 
disease events in a number of large clinical trials (Scandinavian Simvastatin 
Survival Study (4S) Group, 1994). As a result, statins are now considered to 
represent one of the most powerful classes of agents for the treatment of 
cardiovascular diseases (Lefer et al., 2001). Originally, reductions in 
cardiovascular disease events and mortality and overall improved outcomes were 
attributed to dramatic reductions in circulating serum lipid levels that were 
mediated by inhibition of liver 3-hydroxy 3-methyl glutaryl coenzyme A (HMG-
CoA) reductase. However, half of all coronary events occur in persons without 
overt hyperlipidemia (Braunwald, 1997). The search for new and better predictors 
of risk has led researchers to a broader understanding of the potential, for example 
of cardioprotective diet and pharmacological treatment that reflect an emerging 
appreciation of the importance of inflammation in atherogenesis and thrombosis. 
From a dietary perspective a number of epidemiological studies provide evidence 
that consumption of fruit and vegetables is associated with reduced risk of 
cardiovascular disease. This cardioprotective effect is might be due, at least in 
SDUW WR PLQRU FRPSRQHQWV RI IUXLW DQG YHJHWDEOHV FDOOHG ÀDYRQRLGV (Cook and 
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Samman, 1996). Some epidemiologic studies suggest a cardioprotective role of 
flavonoids against coronary heart disease. One large clinical study indicated that 
flavonoids may reduce mortality from coronary heart disease (Hertog et al., 1993) 
Various cohort studies indicated an inverse association between flavonoid intakes 
and coronary heart disease mortality (Hertog et al., 1995; Knekt et al., 1996; 
Skibola and Smith, 2000). Furthermore, epidemiologic studies suggest a 
protective role of dietary flavonoids against coronary heart disease (de Groot and 
Rauen, 1998). These studies are promising and indicate that flavonoids may be 
useful medical compounds. From a pharmacological perspective, statins are 
rapidly becoming frontline therapy for diabetes mellitus, hypertension, and other 
known cardiovascular disease risk factors. They are considered to act more 
broadly than simply by reducing plasma cholesterol levels, potentially via 
inhibiting inflammatory processes. 
 
In this Introduction I will outline the evidence that inflammatory processes are 
important in the development of atherosclerosis, sepsis and other cardiovascular 
diseases. I will highlight the potential to use lipopolysaccharide in vitro, to model 
some of these changes. I will then discuss the chemistry, metabolism and 
biological actions of various flavonoids including quercetin and catechins. 
Finally, I will outline the evidence for statins, a key drug class in treatment of 
atherosclerosis, to influence inflammatory responses.  
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1.1 Pathology of Atherosclerosis 
Atherosclerotic narrowing of the epicardial coronary arteries, together with 
thrombosis, platelet aggregation, and vasospasm, all contribute to the 
development of ischaemic heart disease (IHD). IHD results from an imbalance 
between perfusion (supply) and workload (demand) of the heart. Ischaemia not 
only involves oxygen insufficiency, but also reduced nutrient concentration and 
inadequate removal of metabolites.  In more than 90% of cases, ischaemia is due 
to atherosclerosis. For this reason, ischaemic heart disease is often termed 
coronary artery disease and symptomatically can appear as either angina pectoris, 
acute coronary syndromes, such as myocardial infarction and heart failure, and 
also sudden cardiac death (Libby and Simon 2001).  
 
Atherosclerosis, formerly considered as a bland lipid storage disease, actually 
involves an ongoing inflammatory response of the major conduit arteries of the 
heart, brain, legs and other major organs. It is now generally accepted that 
inflammation plays a fundamental role in mediating all stages of atherosclerosis, 
from initiation through progression and, ultimately, the thrombotic complications 
of the condition (Figure 1.1). Numerous clinical studies have shown that the 
biology of inflammation in atherosclerosis applies directly to human patients. 
Elevation in markers of inflammation predicts outcomes for patients with acute 
coronary syndromes, independently of myocardial damage. In addition, low-grade 
chronic inflammation, as indicated by levels of the inflammatory marker C-
reactive protein, prospectively defines risk of atherosclerotic complications, thus 
adding to prognostic information provided by traditional risk factors. Moreover, 
certain treatments that reduce coronary risk also limit inflammation. In the case of 
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lipid lowering with statins, this anti-inflammatory effect does not appear to 
correlate with reduction in low-density lipoprotein levels (De Denus and Spinler, 
2002; Giusti-Pavia et al., 2004; Kaesemeyer et al., 1999). 
Growing evidence supports the role of local and systemic inflammation as a 
common pathophysiological mechanism in different cardiovascular diseases like 
congestive heart failure (CHF) or coronary artery disease (CAD). Elevated plasma 
levels of cytokines like interleukin (IL-) 6 and tumor necrosis factor- Į71)- Į
were not only consistently detected in patients with CHF (Levine et al., 1990; 
Lommi et al., 1997; Torre-Amione et al., 1996) but also in patients with stable or 
unstable angina and myocardial infarction (Gabriel et al., 2000; Ikeda et al., 2001; 
Kanda et al., 2000). Inflammatory mediators such as cytokines can modulate 
cardiac contractility and, therefore, might influence CHF progression (Kelly and 
Smith, 1997; Mann and Young, 1994; Niebauer, 2000). Cytokines such as IL-1, 
IL-6, and TNF-Į H[HUWH negative inotropic effects in isolated cells and 
hearts (Rietschel and Brade, 1992; Weisensee et al., 1993). 
 
1.1.1   Role of the Inflammatory Process in Atherosclerosis 
,QÀDPPDWLRQLVDQRUFKHVWUDWHGELRORJLFal process, induced by microbial infection 
RUWLVVXHLQMXU\$PDMRUWULJJHURILQÀDPPDWLRQLVWKHUHFRJQLWLRQRIPLFUREHVE\
VSHFL¿F UHFHSWRUVRI WKH LQQDWH LPPXQHV\VWHPZKLFKSOD\ DFUXFLDO UROH LQ WKH
induction of early signals initiating and establisKLQJ WKH LQÀDPPDWRU\ VHWWLQJ
(Nathan, 2002) 'XULQJ LQÀDPPDWLRQ KLJK FRQFHQWUDWLRQV RI QLWULF R[LGH
produced by inducible nitric oxide synthase in macrophages can result in 
oxidative damage. In such circumstances, activated macrophages greatly increase 
the simultaneous production of both nitric oxide and super-oxide anions. Nitric 
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oxide reacts with free radicals, thereby producing the highly damaging 
peroxynitrite that can directly oxidize LDL, resulting in irreversible damage to the 
cell membrane (Haenen et al., 1997).  
Inflammation plays a role in all stages of atherothrombosis. Early in the process, 
in response to oxidized low-density±lipoprotein cholesterol (LDL-C), injury, or 
infection, resident or circulating leukocytes bind monocytes to the site of a 
developing lesion. As they continue to ingest chemically modified lipids and 
lipoproteins, monocytes transform into activated macrophages and then become 
foam cells. More than half of all cells at the immediate site of plaque rupture are 
macrophages; they are the dominant type of atherosclerotic inflammatory cell 
infiltrate (Moreno et al., 1994). At the same time, other inflammatory cells, 
including activated T cells and mast cells, also attach themselves to the 
endothelium. All of these inflammatory cells eventually contribute to the 
formation of the atheromatous lesion, which consists of a lipid pool protected by a 
fibrous cap. The monocyte-macrophages release a variety of enzymes including 
metalloproteinases. These proteolytic enzymes can break down collagen in the 
fibrous cap, leaving it prone to rupture, and exposing the tissue factor and 
atherosclerotic debris beneath to arterial blood, inducing thrombosis. At the same 
time, smooth muscle cells (SMCs) secrete factors that recruit additional 
monocytes (Lefkowitz and Willerson, 2001).  Local stimulation of SMCs in the 
artery wall can amplify the inflammatory response and promote a local 
procoagulant effect (Lefkowitz and Willerson, 2001; Libby and Simon, 2001). 
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Figure 1-1 Sequences in progression of atherosclerosis (Libby et al., 2002). 
A- Initiation of atherosclerosis
B- Progression of atherosclerosis.
C- Thrombotic complication of atherosclerosis
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It has been proposed for several decades that infections may be responsible for the 
accelerated development of atherosclerosis. Numerous studies have shown an 
association between atherosclerosis and both viral and bacterial infections 
(Muhlestein, 1998) . IL-6 is an important regulator of the acute phase reaction and 
its proinflammatory effects are likely to adversely affect the cardiovascular 
system. NF-kB is a vital element in the production of proinflammatory proteins 
and is activated in patients with active CAD. However, recent findings suggest 
that NF-kB may have proinflammatory (Kempe et al., 2005) or anti-inflammatory 
actions (Sethi et al., 2008) depending on the phase of the inflammatory process. 
 
1.2 Proinflammatory Factors (Lipopolysaccharide) 
Over the past decade it has become accepted that cardiovascular disease (e.g. 
atherosclerosis) has a significant inflammatory component (Hansson, 2005). High 
levels of plasma cholesterol, particularly associated with raised low density 
lipoprotein (LDL), is associated with raised plasma markers for inflammation, 
e.g. C-reactive protein, and expression of cell adhesion molecules on cells. In 
order to model some of these inflammatory changes in vitro, against which the 
potentially beneficial effects of flavonoids can be assessed, it is necessary to use 
known pro-inflammatory agents. Presently there are many agents used to elicit 
inflammation in vitro, lipopolysaccharide and oxidised low density lipoprotein 
(oxLDL).  Epidemiological studies indicate that endotoxemia at levels as low as 
50 pg/ml represents a strong risk factor for the development of atherosclerosis 
(Kiechl et al., 2001; Wiedermann et al., 1999). A variety of gram-negative 
infections were associated with an increased risk of atherosclerosis (Kiechl et al., 
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2001), supporting the hypothesis that endotoxin may be pathogenically linked to 
the development of atherosclerosis. 
 
Lipopolysaccharide (LPS) is the main component of the outer membrane of gram-
negative bacteria and is responsible for many of the pathophysiological effects. It 
consists of three domains, a lipid moiety (lipid A), a core region and an O-specific 
chain, of which lipid A is structurally the most conserved among different 
pathogenic bacteria and represents the toxic principle of LPS (Rietschel et al., 
1994). The presence of LPS in the systemic circulation causes a widespread 
activation of the innate immune response leading to the uncontrolled production 
of numerous inflammatory mediators, including tumour necrosis factor-Į71)-
Į LQWHUOHXNLQ-ȕ ,/-ȕ DQG LQWHUOHXNLQ-6 (IL-6), by cells of the 
monocyte/macrophage lineage, as well as others such as nitric oxide produced by 
the endothelial cells, which act to cause a frequent fatal systemic inflammatory 
UHVSRQVHFDOOHG³VHSWLFVKRFN´(Cinel and Opal, 2009).   
 
Many studies indicated that either short-term or long-term infusion of LPS has 
been shown to depress the response to vasoactive agents and to induce 
hypotension in pigs in vivo (Datta and Magder, 1999). Effects of LPS in pigs not 
only demonstrated the vascular function change but also induced an accumulation 
in the plasma content of cycloxygenase products (Hellyer et al., 1997).   Many of 
these effects have been replicated in human volunteers who have been exposed to 
a low dose of LPS ± an experimental model of human endotoxaemia (O`Brien and 
Abraham, 2004).  
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Some of the inflammatory changes induced by LPS in vivo can also be observed 
in isolated cells.  For example, LPS (10ng/ml) has been shown to induce TNF-Į
interleukin-6 and interleukin 1ß in human peripheral blood mononuclear cells 
(Hougee et al., 2005; Richard et al., 2005).  Higher concentrations (0.1-1µg/ml) 
have been shown to increase nitrite production in the macrophage cell line RAW 
264.7 and mouse microglia (Chen et al., 2005; Kim et al., 2005). The model of 
LPS-treated J774.2 macrophages is widely used in studies of mechanisms of 
iNOS induction (Swierkosz et al., 1995; Szabo et al., 1993; Wu et al., 1995). 
Activation of J774.2 macrophages with LPS resulted in accumulation of nitrite in 
culture medium. This accumulation of nitrite reflected NO production due to 
induction of iNOS in LPS-treated cells (Wu et al., 1995).  
 
Two glycoproteins are clearly implicated in the molecular and cellular basis of the 
interaction between endotoxin and macrophages (Morrison and Ryan, 1987; 
Ulevitch and Tobias, 1995). Firstly, lipopolysaccharide-binding protein (LBP), 
present in normal serum, recognizes and binds LPS with high affinity through its 
lipid A moiety (Schumann et al., 1990; Su et al., 1995). LPS-LBP complexes then 
activate cells through the second glycoprotein, membrane-bound CD14 (mCD14) 
to produce inflammatory mediators (Martin et al., 1994; Ulevitch and Tobias, 
1995; Wright et al., 1990). Secondly, several reports have shown CD14 to be 
critical to the response of macrophages to low concentrations of LPS in the 
presence of LBP (Dentener et al., 1993; Kielian and Blecha, 1995; Maliszewski, 
1991). The LPB: LPS complex is then capable of being transferred to TLR4, 
although full activation of the receptor requires the membrane receptor CD14 and 
an accessory protein, MD2 (Figure 1.2).  
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The engagement of the TLR4 complex results in the recruitment of several 
adapter proteins, including myeloid differentiation factor-88 (MyD88), TNF 
receptor associated factor (TRAF) and tumor necrosis factor (TNF), interleukin 
receptor-associated kinase (IRAK), creating a signaling complex that, in turn, 
leads to activation of downstream signaling through the mitogen-activated protein 
(MAP) kinase and phospahtidylinositol-3 (PI3) kinase pathways, and through the 
activation of the transcription factor, NF-ț%7KHFRQVHTXHQFHLVWKHWUDQVFULSWLRQ
of members of a family of early proinflammatory genes, including interleukin-1 
(IL-1) and tumor necrosis factor (TNF), and their release from the cell. IL-1 and 
TNF then act on target cells through their own specific receptors, evoking further 
cellular responses that shape the phenotype of sepsis by, for example, activating 
coagulation through increased expression of tissue factor or inducing 
vasodilatation through upregulation of synthesis of nitric oxide catalyzed by 
inducible nitric oxide synthase (Brookes et al., 2009).  
 
In blood vessels, lipopolysaccharide (LPS) cause expression of inducible nitric 
oxide synthase (iNOS) consequently leading to NO overproduction and 
development of hyporeactivity to vasoconstrictor agonists (for review see (Stoclet 
et al., 1993; Szabo, 1995; Thiemermann, 1997). Furthermore, higher 
concentrations of LPS (10-100 µg/ml) were reported by Wei (2006) to inhibit KCl 
and U46619-induced contractions of the porcine isolated coronary artery.  This 
effect was associated with an increase in cellular cyclic GMP, an increase in 
TNF-Į VHFUHWLRQ DQG K\SRUHVSRQVLYHQHVV WR WKH YDVRGLODWRUV VRGLXP
nitroprusside, substance P and bradykinin (Wei, 2006). 
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,W KDV EHHQ UHSRUWHG WKDW ORZ OHYHOV RI HQGRWR[LQ FDXVHG SURLQÀDPPDWRU\
activation of human coronary artery endothelial cells and human carornary artery 
smooth cells,  including the secretion of cytokines (Stoll et al., 2004 ) and 
enhanced expression of cell adhesion molecules (CAM) (Faure et al., 2000). 
Endothelial activation by LPS leads to enhanced leukocyte adhesion and tissue 
UHFUXLWPHQW IURP WKH FLUFXODWLRQ D NH\ UHJXODWRU\ VWHS LQ WKH LQÀDPPDWRU\
response (see Figure 1a).  Binion and colleagues reported that cultured human 
intestinal microvascular endothelial cells (HIMEC) are also strongly activated by 
bDFWHULDO /36 DV GHPRQVWUDWHG E\ VLJQL¿FDQWO\ HQKDQFHG &$0 H[SUHVVLRQ DQG
increased leukocyte-binding activity (Binion et al., 1997). Although endothelial 
cells do not possess membrane-bounded CD14 (mCD14), complexes of soluble 
CD14 (sCD14) and LPS are able to stimulate cells including endothelial 
cells (Pugin et al., 1993) to produce these effects. The clinical significance of 
soluble CD14 is underlined by finding that elevated levels of LPS and soluble 
CD14 could be measured in patients with CHF (Anker et al., 1997; Niebauer et 
al., 1999; Rauchhaus et al., 2000). As described in monocytes and macrophages, 
endothelial cells are also believed to undergo activation through ligation of Toll-
OLNHUHFHSWRU7/5DUHFHQWO\LGHQWL¿HGUHFHSWRUDQGVLJQDOWUDQVGXFHURI/36
(Aderem and Ulevitch, 2000; Zeuke et al., 2002). Ligation of TLR4 leads to 
recruitment of MyD88, phosphorylation of IL-1R associated kinase, 
oligomerization of TNFR-associated factor 6, and subsequent degradation of I-B. 
These events lead to the activation of NF-Ƹ% DQG UHVXOWDQW WUDQVFULSWLRQ RI
immune responsegenes (Brookes et al, 2009) . 
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Figure 1-2  Activation of endothelial cell TLR-4 by LPS  
          Adapted from  (Brookes et al., 2009). 
 
LPS is recognized by TLR-4 at the cell surface through interactions with several 
extracellular proteins. LBP delivers LPS to CD14. LPS then transfers to MD-2 to 
form an endotoxin- MD-2 complex which binds and activates TLR-4. Activation of 
TLR-4 induces a signalling cascade which leads to the activation of the 
transcription factor NF-ț% PHGLDWLQJ WKH SURGXFWLRQ RI SUR-inflammatory 
cytokines including TNF-ĮDQG,/-1.  
Abbreviation: IRAK: interleukin receptor-associated kinase; TRAF: TNF receptor 
associated factor; MYD-88: myeloid differentiation factor-88. 
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Taken together, although many of the key symptoms of ischemic heart disease 
can be accounted for by inflammatory changes associated with the development 
of atherosclerosis in blood vessels, much of our understanding of the cellular 
events has depended on a study of the effect of lipopolysaccharide in immune 
cells, rather than the presumed pro-inflammatory factor oxidized LDL in vascular 
smooth muscle. 
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1.3 Flavonoids  
Flavonoids belong to a group of natural substances, with variable phenolic 
structures. They  are found in fruit, vegetables, grains, bark, roots, stems, flowers, 
tea, and wine (Middleton, 1998). They comprise a common flavan core, formed 
with 15 carbon atoms arranged in 3 rings (C6-C3-C6) consisting of 2 aromatic ones 
linked through 3 carbons, usually forming an oxygenated heterocycle nucleus, the 
flavan nucleus (Bravo, 1998). The different patterns of this nucleus permit the 
classification of flavonoids into several subgroups, i.e., flavanols that use 2-
hydroxy-2H-chromen-3-ol skeleton. These include the catechins, epicatechin and 
catechin gallate, flavonols; that have the 3-hydroxy-2-phenylchromone 4-one 
backbone and includes quercetin, myricetin and kaempferol, anthocyanidins 
(cyanidin, delphinidin), flavones (apigenin, diosmin), and flavanones (naringenin, 
hesperetin) (Bravo, 1998). 
 
These natural products were known for their beneficial effects on health long 
before flavonoids were isolated as the effective compounds. More than 4000 
varieties of flavonoids have been identified, many of which are responsible for the 
attractive colors of flowers, fruit, and leaves (de Groot and Rauen, 1998). 
Research on flavonoids received an added impulse with the discovery of the 
French paradox, i.e., the low cardiovascular mortality rate observed in 
Mediterranean populations, in association with red wine consumption and a high 
saturated fat intake. Numerous epidemiological studies indicate that flavonoid 
intake as part of a balanced diet confers beneficial health effects in man, including 
improved cardiovascular function, reduced incidence of cancer and amelioration 
of symptoms associated with inflammatory disorders (Boots  et al., 2008).   
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Until recently, considerable attention has focused on the antioxidant properties of 
Àavonoids, with the presumption that they scavenge free radicals and prevent 
deleterious changes to the vascular endothelium (Vita, 2005). However, the 
VLJQL¿FDQFHRIWKLVDFWLRQKDVEHHQFDOOHGLQWRTXHVWLRQE\UHSRUWVWKDWSURORQJHG
ingestion of non-Àavonoid antioxidants failed to reVXOW LQ EHQH¿FLDO
cardiovascular outcomes (Brigelius-Flohe et al., 2005; Devaraj and Jialal, 2005). 
7KXV RWKHU SRWHQWLDOO\ UHOHYDQW DFWLRQV RI ÀDYRQRLGV LQFOXGLQJ DQWL-
LQÀDPPDWRU\DQWL-thrombotic and direct vascular effects (Middleton et al., 2000) 
, now need to be considered in greater detail. However, before commenting on the 
non anti-oxidant activities of flavonoids it is necessary to outline basic properties 
of vascular endothelium and smooth muscle that comprise blood vessels. 
 
 
1.3.1 Nitric Oxide and Endothelial Function 
The vascular endothelium is probably the most extensive tissue in the body, and 
its continuous smooth and non-thrombogenic surface forms a highly selective 
impermeable barrier (Desideri and Ferri, 2005; Furchgott and Zawadzki, 1980). A 
single layer of endothelial cells lines the entire vascular system, and normality of 
both endothelial cell structure and functions are of great importance in the 
maintenance of vessel wall integrity (Desideri and Ferri, 2005; Furchgott and 
Zawadzki, 1980). In this regard, endothelial cells actively regulate vascular 
reactivity by responding to mechanical forces and neurohormonal mediators with 
the release of a variety of relaxing and contracting factors (Desideri and Ferri, 
2005; Furchgott and Zawadzki, 1980; Palmer et al., 1988). The most important 
endothelium-derived vasodilator is nitric oxide (NO), an endogenous gas that is 
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synthesized by NO synthase (NOS) starting from L-arginine. After diffusion from 
endothelial to vascular smooth muscle cells, NO increases intracellular cyclic 
guanosine monophosphate (GMP) concentrations and then leads to vascular 
relaxation (Desideri and Ferri, 2005; Palmer et al., 1988).  
 
NO is released from endothelial cells in response to shear stress, acetylcholine, 
and other stimuli and can profoundly affect both function and structure of the 
underlying vascular smooth muscle cells (Desideri et al., 2003; Ferri et al., 1999). 
Indeed, continuous production of NO by constitutive NOS maintains the 
vasculature in a state of vasodilation, whereas its phasic generation by inducible 
NOS can acutely dilate an artery in response to either physiological or 
pathological stimuli (Desideri et al., 2003; Desideri and Ferri, 2005; Ferri et al., 
1999; Furchgott and Zawadzki, 1980). However, NO is a reactive nitrogen 
compound and can be rapidly transformed into peroxynitrite (ONOO±) by 
superoxide anion (O2±). In addition, O2± and other endogenous oxidants are able 
to favour NOS uncoupling (Deanfield et al., 2007; Desideri and Ferri, 2005; 
Furchgott and Zawadzki, 1980). In turn, uncoupled NOS induce O2± generation 
and then further decreases NO bioavailability and increases ONOO± formation 
(Deanfield et al., 2007; Desideri et al., 2003; Desideri and Ferri, 2005). Finally, 
augmented ONOO±concentration decreases tetrahydrobiopterin, a fundamental 
cofactor in NO generation/activity, thereby further reducing NO bioavailability 
(Deanfield et al., 2007). Thus, an increased oxidative stress may result in a 
complete derangement of the NO system, with decreased NO bioavailability and a 
paradoxical NOS-related increment in oxidant generation.  
Because of the antiatherogenic, antithrombotic properties of NO (Deanfield et al., 
2007; Ferri et al., 2007; Ferri et al., 2006) and the proatherogenic prothrombotic 
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actions of endogenous oxidants (Deanfield et al., 2007; Desideri and Ferri, 2005; 
Ferri et al., 2007), a decreased NO bioavailability with increased oxidative and 
nitrosative stress will result not only in impaired endothelium-dependent 
vasorelaxation and blood pressure regulation but also in the acceleration of 
atherogenesis and onset of acute atherotrombotic events (Deanfield et al., 2007; 
Ferri et al., 1999; Ferri et al., 2007; Ferri et al., 2006; Palmer et al., 1988). Thus, 
improved NOS activity and NO bioavailability and decreased oxidant generation, 
particularly of O2± and ONOO±, are both expected to protect the vessel wall and 
favour blood pressure homeostasis (Deanfield et al., 2007; Desideri et al., 2003; 
Desideri and Ferri, 2005; Ferri et al., 1999; Ferri et al., 2006; Palmer et al., 1988). 
 
1.3.2 Mechanism of vasorelaxation effect of flavonoids 
The up-UHJXODWRU\HIIHFWRIÀDYRQRLGVRQ12OHYHOVRFFXUVWKURXJKHLWKHUDFWLYDWLRQ
of endothelium nitric oxide synthase (eNOS) or by removing O2± and thereby 
inhibiting consumption of NO (Benito et al., 2002; Huk et al., 1998; Pechanova et 
al., 2004). Other than increasing eNOS activity (Benito et al., 2002)ÀDYRQRLGVPD\
additionally induce eNOS expression (Hung et al., 2004; Olszanecki et al., 2002). As 
eNOS is a calcium-dependent enzyme, elevation of intracellular Ca2+ has been 
suggested as the mechanism of the endothelium-dependent NO -mediated 
YDVRUHOD[DWLRQ E\ ÀDYRQRLGV (Akhlaghi and Brandy 2009; Andriambeloson et al., 
1998; Martin et al., 2002; Stoclet et al., 1999) (Figure 1. 3). Flavonoids likely 
increase intracellular Ca2+ by stimulating both Ca2+ entry from the extracellular 
milieu and Ca2+ release from intracellular Ca2+ stores (Martin et al., 2002). 
Surprisingly, the rise of Ca2+ E\ÀDYRQRLGVRFFXUVDVDUHVXOWRILQFUHDVHGSURGXFWLRQ
of O2± as application of superoxide dismutase plus catalase attenuated the Ca2+ 
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elevation (Durate et al., 1993)7KHVHUHVXOWVVXJJHVWWKDWWKHHIIHFWRIÀDYRQRLGVRQ
NO levels can occur both through stimulating O2± production inside endothelial cells 
(stimulating eNOS activity), and through scavenging O2± LQ WKH LQWHUVWLWLDO ÀXLG
(preserving NO). NO. is generally produced by eNOS attached to the endothelium 
plasma membrane and delivered to smooth muscle cells where it manifests its 
biological functions (Sudano et al., 2006). In smooth muscle cells, NO. activates 
guanylate cyclase which synthesizes cyclic GMP (cGMP), an important mediator of 
vasodilation (Figure 1.3) cGMP acts by activating protein kinase G which affects a 
number of target proteins including those involved in Ca2+ channels, decreasing 
cytosolic Ca2+ through activating endoplasmic reticulum Ca2+ uptake and inhibiting 
extracellular Ca2+ entry. The eventual low intracellular Ca2+ in smooth muscle cells 
mitigates cellular contractility and yields relaxation (Figure 1.3). Other possible 
PHFKDQLVPVRIÀDYRQRLGYDVRUHOD[DWLRQDUH inhibition of phosphodiesterases (PDE) 
and lowering Ca2+ in smooth muscle cells (Akhlaghi and Brandy 2009). 
 
. 
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Figure 1-3 Mechanism of vasorelaxant effects of flavonoids.   
Adapted from (Akhlaghi and Brandy 2009). 
 
Flavonoids may reduce vascular tone through stimulating O2± production 
inside endothelial cells, and through scavenging O2± in the interstitial 
Àuid. In smooth muscle cells, by reducing cystolic Ca+2. 
Abbreviation: GTP: Guanosine-5'-triphosphate; cGMP: cyclic 
guanosine monophosphate; PDE: phosphodiesterases; PKG:  protein 
kinase G.  
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1.3.3 Mechanism of anti-inflammatory effect of flavonoids 
There have been several proposed cellular action mechanisms explaining in vivo 
anti-inflammatory activity of flavonoids. They possess antioxidative and radical 
scavenging activities. Certain flavonoids modulate the enzyme activities of 
arachidonic acid metabolizing enzymes such as phospholipase A2, 
cyclooxygenase, and lipoxygenase and the nitric oxide producing enzyme, nitric 
oxide synthase. An inhibition of these enzymes by flavonoids reduces the 
production of AA, prostaglandins (PG), leukotrienes (LT), and NO, crucial 
mediators of inflammation. Thus, the inhibition of these enzymes exerted by 
flavonoids is definitely one of the important cellular mechanisms of anti-
inflammation. Furthermore, in recent years, many lines of evidence support the 
idea that certain flavonoids are the modulators of gene expression, especially of 
proinflammatory gene expression, thus leading to the attenuation of the 
inflammatory response. At present, it is not known to what extent this 
proinflammatory gene expression contributes to the inflammatory response. 
However, it is evident that flavonoids show anti-inflammatory activity, at least in 
part, by the suppression of this proinflammatory gene expression. Flavonoids can 
also inhibit production of pro-LQÀDPPDWRU\ cytokines, such as tumor necrosis 
factor (TNF)-ĮLQWHUOHXNLQ,/-ȕ IL-6, and interferon-Ȗ(Marfella et al., 2006). 
0RUHRYHU ÀDYRQRLGV DQG RWKHU polyphenols have shown inhibitory effects on 
expression of adhesion molecules such as ICAM-1, VCAM-1, and E-selectin 
(González-Gallego et al., 2007; Kris-Etherton et al., 2004; Manthey, 2000). 
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Figure 1.4 The mechanism of anti-inflammatory effect of flavonoids. 
Adapted from (Kim et al; 2004). 
 
Flavonoids show anti-inflammatory activity by the suppression of these 
proinflammatory gene expressions and inhibit production of pro-LQÀDPPDWRU\
cytokines, such as tumor necrosis factor (TNF)-Į LQWHUOHXNLQ ,/-ȕ IL-6, and 
interferon-Ȗ DV ZHOO DV FKHPRtactic agents . 0RUHRYHU ÀDYRQRLGV have shown 
inhibitory effects on expression of adhesion molecules such as ICAM-1, VCAM-1, 
and E-selectin. 
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1.3.4 Quercetin 
4XHUFHWLQ LV WKH PDMRU GLHWDU\ ÀDYRQRO IRXQG LQ DEXQGDQFH LQ RQLRQV DSSOHV
broccoli, and berries (Hertog et al., 1993). The daily intake of quercetin with a 
typical Western diet was estimated to range between 0 and 30 mg, with a median 
of 10 mg (Hertog et al., 1995). Consumption of flavonoids in general and 
quercetin in particular may be associated with a decreased risk of coronary heart 
disease and other degenerative diseases (Erdman et al., 2007). Chemically, 
qXHUFHWLQLVD¶¶-pentahydroxyflavone (Figure 1.5). 
 
Potential health effects of bioactive compounds depend on their bioavailability 
following oral administration. In plant-derived foods, quercetin is mainly present 
as various glycosides. It has been repeatedly shown that the sugar moiety is a 
major determinant of the rate of intestinal absorption of quercetin (Lesser and 
Wolffram, 2007). In all species investigated so far, including humans, pigs, and 
rats, quercetin and its methylated derivatives with an intact flavonol structure 
(isorhamnetin, tamarixetin) are not present as free aglyca but only in the 
conjugated form (mainly glucuronide and sulfate conjugates). Data on 
bioavailability of quercetin aglycone or quercetin glycosides vary substantially 
between studies, according to the methods applied for quercetin measurement, 
and in different species (Lesser and Wolffram, 2007). In humans, absorption after 
oral supplementation ranged from 0 to over 50% of the administered dose 
(Hollman et al., 1995; Hollman et al., 1996).  
 
As to the biological activities of quercetin, in vitro studies indicate antioxidant, 
antiinflammatory, antithrombotic, anticarcinogenic, and vasodilatory actions 
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(Erdman et al., 2007). However, quercetin intervention trials in humans have so 
far shown inconclusive and even conflicting results (Erdman et al., 2007; 
Williamson and Manach, 2005). Quercetin had favorable effects on a variety of 
antioxidant biomarkers, such as antioxidant enzymes, plasma antioxidant 
capacity, resistance to LDL oxidation, reduced lymphocyte DNA damage, and 
reduced urinary 8-OH-2'-deoxyguanosine. However, other studies did not support 
these data (Edwards et al., 2007; Kim et al., 2003). The majority of human studies 
used rather high doses of quercetin (and mostly only 1 concentration) and/or 
quercetin was not administered as a pure compound but via quercetin-rich 
foods/meals (e.g. white onions, onion soup) containing further phytochemicals, 
which may have influenced the results.  
 
Anti-LQÀDPPDWRU\ Hơects have also been found in vivo, when quercetin was 
reported to suppress experimentally induced arthritis in rats (Mamani-Matsuda et 
al., 2006), and prevented gastric ulcer formation caused by the oral administration 
of absolute ethanol (Mizui et al., 1987). Mechanistically, It was reported that 
quercetin inhibited LPS-induced STAT-1 and NF-ț% Dctivations, and iNOS 
expression in activated macrophages (Hamalainen et al., 2007). Additionally, 
Chen et DOKDYHUHSRUWHGWKDWTXHUFHWLQLQKLELWV,)1Ȗ-induced STAT-1 activation 
in mouse BV-2 microglia (Chen et al., 2005). Various flavonoids, including 
quercetin, stimulate endothelial cells to release NO following elevation of 
intracellular calcium level [Ca++] (Martin et al., 2002; Stoclet et al., 1999a) . 
Indeed, the infusion of flavonoids into the coronary circulation of isolated guinea 
pig hearts caused immediate vasodilatation. These responses were strongly 
inhibited by L-NAME, non-selective NOS inihibitor, which also abolished the 
response to bradykinin, a standard NO-dependent vasodilator (Chlopicki et al., 
Chapter 1: General Introduction 
 
- 25 - 
 
1999). Interestingly, in contrast with the influence on iNOS induction, quercetin 
appeared to be a more potent endothelial NOS simulator than kaempferol and 
apigenin. Apparently, flavonoids stimulate endothelial eNOS and inhibit iNOS 
induction in LPS-treated macrophages by different mechanisms (Olszanecki et 
al., 2002). 
 
Fitzpatrick and colleagues demonstrated that wine and grape products such as 
quercetin and tannic acid cause endothelium-dependent relaxation in rat thoracic 
aorta (Fitzpatrick et al., 1993), and there have been several subsequent reports of 
WKHSKDUPDFRORJLFDODFWLRQVRIÀDYRQRLGVRQYDVFXODUVPRRWKPXVFOHWRQH(Chen 
and Pace-Asciak, 1996; Durate et al., 1993; Flesch et al., 1998). 
 
Numerous studies in the rat and human have demonstrated that dietary quercetin is 
partly absorbed into the body and accumulates as its glucouronides and sulphate 
conjugates in the blood. The amount of quercetin that remains biologically 
available may not be of sufficient concentration, theoretically, to explain the 
beneficial effects seen with the Mediterranean diet. However, Tribolo et al (2007) 
found that both quercetin and its metabolites (glucouronidated, sulphated and 
methylated) at physiological concentrations (2 µmol/L and 10 µmol/L) can inhibit 
the LPS-induced expression of cell adhesion molecules, such as vascular cell 
adhesion molecule-1 (VCAM-1) and intercellular cell adhesion molecule-1 (ICAM-
1) on human umbilical vein endothelial cells (Tribolo et al., 2008b). More recently, 
Lodi and co-worker have established that quercetin and quercetin-ƍ-sulfate or 
quercetin-3-glucuronide inhibited NADPH oxidase-derived O2í release and 
prevented the endothelial dysfunction induced by incubation with ET-1. These 
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data indicate that the conjugated metabolites could be responsible for the in 
vivo protective activity of quercetin on endothelial dysfunction (Lodi et al., 2009). 
 
Myricetin (3,5,7,3',4',5'-hexahydroxyfavone), another naturally occurring 
flavonoid, differs from quercetin only by the addition of a hydroxyl at the 5`-OH 
of the phenyl moiety (Figure 1.5). It has been shown to exhibit a biphasic 
contractile response in pre-contracted rat thoracic aorta (Berger et al., 1992; 
Herrera et al., 1996). At low concentrations (<50 µM), it potentiates the responses 
to different contractile agents such as noradrenaline, high KCl and phorbol 12-
myristate 13-acetate in rat aortic rings, whereas at higher concentrations, it exerts 
a vasorelaxant effect on vessels precontracted with these agents (Herrera et al., 
1996). The potentiating effect of myricetin has been reported in a number of 
arteries from different species such as the rat tail and femoral arteries (Berger et 
al., 1992) or the rabbit pulmonary artery (Russell and Rohrbach, 1989). The 
mechanisms involved in the vasoconstrictor response are through an activation of 
PGH2-TXA2 receptors on vascular smooth muscle by the TXA2 released from 
endothelium by a Ca2+-sensitive activation of the arachidonic acid cascade 
(Jimenez et al., 1999). 
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1.3.5 Catechins 
The catechins are polyphenolic compounds, and are found in green tea, chocolate, 
grapes and apples. Catechins can be found in common foodstuffs as well as in 
herbal remedies. A prospective cohort study (Zutphen Elderly study) provides 
evidence for a primary protective effect of flavanols (Buijsse et al., 2006; Hertog 
et al., 1993; Streppel et al., 2009). Catechins belong to the flavan-3-ol class of 
flavonoids. The most abundant of the polyphenolic compounds in green tea is 
epigallocatechin gallate (EGCG), with other catechins such as epicatechin (EC), 
epigallocatechin (EGC) and epicatechin gallate (ECG) also present (Figure 1.6). 
The catechins have been reported to exhibit several beneficial health effects by 
acting as antioxidant (Bors and Michel, 1999), anticarcinogen (Guruvayoorappan 
and Kuttan, 2008), cardiopreventive (Heiss et al., 2003), anti-microbial, anti-viral, 
(Selway, 1986) and neuro-protective agents (Bastianetto et al., 2006 ). 
 
The bioavailability of tea catechins appears to be relatively low. When healthy 
volunteers were given a single serving of 4.5 g of green tea solids dissolved in 
500 mL of water, peak plasma concentrations of individual catechins (conjugated 
and unconjugated) were <2 µmol/L (Yang et al., 1998a). Average peak plasma 
catechin concentrations (conjugated and unconjugated) in healthy volunteers 
given a single dose of 1.5 mmol of pure EGC, ECG or EGCG were 5.0, 3.1 and 
1.3µmol/L, respectively (Van Amelsvoort et al., 2001). These values represent 
peak plasma levels after high doses of green tea or pure catechins. Average 
plasma catechin concentrations are likely to be considerably lower. Because 
WKHDÀDYLQVDQGWKHDUXELJLQVDUHGLIILFXOWWRGHWHFWLQEORRGRUXULQHWKHUHLVOLWWOH
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information regarding the biotransformation or bioavailability of black tea 
polyphenols in humans or animals. 
 
Upon ingestion, the catechins are rapidly and extensively metabolized in the 
intestines, liver and kidneys. The major biotransformation reactions of tea 
catechins are glucuronidation, sulfation and methylation (Bell et al., 2000; Kim et 
al., 2000); indeed, some of the variability in reported plasma concentrations may 
be due to the difficulties in measXULQJFKHPLFDOO\ PRGL¿HGDVZHOODVXQDOWHUHG
catechins.  
 
Many in vitro studies on catechins report mechanisms consistent with protection 
against degenerative diseases (Adcocks et al., 2002; Huang et al., 1999; 
Nakagawa et al., 2002; Nie et al., 2002). Many of these studies however used 
KLJK FRQFHQWUDWLRQV RI FDWHFKLQ DQG WKXV GR QRW UHÀHFW W\SLFDO FDWHFKLQ
FRQFHQWUDWLRQV IRXQG LQ DQLPDO RU KXPDQ SODVPD ,W LV GLI¿FXOW WR H[WUDSRODWH
these results to in vivo situations. Moreover, non galloylated catechins are present 
in plasma as conjugated forms (Kim et al., 2000; Lee et al., 2002; Piskula and 
Terao, 1998), except for EGCG and ECGZKLFKDUH VLJQL¿FDQWO\ XQFRQMXJDWHG
(Ullmann et al., 2003). However, because of the lack of conjugated forms as 
standards or test compounds, it is not possible to test the in vitro biological effects 
of the conjugates. 
 
They have been found to have anti-LQÀDPPDWRU\SURSHUWLHVZKLFKPD\EHGXHWR
their ability to inhibit tumor necrosis factor (TNF) synthesis (Yang et al., 1998b), 
possibly by the inhibition of kinase(s) in signaling cascades, leading to activation 
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of certain transcription factors (Liang et al., 1999; Lin et al., 1999; Mukhtar and 
Ahmad, 1999). 
 
The ability of the catechins to activate endothelial NOS and then improve NO 
bioavailability is likely to represent the primary mechanism underlying the blood 
pressure reduction observed in different human studies (Engler et al., 2004; 
Soares et al., 2002; Taubert et al., 2007), and the same mechanism has been 
strongly implicated as the main process responsible for the blood pressure-
lowering effects exerted by either short-term (Engler et al., 2004) or long-term 
(Taubert et al., 2007) cocoa administration. 
 
Oxidized LDL is a well recognized and the most studied risk factor for CVD. 
Many studies reported that catechins can inhibit the oxidation of LDL both in 
vitro and in animal studies (Ishikawa et al., 1997; Stangl et al., 2006; Sumpio et 
al., 2006; Tijburg et al., 1997; Yamanaka et al., 1997). It was also shown that 
EGCG alone has a lipoprotein bound antioxidant activity that is greater than that 
of tocopherol (Vinson et al., 1995). TKHDGGLWLRQRIWRȝJPORI(&(&*
(*&RU(*&*WRPDFURSKDJHVFRQVHUYHGWKHĮ-tocopherol content of LDL and 
delayed the onset of lipid peroxidation (Zhu et al., 1999). 
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Figure 1-5  Chemical structure of flavonols (Boots et al., 2008).   
 
 
Figure 1-6  Chemical structure of flavanols (Boots et al., 2008).   
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1.4 Statins 
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) lower 
plasma cholesterol, are widely used in patients with hyperlipidemia and coronary 
artery disease, and are beneficial in the primary and secondary prevention of 
cardiovascular disease. Statins were shown to reduce cardiovascular morbidity 
and mortality in a number of large clinical trials, such as the Scandinavian 
Simvastatin Survival Study (4S) (Scandinavian Simvastatin Survival Study (4S) 
Group, 1994), the Cholesterol and Recurrent Events (CARE) (Sacks et al., 1996), 
the Long-term Intervention with Pravastatin in Ischemia Disease (LIPID) (The 
Long-Term Intervention with Pravastatin in Ischaemic Disease, 1998), the West 
of Scotland Coronary Prevention Study (WOSCOPS) (Shepherd et al., 1995 ), the 
Air Force/Texas Coronary Atherosclerosis Prevention Study 
(AFCAPS/TexCAPS) (Downs et al., 1998)  and the Heart Protection Study (HPS) 
(Heart Protection Study Collaborative Group MRC/BHF Heart Protection, 2002).  
 
There is increasing interest in the possibility that statin therapy may be protective 
in the condition of sepsis (Almog, 2003). Thus, a retrospective review of patients 
admitted to intensive care with bacteraemia showed a significant reduction in 
mortality in those receiving statin therapy at the time of admission (Liappis et al., 
2001). Additionally, a small prospective study of patients with acute bacterial 
infection found a reduced rate of development of severe sepsis in patients treated 
with statins (Almog et al., 2004).  Animal studies have shown beneficial effects 
on mortality of statin treatment given 12h and 1h before lipopolysaccharide (LPS) 
(Ando et al., 2000), or 18h and 3h before caecal ligation and puncture (Merx et 
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al., 2004), although little is known of the underlying mechanisms for these 
beneficial effects.   
 
Statins are the principal therapy for more than 25 million people at risk of 
cardiovascular disease worldwide. Statins lower blood cholesterol concentration 
and reduce the relative risk of coronary events by about 30% in both primary and 
secondary prevention. Statins are now widely prescribed to patients with ischemic 
heart disease, and it is increasingly clear that they have favourable effects 
unrelated to lipid lowering (Werner et al., 2002). For example, pravastatin has 
been claimed to reduce left-ventricular (LV) mass in hypertensive patients (Su et 
al., 2000) and in the 4S study patients receiving long-term simvastatin treatment 
had a reduced incidence of heart failure (Kjekshus et al., 1997). Statins have also 
recently been shown to prevent stroke (Heart Protection Study Collaborative 
Group, 2002), and the mechanism is likely to be multifactorial. Finally, in another 
study, statins were observed to reduce the incidence of atrial fibrillation (AF) in 
patients with coronary artery disease (Young-Xu et al., 2003).  
 
Lovastatin is a fungal metabolite, of which pravastatin and simvastatin are semi-
synthetic derivatives, whereas fluvastatin, atorvastatin and rosuvastatin are 
entirely synthetic (Hamelin and Turgeon, 1998). Lovastatin and simvastatin are of 
the lactone pro-drug form, whereas atorvastatin, fluvastatin and pravastatin are 
presented in the active (acid) form (Ishigami et al., 2001). The structures can be 
broadly divided into three parts (Gaw and Packard, 2000) an analogue of the 
target enzyme substrate, HMG-CoA; a complex hydrophobic ring structure that is 
covalently linked to the substrate analogue and is involved in binding of the statin 
WR WKH UHGXFWDVH HQ]\PH VLGH JURXSV RQ WKH ULQJV WKDW GH¿QH WKH VROXELOLW\
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properties of the drugs and therefore many of their pharmacokinetic properties 
(Figure 1.7). Lovastatin and simvastatin are relatively lipophilic compounds, 
while pravastatin and rosuvastatin are more hydrophilic as a result of a polar 
hydroxyl group and methane sulphonamide group, respectively (McTavish and 
Sorkin, 1991). 
 
All statins are relatively hepatoselective with respect to inhibition of HMG-CoA 
reductase, an important property given that the majority of endogenous 
cholesterol production occurs in the liver. The mechanisms contributing to this 
KHSDWRVHOHFWLYH HIIHFW DUH JRYHUQHG E\ WKH VROXELOLW\ SUR¿OH RI WKH VWDWLQ )RU
lipophilic statins, passive diffusion through hepatocyte cell membranes is 
primarily UHVSRQVLEOH IRUHIILFLHQW¿UVWpass uptake, while for hydrophilic statins 
extensive carrier-mediated uptake is the major mechanism (Hamelin and 
Turgeoun, 1998; Nezasa et al., 2003). While lipophilicity results in efficient 
hepatic shunting, the same property will result in ready passage through 
nonhepatic cell membranes. All statins are absorbed rapidly following 
administration, reaching peak plasma concentration (Tmax) within 4 h. Simvastatin 
and lovastatin are mainly metabolized by cytochrome P450 (CYP) 3A, fluvastatin 
is metabolized by CYP2C9, and pravastatin is excreted largely unchanged.  
 
There is a growing awareness that statins might have important anti-inflammatory 
effects, in addition to their lipid-lowering effects (Jialal  et al., 2001; Yoshida et 
al., 2001). For example, cerivastatin inhibited firm adhesion of U-937 cells to IL-
1-activated human umbilical vein endothelial cells while down-regulating surface 
expression of CD11a, CD18, and VLA4 and inhibiting actin polymerization in the 
U-937 cells (Yoshida et al., 2001). Rice and co-workers have demonstrated that 
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clinically relevant levels of endotoxin induce proinflammatory activation of intact 
human blood vessels. Endotoxin-induced release of IL-8 and induction of 
monocyte binding are blocked by atorvastatin, suggesting a beneficial effect of 
statins unrelated to cholesterol lowering. The mechanism for this inhibition of 
monocyte binding by atorvastatin appears to be reduced synthesis of mevalonate. 
Reduction in mevalonate formation could interrupt endotoxin signaling at a 
number of steps, leading to inhibition or down-regulation of chemoattractant 
molecules such as intercellular adhesion molecule-1 and vascular cell adhesion 
molecule; cytokines such as MCP-1 or IL-8; and/or production of reactive oxygen 
species (Rice et al., 2003). 
 
Several groups have now investigated the enticing possibility that these various 
anti-inflammatory and immune-modulatory effects might have utility in disease 
states beyond atherogenesis. Sparrow and colleagues demonstrated that 
simvastatin had a comparable anti-inflammatory effect to that of indomethacin in 
the carrageenan-induced foot pad oedema inflammatory model (Sparrow et al., 
2001). Statins have been shown to inhibit the production of TNF-ĮDQGLQGXFLEOH
nitric oxide synthase by microglia and astrocytes (Pahan et al., 1997). Statin 
treatment results in inhibition of NF-Ƹ%DFWLYLW\DQGVXEVHTXHQt reduction of the 
pro- inflammatory cytokines tumor necrosis factor (TNF)- and interleukin (IL)-6 
(Ortego et al., 1999; Weis et al., 2001; Zelvyte et al., 2002). Furthermore, statins 
inhibit lipopolysaccharide (LPS)-mediated activation of human peripheral 
mononuclear cells and endothelial cells (Neurauter et al., 2003; Rice et al., 2003; 
Zeuke et al., 2002). Methe and colleagues demonstrated that statins exert direct 
regulatory effects on TLR4 expression in human monocytes that influences 
cellular activation. Statins reduce TLR4 surface expression on CD14 monocytes 
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in vivo and ex vivo in a dose-dependent fashion, causing downregulation of  
IRAK-1 kinase activity and reduced expression of proinflammatory cytokines and 
B7-1 (Methe et al., 2005). 
 
1.4.1 Mechanism 
Statin-induced inhibition of the enzyme HMG-CoA reductase leads to a reduction 
in the formation of mevalonate. As cholesterol and isoprenylated proteins are both 
products of mavelonate, HMG-CoA reductase inhibition can reduce levels of both 
cholesterol and isoprenylated proteins (e.g., Ras, Rho, Rac, Rap). Reduction of 
hepatic cholesterol synthesis activates SREBP2 (sterol response element binding 
protein 2), causing an increase in the transcription of the gene coding for the 
hepatic LDL receptor. Elevated numbers of LDL receptors lead to an increase in 
the clearance of circulating LDLs, the major mechanism by which statins reduce 
plasma LDL-C. In addition, reduced availability of hepatic free cholesterol and/or 
cholesteryl ester for incorporation into very low density lipoproteins (VLDLs) 
may reduce the production rate of these lipoproteins. On the other hand, inhibition 
of mevalonate synthesis also causes a decrease in the formation of other 
intermediates in the cholesterol synthetic pathway, such as farnesyl 
pyrophosphate, geranyl pyrophosphate, and gernyl geranylpyrophosphate. These 
isoprenoid-like molecules are involved in posttranslational modification of 
proteins, termed isoprenylation. Genarylgeneranylation is of particular interest, as 
it affects G protein±dependent cellular activation and numerous signaling 
pathways. Reduction of protein isoprenylation is the molecular mechanism 
underlying most lipid-lowering-independent effects of statins, collectively termed 
pleiotropic effects (Figure 1.8) (Alegret and Silvestre, 2006). 
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Figure 1-7 Chemical structure of statins. 
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Figure 1-8 Molecular mechanisms responsible for the lipid lowering and non-
lipid lowering effects of statins.  Adapted from (Alegret and Silvestre, 2006). 
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1.5 Aim of study  
Although statins have an established major role in preventing the development of 
ischaemic heart disease and treating atherosclerosis, the widespread use is not 
without problems. The emerging evidence that dietary flavonoids may be of 
benefit in preventing ischaemic heart disease raises the question whether 
appropriate use of foods rich in quercetin or catechin could be used prior to the 
need for medical intervention. Basically, can we give specific dietary advice to 
the growing elderly population to promote better health?   
To this end, I propose to 
1. Optimize the conditions to develop suitable vascular models of inflammation to 
evaluate the effects of dietary flavonoids and statins. 
2. To investigate the effect of quercetin, and two of the key metabolites in man, 
TXHUFHWLQƍ-sulphate and quercetin 3-glucuronide, against LPS-induced changes 
in contractions of the porcine isolated coronary artery and the generation of nitric 
oxide. 
3. To investigate the effects of flavanol type flavonoids (catechins, epicatechin and 
epigallocatechin gallate) on the vascular reactivity and the generation of nitric 
oxide of porcine isolated coronary artery exposed to LPS in vitro. 
4. To examine the effect of simvastatin and pravastatin on LPS-induced changes in 
vascular responses and to investigate the combined effects of low concentrations 
of epicatechin and simvastatin on LPS-induced inflammatory changes on porcine 
isolated coronary artery function. 
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2.1 Introduction 
In this laboratory, when the porcine coronary artery is used in the 
pharmacological studies, it is usually stored in Krebs-Henseleit solution overnight 
at 4°C prior to performing the contractile experiment the following morning. 
However, for in vivo vasculature studies related to inflammatory process with 
LPS or other proinflammatory factors, vessels are generally stored at a 
physiological temperature, i.e. 37°C, over several hours. Therefore, before this 
work can begin it is essential that optimizing the conditions required for 
maintaining the properties of the blood vessels during prolonged storage (one or 
two days) at 37oC is established. 
 
The induction of inflammatory changes in cultured cells and isolated blood 
vessels often requires prolonged exposure to LPS (1-2 days).  Cells are usually 
FXOWXUHG LQ D FKHPLFDOO\ GHILQHG PHGLXP HJ 'XOEHFFR¶V 0RGLILHG (DJOH
Medium (DMEM), and the assays conducted using this medium (Schildknecht, 
2004). In the case of isolated blood vessels, however, contractile experiments are 
usually conducted in Krebs-Henseleit solution (Bishop-Bailey et al., 1997; 
O'Brien et al., 2001).  Previous work in this laboratory compared the effect of 
incubation of the porcine coronary artery overnight in previously gassed Krebs-
Henseleit solution and DMEM (37oC and in an atmosphere of 95%O2, 5%CO2) 
and surprisingly found little difference in the responsiveness of the vessel to KCl, 
U46619 and the endothelium-dependent relaxant substance P (Wei, 2006) . 
However, in further experiments Wei (2006) noted a 50% decline in the 
magnitude of the contractions to both KCl and U46619 when the period of 
incubation in Krebs-Henseleit solution was extended to 42 hours.  
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As reported by Rees (2007), the current use of phosphate/bicarbonate- buffered 
saline was instigated in 1932 by Krebs & Henseleit, for studies on isolated 
homogenates of mitochondria, i.e. intracellular organelles, from pigeon liver. 
During the 1950s, this medium was further developed by Krebs in his classical 
study on the analysis of oxygen consumption in tissue slices from different organs 
in a variety of animal species.  Krebs later acknowledged that substrate depletion in 
isolated tissue/organ preparations over time was a consideration that had not been 
addressed in the composition of previous physiological solutions.  
Phosphate/bicarbonate buffers have been in use for sixty years and remain the 
most popular perfusion/preservation solutions for experimental studies on 
mammalian and human tissues/organs.   
 
Although there are minor differences in the composition of the buffer between 
labs, the majority of investigators use a solution comprising NaCl  (118.4 mM), 
KCl (4.7 mM), MgSO4.7H2O (1.2 mM), CaCl2.2H2O (2.5 mM), NaHCO3 (24.9 
mM) and KH2PO4 (1.2 mM). In addition 2g/L of glucose is added as an energy 
source for cell maintenance (Rees, 2007).   
 
During the past 3 years a non-phosphate based solution (AQIX  RS-I) has been 
marketed for the preservation and transportation of organ under normothermic 
conditions.  Historically, large organs have been transported between transplantation 
centres in a variety of different preservation solutions generally maintained at low 
temperatures to reduce metabolic activity.  However, problems arise from the need to 
subsequently reperfuse the organ and slowly elevate the temperature back to body 
temperature, which may give rise to generation of damaging free-radicals.  
                                                                                                                                 Chapter 2 
 
- 42 - 
 
AQIX RS-I mammalian physiological solution has been developed over the last 20 
years and designed with the aim of being a universal organ solution based upon the 
' free' serum levels of the ionic species, while providing a suitable nutritive, buffered 
environment at room temperature.  The concentration of ionic species in AQIX RS-I 
solution acknowledges the activity coefficients of each ionic species and not simply 
their total serum concentrations.  Thus, the concentration of calcium ions, for example, 
is half (1.25 mM) that of Krebs-Henseleit solution because 50% of calcium in serum is 
protein-bound. A major distinguishing and novel feature of AQIX RS-I solution in 
comparison to conventional perfusion saline is the absence of inorganic phosphate 
which, for the past 60 years, has been used as the buffer vehicle in conventional, 
perfusion solutions. AQIX  RS-I is osmotic to human serum (ca. 290 mOsmoles/L) 
and does not appear to necessitate the inclusion of plasma expanders as 
demonstrated by the fact that only minor changes (ca. 8%) in hydration occur during 
long term (i.e. 4-52 h) hypothermic perfusion of the isolated rat heart (Rees, 2007).   
 
The main components of AQIX RS-1 solution are NaCl (110 mM), KCl (5.00 
mM), CaCl2 (1.25 mM) and MgCl2 (0.45 mM). It also contains NaHCO3 (25.0 
mM), BES (5.00 mM), D-glucose (10.00 mM), glycerol (0.11 mM), glutamate 
(0.3 mM), glutamine (0.4 mM), aspartate (0.02 mM), carnitine (0.05 mM) and 
choline chloride (0.01 mM). In addition to thiamine pyrophosphate TPP (40.00 
nM) and insulin (28.00 mIU) (Rees, 2007).  
 
Initial studies using AQIX RS-I was focused on isolated, small animal tissues and 
organ bath system using oxygenated AQIX RS-I at 15-37°C. Such studies 
demonstrated functional viability of rat jejunum for 9 days, rat colon for 5 days, and 
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rabbit uterus for 7 days  (Rees, 1989a). Interestingly, a direct comparison of the effect 
of Krebs Henseleit solution and AQIX   RS-I on contractile responses of human colon 
revealed quantitative and qualitative differences in the magnitude of responses to 
carbachol, suggesting that AQIX   RS-I may exert different effects on the electrical 
properties of electrically excitable tissues.  
 
To date there have been no studies regarding the effect of AQIX  RS-I  on the 
contractile properties of vascular smooth muscle or on the effect of prolonged 
incubation in a static, non-perifused state. Therefore, I will compare vascular 
responses of the porcine coronary artery in experiments undertaken in either 
Krebs-Henseleit solution or AQIX RS-I. Then, I will then examine how the 
responses are affected by the medium used for storage, the temperature of incubation 
and the duration of incubation. 
 
Previous studies have shown that the response of porcine isolated coronary artery 
to KCl and U46619 is significantly impaired following overnight exposure to a 
high concentration of lipopolysaccharides arising from the induction of nitric 
oxide synthase (Wei, 2006). To date most studies that have employed LPS to alter 
vascular responses in vitro have tended to used high concentrations of LPS a 
concentraction of  10-100 microgram per ml (Muller-Scheinitzer et al., 2004 ; 
O`Brien and Abraham, 2004). However, some researchers have found that only a 
low concentration of LPS is required to induce cytokine production or expression 
of adherence molecules in human coronary artery endothelial cells (Patton, 2006; 
Yang, 2005).  
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Previous discoveries have indicated that soluble serum components such as 
lipopolysaccharide binding protein (LBP) and CD14 influence the biological 
potency of bacterial LPS, and these findings have significantly advanced the 
understanding of the pathogenesis of gram negative bacterial diseases (Kielian 
and Blecha, 1995). Wei 2006 demonstrated that exposure of isolated porcine 
coronary artery to high FRQFHQWUDWLRQV RI /36 ȝJPO for 42 hour in the 
presence of serum, potentiated the effects of LPS.  It is interesting to examine 
what the responsiveness of porcine isolated coronary artery is following 42 hours 
(approximately two nights) exposure to low concentrations of LPS, and whether 
the serum factors enhance the responses of porcine coronary artery to LPS in 
terms of contractile function. However, as a prelude to the above studies it is 
important to optimize the conditions required for investigating the effects of the 
anti-inflammatory agents on LPS-induced pro-inflammatory changes in isolated 
blood vessels. 
 
Thus, there are two major aims for this chapter. First, to undertake a direct 
comparison of the influence of Krebs-Henseleit solution and AQIX-RS-I on 
contractile responses of the porcine coronary artery. Second, to examine the 
influence of serum factors on the inhibitory effect of LPS on the coronary artery.  
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2.2 Materials and Methods 
2.2.1 The influence of incubation temperature on the responsiveness of the 
porcine coronary artery 
Porcine hearts were obtained from a local abattoir and transported to the 
laboratory in ice-cold Krebs-Henseleit (K-H) solution within one hour of death. 
The anterior descending branch of the porcine coronary artery was dissected and 
cleaned of fat and connective tissues. The arteries were then divided into 5mm 
long segments and placed in a sterile vial containing 2ml K-H solution with 2% 
ficoll and a combination of 60µg/ml benzyl penicillin and 20µg/ml streptomycin 
sulphate.  The inclusion of the ficoll in the bathing medium was to prevent 
swelling of the tissue during storage. Prior to sealing the vials, the solution was 
gassed with 95% O2 and 5% CO2 for 5 minutes and then incubated overnight at 
either 4ºC or 37ºC for a minimum of 16 hours. 
 
On the following day, segments were taken out of the incubation solution and 
prepared for isometric tension recording.  Two stainless steel wire supports 
(0.4mm thick) were placed into the lumen of segments, one of which was linked 
by a cotton thread to a glass force-displacement transducer (Grass Model FT03); 
the other one was linked to a glass support. The segments were then placed into 
an organ bath filled with K-H solution and gassed with 95% O2 and 5%CO2. The 
temperature of the organ bath was maintained at 37ºC by a circulating water 
heater. The transducers were connected to an AD Instruments Quad Bridge pre-
amplifier unit coupled to a Maclab 4e unit running Chart 3.4.5 and the results 
displayed on a Macintosh LCII computer. 
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Following 40 minutes equilibration in K-H solution, an initial resting tension of 
100 mN was slowly applied to each segment. At the end of a further 40 min 
equilibration period, the resting tension had declined to approximately 40-60 mN. 
Three responses to 60mM KCl were elicited in each preparation until 
reproducible responses were obtained. Following washout, each preparation was 
exposed to cumulative concentrations of either KCl (6-60mM) or U46619 (1-
200nM).  
 
2.2.2 The influence of incubation medium on the responsiveness of porcine 
coronary artery 
In order to define the influence of the incubation medium per se,   responsiveness 
of porcine coronary artery following incubation overnight either in  K-H solution 
or AQIX RS-I was examined. Porcine hearts were obtained from a local abattoir 
and transported to the laboratory in ice-cold AQIX RS-I solution within one hour. 
The anterior branches of the coronary artery were dissected from the hearts. The 
dissected segments were separately incubated either in the K-H solution (2ml) or 
in AQIX RS-I including an antibiotic mixture (60µg/ml benzyl penicillin and 
20µg/ml streptomycin sulphate) and were thoroughly gassed before incubation. 
Samples were then stored either at 4ºC or 37ºC. 
 
Following overnight exposure, the segments were prepared for the isometric 
tension recording test.  Following 40 minutes equilibration either in K-H solution 
or AQIX RS-I, an initial resting tension of 100mN was slowly applied to each 
segment. At the end of a further 40 min equilibration period, the resting tension 
had declined to approximately 40-60mN. Three responses to 60mM KCl were 
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elicited in each preparation until reproducible responses were obtained. Following 
washout, each preparation was exposed to cumulative concentrations of either 
KCl (6-60mM) or U46619 (1-200nM). Then the preparations were exposed to 
substance P (10nM) and bradykinin (100nM), to assess the integrity of the 
vascular endothelium.  
 
In another set of experiments, following reproducible responses to 60mM KCl, 
U46619 was added into the organ bath to elicit a sub- maximal response 
equivalent to approximately 60% of the response to 60mM KCl. After the tension 
was stable, the segments were then relaxed by cumulative concentrations of either 
sodium nitro- SUXVVLGH 613 Q0 WR ȝ0 RU LVRSUHQDOLQH Q0 WR ȝ0 WR
evaluate the response of the vessel to dilator agents.  
 
2.2.3 The influence of incubation medium and period on the responsiveness 
of porcine coronary artery 
The anterior branches of coronary arteries were dissected from pig hearts which 
were taken from a local abattoir in ice-cold K-H solution within 1 hour. The 
dissected porcine coronary artery segments were separately incubated in the K-H 
solution (2ml) or AQIX RS-I including an antibiotic mixture (60µg/ml benzyl 
penicillin and 20µg/ml streptomycin sulphate) and were thoroughly gassed before 
incubation. Samples were then stored either overnight or for two days at 37ºC. 
The medium was changed after one night incubation. 
 
Following overnight incubation, the segments were prepared for the isometric 
tension recording test.  Following 40 minutes equilibration either in K-H solution 
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or in AQIX RS-I, an initial resting tension of 100mN was slowly applied to each 
segment. At the end of a further 40 min equilibration period, the resting tension 
had declined to approximately 40-60 mN. Three responses to 60mM KCl were 
elicited in each preparation until reproducible responses were obtained. Following 
washout, each preparation was exposed to cumulative concentrations of either 
KCl (6-60mM) or U46619 (1-200nM). Then the preparations were exposed to 
substance P (10nM) and bradykinin (100nM), as described earlier, to assess the 
integrity of the vascular endothelium. Following two night incubation the 
segments were treated with the same manner with overnight incubation segments. 
 
The results will show that the porcine coronary artery maintained vascular 
contractility following overnight incubation in K-H solution containing 2% ficoll 
DQG ȝJPO EHQ]\O SHQLFLOOLQ DQG ȝJPO VWUHSWRP\FLQ VXOSKDWH +RZHYHU LQ
this study, a noticeable attenuation in the responses to KCl and U46619 was seen 
in the porcine isolated coronary artery segments incubated in AQIX RS-I at 37°C 
either overnight or for two nights. I conclude that the best method of preserving 
the vasculature for 18 hours is to use K-H solution. Therefore, Krebs-Henseleit 
(K-H) solution was used as incubation medium in subsequent studies. 
 
2.2.4 The effect of exposure of porcine coronary artery to LPS in the absence 
or presence of 10% foetal calf serum overnight  
Segments were incubated in 2ml Krebs-Henseleit solution (previously gassed 
with 95%O2 and 5% CO2 for 5 min.) including 2% ficoll and a combination of 
ȝJPOEHQ]\OSHQLFLOOLQDQGȝJPOVWUHSWRP\FLQVXOSKDWHDQGWKHDEVHQFHRU
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SUHVHQFH RI OLSRSRO\VDFFKDULGHV /36 ( &ROL 2% DW ȝJ PL-1 RU ȝJ
mL-1 in separate experiments with the absence or presence of 10% foetal calf 
serum (FCS). Following the incubation procedure, segments were taken out of the 
incubation solution and prepared for isometric procedure as described above. 
 
2.2.5 The effect of exposure of porcine coronary artery to different 
concentrations of LPS 
Segments of porcine coronary artery were separately incubated in 2ml K-H 
solution (including 10% FCS, ILFROOȝJPOEHQ]\OSHQLFLOOLQDQGȝJPO
streptomycin sulphate) aQGH[SRVHGWRDQGȝJP/-1 LPS respectively or 
a vehicle control. Following gassing with 95% O2 and 5% CO2 for 5 minutes, the 
samples were then sealed in sterile vials and incubated in an air incubator at 37oC. 
After 18 hours incubation the segments were then prepared for the isometric 
tension recording as described previously. Following equilibration, the 
preparations were exposed to three applications of 60mM KCl to get reproducible 
response. Then, segments were exposed to cumulative concentrations of KCl (6-
60mM) followed by cumulative concentrations of U46619 (1-200nM).  
 
2.2.6 The effect of exposure of porcine coronary artery WRȝJP/-1LPS for 
42 hours 
Segments of porcine coronary artery were incubated in K-H solution (including 
10% FCS,  ILFROO ȝJPO EHQ]\O SHQLFLOOLQ DQG ȝJPO Vtreptomycin 
sulphate) IRUKRXUVDW&ZLWKWKHDEVHQFHRUSUHVHQFHRIȝJP/-1LPS. The 
medium was changed on the following morning. Following the incubation 
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procedure, the isometric test was used to examine the responsiveness to KCl and 
U46619. 
 
2.2.7 The effect of removal of the endothelium on contractile responses of 
porcine coronary artery to KCl and U46619 
,Q D IXUWKHU VHW RI H[SHULPHQWV WKH HIIHFW RI ȝJ P/-1LPS was examined in 
contractile responses in endothelium-denuded segments of the coronary artery. 
The endothelium was removed by gently rubbing the lumen with the edge of a 
fine force tip; care was taken to ensure that the integrity of the endothelium was 
maintained.  
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2.3 Drugs and Solutions  
The composition of Krebs-Henseleit solution was (mM): NaCl 118; KCl, 4.8; 
MgSO4 .7H2O, 1.2; CaCl2.2H2O, 1.3; NaHCO3, 25.0; KH2PO4, 1.2. Benzyl 
penicillin, streptomycin sulphate, bradykinin, ficoll and lipopolysaccharide E.coli. 
O11:B4 were obtained from Sigma-Aldrich Company Ltd (Poole, Dosert, UK.). 
Substance P was obtained from Bachem (UK) Chemical Company (Delphe Court, 
Merseyside, UK). U46619 (9, 11-dideoxy-11a, 9a-epoxymethanoprostaglandin 
FĮ) was obtained from Alexis Corporation (Nottingham UK). AQIX RS-I 
solution obtained from ICP bio Ltd, New Zealand. The composition of AQIX RS-I 
was NaCl (110 mM), KCl (5.00 mM), CaCl2 (1.25 mM) and MgCl2 (0.45 mM). It 
also contains NaHCO3 (25.0 mM), BES (5.00 mM), D-glucose (10.00 mM), 
glycerol (0.11 mM), glutamate (0.3 mM), glutamine (0.4 mM), aspartate (0.02 
mM), carnitine (0.05 mM) and choline chloride (0.01 mM), TPP (40.00 nM) and 
insulin (28.00 mIU). 
 
2.4 Data Analysis 
The contraction elicited by KCl and U46619 was expressed as milliNewtons force 
(mN) and is shown as mean± standard error of the mean (SEM). The maximum 
responses of constrictors were also expressed as mN force. The potency of the 
constrictor agents was determined as the negative logarithm of the concentration 
causing 50% of the maximum response (pD2) by using a logistic equation 
(Kaleidagraph, Version 3.6 Synergy Software).  In terms of vasodilators, the 
relaxations were expressed as percentages of the tone against U46619 and the 
sensitivity was determined by pD2 if the maximum relaxation was achieved.  All 
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responses were expressed as mean ±SEM. In most instances, differences of mean 
values between groups were compared using a Student¶s paired t-test (two tailed). 
 
Where there was more than one treatment condition assessed differences were 
analysed by ANOVA followed by post hoc 'XQQHWW¶VWHVW$p-value < 0.05 was 
considered statistically significant. 
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2.5 Results 
2.5.1 The influence of incubation temperature on the contractility of the 
porcine coronary artery 
KCl and U46619 elicited concentration-dependent contractions of the porcine 
coronary artery. Figure 2.1 represents the effect of the incubation temperature on 
responses to KCl and U46619 in porcine isolated coronary artery. The results 
showed that the difference was not significant with response to the Emax and 
sensitivity to KCl when the vessels were stored overnight either at 4ºC or 37ºC 
(Figure 2.1a).  When the tissues were stored overnight at 37ºC, the magnitude in 
the responses to U46619 was not different statistically to that of those in the 
arteries incubated overnight at 4ºC. However, an attenuation (1.2-fold) in the 
sensitivity was seen in the preparation incubated at 37ºC (Figure 2.1b pD2: 4ºC 
group 7.86±0.07 vs. 37ºC group 7.5±0.2, p=0.07, n=10).  
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Figure 2-1 Cumulative concentration response curves of (a) KCl and (b) U46619 on 
the porcine isolated coronary artery incubated overnight in K-H solution at 4ºC or 
37ºC. Responses are expressed in milliNewtons and shown as mean ±SEM of 10-11 
investigations. 
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2.5.2 The influence of incubation medium on the responsiveness of the porcine 
coronary artery. 
Figure 2.2 shows digitized representative recording traces of the effects of 60mM 
KCl and cumulative concentrations of U46619 on porcine coronary artery stored 
overnight in Krebs-Henseleit solution or AQIX RS-I and studied in the respective 
solution.  KCl and U46619 caused sustained, concentration-dependent contraction in 
either Krebs-Henseleit solution or AQIX RS-I. However, in 4/12 preparations 
segments studied in AQIX RS-1, spontaneous contractions to U46619 were observed 
(Figure 2.2).  
 
There was a significant difference in the magnitude of contraction due to KCl. The 
magnitude of the response to KCl was greater in the arteries incubated in AQIX RS-I 
at 4 ºC (Figure 2.3a), However, the vasoconstrictor response to U46619 was reduced 
by 22±15.4%, reduced in the segments stored overnight in AQIX RS-I at 4ºC 
compared with those stored in Krebs-Henseleit solution (Figure 2.3c). The difference 
was not statistically significant with the Emax and sensitivity to KCl and U46619 
when the vessels were stored overnight either in K-H solution or AQIX RS-I at 37ºC 
(Figure 2.3b and 2.3d). 
 
The responses of the preparations incubated overnight either in Krebs-Henseleit 
solution or AQIX RS-I at 37ºC to both endothelium-dependent relaxants, 10nM 
substance P and 100nM bradykinin, were reduced compared with tissues that were 
stored at 4 ºC in either Krebs-Henseleit solution or AQIX RS-I (Table 2.1). 
However, in terms of the endothelium-independent relaxants, sodium nitro prusside 
and isoprenaline, the percentage of relaxation to U46619 of the preparations were the 
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same in both conditions. There was a trend towards an increase in sensitivity (pD2) 
for both agonists in the presence of AQIX RS-I but it did not attain statistical 
significance (Table 2.2).    
                                                                                                                                 Chapter 2 
 
- 57 - 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2 The digitized representative recording traces of the effect of 60 mM KCl, 
cumulative response curves to U46619 (1nM-200 nM), substance P (10 nM) and 
bradykinin (100 nM) on the porcine isolated coronary artery stored overnight either 
in AQIX RS-I (Upper) or in Krebs-Henseleit solution (Lower). 
 
AQIX RS-1
1 2              5                10            20      50      100  200  SP     BK
U46619 (nM)
60mM
KCl
1 2              5                10            20      50      100  200  SP     BK
U46619 (nM)
60mM
KCl
Krebs-Henseleit  Solution
4 g wt
30 min
4 g wt.
30 min
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Figure 2-3 The cumulative response curve of KCl (a, b) and U46619 (c, d) on the 
porcine isolated coronary incubated either in Krebs-Henseleit solution or AQIX RS-I 
at 4 or 37ºC overnight. Responses are expressed as milliNewton and shown as mean 
± SEM of 12- 16 observations. *denotes a statistically significant# difference from 
FRQWUROWLVVXHE\SDLUHG6WXGHQW¶VW-test (p<0.05). 
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Table 2-1 Percentage relaxation to substance P and bradykinin against U46619-
induced contractions of the porcine isolated coronary artery following overnight 
storage at 4oC or at 37oC in either Krebs-Henseleit solution or AQIX RS-I. 
 
 Substance P 
(10nM) 
% relaxation 
Bradykinin 
(100nM) 
% relaxation 
K-H solution (4°C) 
K-H solution (37°C) 
72.4±1. 
43.4±6.2* 
96.9±1.5 
54.2±6.3* 
AQIX RS-I solution (4°C) 
AQIX RS-I solution (37°C) 
82.7±2.7 
46.8±5.7* 
97.4±1.2 
61.1±6.5* 
 
Data are shown as mean ± SEM of 12- 16 observations. * denotes a statistically 
difference from control tissue E\SDLUHG6WXGHQW¶VW-test (p<0.05). 
 
 
 
Table 2-2 Percentage relaxation to sodium nitroprousside and isoprenaline against 
U46619-induced contractions of the porcine isolated coronary artery following 
overnight storage at 4oC in either K-H solution or AQIX RS-I. 
 
 Sodium nitroprusside Isoprenaline 
% of U46619       pD2        % of U46619     pD2 
K-H  
Solution 
     92.0±2.7 6.8±0.16      99.9±1.3       7.2±0.16 
AQIX RS-I       93.7±1.6 7.2±0.21      102.0±2.3      7.46±0.1 
 
  Data are shown as mean ± SEM of 10 observations. 
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The experiments to date have shown that there is little difference in the response 
to KCl, U46619, SP and bradykinin when vessels are stored overnight at 37 ºC in 
either Krebs-Henseleit solution or AQIX RS-I. Previous work by Wei (2006) has 
shown that low concentrations of LPS may produce changes in vascular responses 
if the duration of incubation is two nights (approx 42 hours). Thus in this study I 
have examined the responsiveness of the arteries when stored for two nights in 
either AQIX RS-I or Krebs-Henseleit solution. However, in light of the fact that 
there were no major differences between Krebs and AQIX, I decided that further 
experiments comparing the different solutions should be limited to the incubation 
of the arteries; all tissue were collected in Krebs- Henseleit solution.  
 
2.5.3 The influence of incubation medium and period on the responsiveness 
of the porcine coronary artery. 
KCl and U46619 produced concentration-dependent contractions of the coronary 
artery stored overnight at 37ºC in either Krebs-Henseleit solution or AQIX RS-I. 
However, a further day of storage resulted in a proportion of preparations that 
failed to respond. In the case of preparations stored in Krebs-Henseleit solution 
for two nights only 12/16 preparation responded to the agents (> 40 mN), while 
only 6/16 preparations stored in AQIX RS-I solution for 2 days responded. 
Therefore, in the following figure (2.4) the data shown represent only these 
segment that responded to KCl (60mM) with contraction >40mN. 
 
Figure 2.4a and 2.4b describe the concentration response curves of KCl and 
U466199 in porcine coronary artery incubated in AQIX RS-I overnight or for 40 
hrs at 37ºC. A profound attenuation in the magnitude in the response to KCl and 
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U46619 was seen in the preparations incubated in AQIX RS-I for 40 hr compared 
to the preparations that were stored overnight in the same medium (Figure 2.4a, 
4b). Figures 2.4c and 2.4d show the cumulative responses to KCl and U46619 in 
porcine coronary arteries incubated in Krebs-Henseleit solution overnight or for 
40 hr at 37ºC. There were not statistical significant differences in the Emax and 
sensitivity to KCl when the tissues were stored either overnight or for 40 hr.  As 
shown in Table 2.3 there was no difference in the sensitivity of the preparations 
incubated at 37ºC either in AQIX RS-I or in Krebs-Henseleit solution to KCl. 
However, there is significant reduction in the sensitivity to U46619 of segments 
incubated in Krebs-Henseleit solution or in AQIX RS-I for 40 hr.  
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Figure 2-4  Cumulative responses curve to KCl (a,c) and U46619 (b,d) of  porcine 
isolated coronary arteries incubated in either Krebs-Henseleit solution or AQIX RS-I 
at 37ºC for 16 hours or 40 hours. Responses are expressed as milliNewton and 
shown as mean±SEM of 6-12 observations. 
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Table 2-3  The effects of the incubation medium and incubation period on      
responses to KCl and U46619 in the porcine coronary artery. 
 
Incubation  
Condition 
KCl (n=12) U46619(n=6) 
      Max (mN) pD2 Max (mN)     pD2 
Overnight 
 In K-H  
solution 
124.6±11.7 1.64±0.03 132.2±14.7 7.8±0.09 
40 hours 
In K-H  
solution 
 
113.6±15.6 
 
1.49±0.05 
 
114.6±21.5 
 
7.5±0.17* 
Incubation  
Condition 
KCl (n=9) U46619(n=6) 
ax        Max(mN)     pD2 Max (mN) pD2 
Overnight 
In AQIX  
solution 
146.5±13.7 1.57±0.6 158.6±19.8       7.9±0.03 
40 hours 
In AQIX  
solution 
 
86.4±7.8** 
 
1.45±0.04 
 
94.6±11.6* 
 
7.0±0.13** 
 
The values shown represent the mean ± SEM of 6-12 investigations.  
 GHQRWHV D VWDWLVWLFDOO\ GLIIHUHQFH IURP FRQWURO WLVVXH E\ SDLUHG 6WXGHQW¶V W-test 
(p<0.05). 
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2.5.4 The effect of a high concentration of LPS on the porcine isolated coronary 
artery in presence or absence of 10% foetal calf serum.  
Figure 2.5 illustrates the cumulative concentration response curves of KCl and 
U46619 in arteries exposed overnight (16-KRXUVWRȝJP/-1LPS.  As seen in 
the figure (2.5a and 2.5c) the responsiveness to KCl and U46619 was not reduced by 
H[SRVXUH WR ȝJ P/-1LPS when the preparations were incubated in Krebs-
Henseleit solution only. In contrast, the Emax to KCl was reduced by 30.5±10.2% 
(n=10) with a 1.2-IROG UHGXFWLRQ LQ WKH SRWHQF\ IROORZLQJ H[SRVXUH WR ȝJ P/-
1LPS and 10% foetal calf serum (FCS) (figure 2.5b). The maximum responses to 
U46619 were also attenuated by 25.7±8.2% (n=10), although the sensitivity was not 
changed in the arterieVH[SRVHGWRȝJP/-1LPS and 10% FCS (figure 2.5d). 
 
Figure 2.6 depicts the responses curves of KCl and U46619 on porcine coronary 
DUWHU\H[SRVHGRYHUQLJKW WRȝJP/-1LPS in the absence (Figure 2.6a and 2.6c) or 
presence (Figure 2.6.b and 2.6d) of 10% foetal calf serum. When the arteries were 
incubated in Krebs-Henseleit solution in the presence of 10% FCS, the maximum 
response to KCl was reduced to 51.9±5.4%, (n=8), with no change in the sensitivity 
(figure 2.6b). However, this effect was absent in the tissues incubated in 10% FCS 
free medium. Similarly, the contraction response curve of U46619 on the artery 
VHJPHQWV H[SRVHG WR ȝJ P/-1LPS  with 10% FCS was reduced to 60.7±4.9% ,( 
Q FRPSDUHGWRWKHDUWHULHVVHJPHQWVWKDWH[SRVHGWRȝJP/-1  LPS only (figure 
2.6d). 
 
Following attainment of maximal contractions to U46619, the addition of 10nM 
substance P was associated with a relaxation (28.77±4.4%, n=8) that was 
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significantly (student`s paired t-test, p <0.05) reduced in preparations previously 
exposed WRȝJP/-1LPS (3.8±0.7%, n=8). 
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Figure 2-5 Cumulative responses curves to KCl and U46619 in the porcine isolated 
coronary artery following 16-KRXU LQFXEDWLRQ LQ WKH SUHVHQFH RU DEVHQFH RI ȝJ
mL-1LPS   in K-H solutions (a and c). Some preparations were exposed to 10% FBS 
(b and d). Responses to KCl or U46619 are expressed as mN and shown as mean ± 
SEM of 10 investigations. * denotes a statistically difference from control tissue by 
SDLUHG6WXGHQW¶V t-test (p<0.05). 
 
 
                                                                                                                                 Chapter 2 
 
- 67 - 
 
 
 
 
 
 
 
 
Figure 2-6 Cumulative responses curves to KCl and U46619 in the porcine isolated 
coronary artery following 16-KRXULQFXEDWLRQLQWKHSUHVHQFHRUDEVHQFHRIȝJP/-
1LPS in K-H solutions (a and c). Some preparations are exposed to 10% FBS (b and 
d). Responses to KCl or U46619 were expressed as mN and shown as mean ± SEM 
of 8 investigations. * denotes a statistically difference from control tissue by paired 
6WXGHQW¶VW-test (p<0.05). 
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A wide range of concentrations of LPS were examined to determine the 
concentration needed to elicit a notable effect on the contractile function of porcine 
FRURQDU\DUWHU\$VVHHQ IURPWKHWDEOHQHLWKHUȝJP/-1/36QRUȝJP/-
1LPS had an effect on the contraction elicited by KCl and U46619. However, a 
significant attenuation in the sensitivity as well as in the maximum responses to KCl 
and U46619 was REVHUYHG LQ WKH VHJPHQWV H[SRVHG WR ȝJ P/-1LPS overnight 
(Table 2.4) 7KHUHIRUH ȝJ P/-1LPS was used for LPS to stimulate the artery in 
subsequent studies. 
 
2.5.5 The effect of 1µg mL -1LPS on the porcine isolated coronary artery 
incubated for 42hr presence of 10% foetal calf serum.  
Since a pronounced effect of serum was established after 16 hours incubation, an 
experiment was designed to investigate the time-dependency of the serum 
HQKDQFHPHQW HIIHFWV RQ ȝJ P/-1LPS responses in segments of porcine coronary 
artery. Figure 2.7 shows statistically significant reduction in the maximum response 
of KCl to 57.4±3.4%, (n=8) of control and U46619 to 59.7±3.9% (n=8) of control of 
WKHVHJPHQWVH[SRVHGWRȝJP/-1LPS for 42 hours in the presence of 10% FCS. At 
the end of the U46619-induced contractions response assay, the addition of 10nM 
substance P produced a transient relaxation (28.7±4.4%, n=8) in control preparations 
that was significantly reduced to (3.8±0.7, n=8) (p <0.05) following LPS treatment. 
                                                                                                                                 Chapter 2 
 
- 69 - 
 
2.5.6 The effect of removal of the endothelium on contractile responses of 
porcine coronary artery to KCl and U46619 
,QOLJKWRIWKHILQGLQJWKDWVXEVWDQFH3LQGXFHGUHOD[DWLRQZDVLPSDLUHGE\ȝJP/-1 
LPS I further examined the influence of endothelium-denudation and exposure to 
LPS on contractions to KCl and U46619. Endothelium denudation was confirmed by 
the absence of a relaxation to substance P following maximum contraction to 
U46619. 
 
)LJXUHVKRZVWKDWDIWHUUHPRYDORIHQGRWKHOLXPRYHUQLJKWH[SRVXUHWRȝJP/-1  
LPS was still associated with a significant reduction in the maximum contractions to 
KCl (76.8±3.8% of control segments, n=8) and U46619 (71.2±4.6% of control 
segments, n=8). 
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Table 2-4  The responses to KCl and U46619 of porcine isolated coronary arteries 
exposed to the different concentrations of LPS overnight in K-H solution in the 
presence of 10% FCS. 
 
 
KCl U46619 
      Max (mN) pD2      Max (mN) pD2 
Control (n=12) 138.8±12.7 1.51±0.02 140.4±12.7 7.77±0.15 
ȝJP/-1LPS 135.8±10.7 1.47±0.02 141.0±4.9 7.70±0.06 
0.ȝJP/-1LPS 132.2±13.7 1.54±0.01 132.2±11.7 7.81±0.05 
ȝJP/-1LPS 66.1±3.2* 1.53±0.04* 66.6±5.7* 7.57±0.06 
 
Responses to KCl and U46619 were expressed as mN force and shown as mean ± 
SEM of 12 investigations. The difference between control and LPS groups was 
compared by ANOVA and considered as significant if p<0.05. *denotes a significant 
GLIIHUHQFHIURP&RQWUROWLVVXHVIXUWKHUFRPSDUHGE\'XQQHWW¶VWHVW 
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Figure 2-7 The cumulative response curves of KCl (a) and U46619 (b) in the 
porcine isolated coronary artery following 42 hour incubation in the presence or 
absence of ȝJ P/-1LPS in K-H solutions.  Responses to KCl or U46619 are 
expressed as mN and shown as mean ± SEM of 8 investigations.  
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Figure 2-8 The cumulative response curves of KCl and U46619 in endothelium-
intact preparation (8a, 8c) and in endothelium-denuded preparations (8b, 8d) 
IROORZLQJ  KRXU LQFXEDWLRQ LQ WKH SUHVHQFH RU DEVHQFH RI ȝJ P/-1LPS in K-H 
solutions.  Responses to KCl or U46619 are expressed as mN and shown as mean ± 
SEM of 8 investigations.  
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2.6 Discussion 
In this chapter I have established that KCl and U46619-induced contractions were 
reduced following overnight incubation at 37°C in Krebs-Henseleit solution 
compared with segments stored at 4°C. The sensitivity of the preparations to KCl did 
not change. However, there was a 1.2-fold reduction in the sensitivity of the 
preparations to U46619. It has previously been reported that U46619-induced 
contractions were attenuated in segments following overnight incubation storage at 
37°C (Wei, 2006a). Similarly, it was also demonstrated that the response of rat aorta 
segments to norepinephrine was attenuated following increasing the temperature in 
the organ bath (Musatafa et al., 2004).  In an earlier study Ingemansson et al., (1995) 
demonstrated that when rat aorta was stored in University of Wisconsin solution at 
22 ºC, for 36 hours, there was a significant decrease in vascular smooth muscle 
function. Another study by the same group demonstrated that vascular smooth 
muscle function can be fully preserved for 36 hours at 0.5 ºC (Ingemansson et al., 
1996). 
 
In terms of endothelium-dependent relaxation, I have established that substance P- 
and bradykinin-induced relaxations were impaired following overnight incubation at 
37ºC. In a previous study, Wei 2006 found that substance P-induced relaxation was 
impaired following overnight incubation at 37ºC. They also reported that this 
reduction was fully prevented by a non-selective iNOS inhibitor L-NAME and a 
protein synthesis inhibitor, dexamethasone, indicating that induction of NO synthesis 
is mainly responsible for the inhibitory effect.  It is well known that, in porcine 
coronary artery, the endothelium-dependent relaxation to agonists such as 
bradykinin, is mediated by a factor termed endothelium-derived hyperpolarization 
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factor (EDHF) by opening potassium channels in smooth muscle membrane, 
resulting in hypopolarization and consequently reduced calcium entry through 
voltage-dependent calcium channels (Hecker, 2000).  Researchers indicated that 
exposure to low temperatures can impair the basal and stimulated release of 
endothelium-dependent relaxation factors (Bodelsson, 1989). However, 
Ingemansson et al (1996) found that no significant impairment in acetylcholine-
induced relaxation was seen after storage rat aorta at 4°C for two days (Ingemansson 
et al., 1996). In contrast, Hashimoto and co-workers (1992) reported that, following 
3 days of prolonged cold storing of porcine coronary arteries, endothelium-
dependent relaxation to substance P was reduced (Hashimoto et al., 1992). 
 
The results showed that there were no obvious difference between AQIX RS-I and 
K-H solution. But it was noted that some of the U46619- induced contraction 
showed phasic activity, rather than a sustained response, suggestion that AQIX RS-I 
solution may suppresses vascular tone (Figure 2.2). Additionally, Krebs-Henseliet 
solution, although unable to preserve endothelium-dependent relaxation, was able to 
preserve almost full contractile capacity after two days storage compared to AQIS-
SR-I and this was due to the fact that Krebs solution contains double the amount of 
calcium compound with that present in AQIX RS-I. It was suggested that prolonged 
storage of smooth muscle cells in solutions containing too little calcium or none at 
all is harmful to contractile function (Ingemansson et al 1995). In contrast, Rees 
(1989a) reported that many isolated tissues have been either perifused or perfused 
with AQIX RS-I solution at room temperature and found to survive for several days 
without major loss of contractile function. This difference in the results may be due 
to the closed system that was used for incubating the blood vessel attenuating the 
                                                                                                                                 Chapter 2 
 
- 75 - 
 
effect of AQIX RS-I solution (Rees 1989a). These preparations include rat uterus, rat 
heart, porcine kidney (Kay, 2007), porcine liver (Vekemans, 2009) and a variety of 
skeletal muscles.  Despite the growing evidence for the potential advantages of a 
phosphate-free incubation medium, I found no clear advantage over Krebs- Henseleit 
solution. So the latter was used in further experiments.  
 
In this chapter, I found that overnight exposure of segments from porcine coronary 
artery to either low or high concentrations of lipopolysaccharide in the presence of 
serum significantly impaired the contractile function of the segments, as well as the 
substance P-induced relaxation. Previous studies have shown the activation of iNOS 
in vascular smooth muscle cells of different species when stimulated by LPS over a 
relative by long culture period (Gabriel et al., 2000; MacNaul and Hutchinson, 1993; 
O'Brien et al., 2001; Shibano and Vanhoutte, 1993) or in vivo endotoxemia animals 
(Szabo et al., 1996; Wen and Han, 2000; Wu et al., 2004).  Additionally, Fujii and 
his group found that injection of E.coli LPS was associated with a progressive 
decline in arterial pressure and a significant rise in serum nitrite±nitrate level, 
pulmonary NOS activity and upregulation of pulmonary iNOS protein expression 
these are attenuated by pre-treatment with P1/F1 peptide (Fujii et al., 2000). 
Moreover, a relatively moderate increase in cGMP production was induced in 
isolated porcine coronary artery under LPS stimulation which was abolished by L-
NAME (Wei, 2006). In tissue culture studies, elevation of cGMP was also reported 
in rat aorta taken from LPS-injected rats (Fleming et al., 1991). LPS also impaired 
the endothelium-dependent vascular relaxation. Following exposure of porcine 
isolated coronary artery overnight or to 2 nights to either low or high concentration 
of LPS the response to substance P was impaired due to induction of iNOS by LPS 
                                                                                                                                 Chapter 2 
 
- 76 - 
 
in endotheial cells (Gibreal et al., 2000). The concentrations of LPS in our study are 
similar to that reported to alter vascular reactivity in other blood vessels (O`Brien 
and Abraham, 2004; Takakura et al., 1994; Tsuneyoshi et al., 1996; Wylam et al., 
2001). In contrast, a previous study by Wei  (2006) indicated that only a high 
concentrations of LPS (ȝJ P/-1LPS) induced significant attenuation of the 
response of the porcine coronary artery segments to KCl and U46619.  
 
Previous findings have indicated that soluble serum components such as 
lipopolysacchaides binding protein and CD14 influence the biological potency of 
bacterial LPS, and these findings have significantly advanced the understanding of 
the pathogenesis of gram negative bacterial diseases (Kielian and Bletcha, 1995). 
Serum enhanced the contractility depression induced by ȝJP/-1LPS, in a similar 
way to that found with 100ȝJ P/-1LPS. Thus these results confirm the previous 
studies of Standiford et al (1990) and Pugin et al (1994) that LPS did not stimulate 
lung cells without serum (Pugin et al., 1994; Standiford et al., 1990).   
 
It is known that LPS binding protein (LBP) binds to the lipid A region of LPS. The 
resulting LPS-LBP complex is recognised by both the membrane-bound (mCD14) 
and soluble form of CD14 ( sCD14) thereby enhancing the ability of LPS to activate 
myeloid, epithelial and endothelial cells (Kielian and Blecha, 1995). Kazunori and 
colleagues suggested that the ability of FCS to suppress LPS-induced activation of 
WEHI-3 cells is mainly dependent on the structure of the polysaccharide chain and 
also on the concentration of LPS employed. For example, they found that the LPS-
induced production of NO and TNF-Į E\ :(+,-3 cells was totally serum-
independent, and that such serum factors as LBP or soluble CD14 might not be 
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necessary. They also found that FCS showed enhancing effects on the production of 
NO and TNF-ĮE\WKHVDPHFHOOVVWLPXODWHGZLWKa low concentrations, (<100ng/ml) 
of LPS and rough mutant Salmonella minnesota Re LPS. In contrast, FCS inhibits 
TNF-ĮSURGXFWLRQE\WKHVDPHFHOOVVWLmulated by a high concentration of smooth 
form LPS S LPS (>1000ng/ml) (Kazunori et al., 1999). 
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2.7 Conclusion 
In summary, the results showed that there were no significant difference between 
AQIX RS-I and Krebs-Henseleit solution. But it was noted that overnight incubation 
of porcine isolated coronary artery in AQIX RS-1 showed reduction in the responses 
to KCl and U46619. I established an endotoxin-induced impaired vascular reactivity 
model in vitro by exposure of porcine coronary artery to ȝJP/-1LPS overnight in 
presence of 10% foetal calf serum. The responses of porcine isolated coronary artery 
to a low concentration LPS is enhanced by serum, possibly due to the participation 
of sCD14 and LBP. In all further studies I prepare to use Krebs-Henseleit solution 
was used to store the segments at 37ºC and 1µg mL-1LPS in the presence of 10% 
foetal calf serum was used to investigate the effects of flavonoids and statins on 
inflammatory changes in PCA. 
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5 Comparison of the 
effects of quercetin, and 
related flavonoids, on 
LPS-induced changes in 
coronary artery in vitro 
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3.1 Introduction 
Quercetin is a major flavonoid found in various foods, such as apples, onions and 
broccoli that are reported to possess a range of biological activities in isolated 
cells and tissues (Boots et al., 2008; Halliwell, 2007). When ingested as a 
supplement by humans some of the effects noted for quercetin have been 
consistent with both the epidemiological and in vitro observations (Williamson 
and Manach, 2005). For example, Edwards and colleagues (2007) demonstrated 
that quercetin lowered blood pressure in hypertensive subjects, an effect 
potentially related to the reported direct vasodilator action of this flavonoid, and 
its metabolites, on isolated blood vessels (Edwards et al., 2007; Perez-vizcaino et 
al., 2002). 
 
With respect to putative anti-inflammatory activity of quercetin, cytokine-induced 
or lipopolysaccharide (LPS)-induced production of nitric oxide and prostanoids in 
human macrophage cell lines have been reported to be sensitive to high 
concentrations (> 10 µM) of the flavonoid (Chen et al., 2002; Hamalainen et al., 
2007).  The mechanism for this protective effect of quercetin has been attributed 
to suppression of LPS-induced activation of NFNB, possibly linked to 
stabilization of the cytoplasmic NFNB/INB complex (Hamalainen et al., 2007) and 
specific inhibition of INB kinase (Chen et al., 2005) . In mouse microglia, 
quercetin (at approx 3 µM) exerted a greater inhibitory effect on LPS-induced nitrite 
production compared to that elicited by interleukin-ȕ(Chen et al., 2005), thereby 
highlighting the selective nature of this action.  The significance of these 
observations has, however, been called into question because the concentrations 
used greatly exceed plasma levels of the aglycone detected in humans (approx 
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30nM) and there is no information regarding the biological activity of key 
metabolites (Kroon et al., 2004). 
 
It is well recognised that the vasculature is a significant component in the 
development of inflammatory responses. Endothelial cells exhibit signs of altered 
expression of cell adhesion molecules (Read et al., 1994), while vasoconstrictor 
responses are reduced under the influence of locally-generated dilator substances 
(Mitchell et al., 2007; van Gil et al., 2008). For example, nitric oxide production in 
blood vessels is increased by inflammatory stimuli and this is recognised as a major 
contributor to increased local blood flow (Mitchell et al., 2007). While there is 
recent information concerning the effect of quercetin and its metabolites on the 
expression of endothelial cell adhesion molecules (Tribolo et al., 2008a), there is no 
comparable study regarding the changes in smooth muscle contractions.   
 
In the present chapter I have investigated the effect of quercetin, and two of the key 
metabolites in humansTXHUFHWLQ¶-sulphate and quercetin 3-glucuronide (Kroon et 
al., 2004; Wang and Morris, 2005), against LPS-induced changes in contractions of 
the porcine isolated coronary artery (Qi et al., 2007) and the generation of nitric 
oxide.  In addition, since many quercetin-rich foods also contain significant amounts 
RI P\ULFHWLQ D ¶ K\GUR[\ODWHG GHULYDWLYH RI TXHUFHWLQ (Fusi et al., 2005; 
Hamalainen et al., 2007), this flavonoid has also been examined.  
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3.2 Materials and Methods 
Porcine hearts were obtained from a local abattoir and placed in modified Krebs-
Henseleit (K-H) solution maintained at 4°C before being transported to the 
laboratory. The anterior descending branch of the coronary artery was dissected 
from the hearts, cleaned of connective tissue, and then divided into 4 mm long 
segments. 
 
3.2.1 Contraction Studies 
For contraction experiments, single segments of the porcine coronary artery were 
incubated in 2ml K-H solution (previously gassed with 95% O2 and 5% CO2 for 5 
PLQ FRQWDLQLQJ  ILFROO DQG D FRPELQDWLRQ RI ȝJPO benzyl penicillin and 
ȝJPO VWUHSWRP\FLQ VXOSKDWH and 10% FCS 7KH VROXWLRQ DOVR FRQWDLQHG ȝJ
mL-1 LPS, various concentrations of quercetin or a combination of LPS and the 
flavonoid (added 60 min before LPS) and then sealed in a sterilized glass vial and 
stored overnight at 37°C for 16-18 h.  In some experiments the effect of 10µM 
P\ULFHWLQ 0 TXHUFHWLQ ¶-sulphate or 10µM quercetin 3-glucuronide in the 
presence of LPS was examined. In addition, the effect of co-incubation with a 
selective inhibitor of NFNB, Bay 11-7082 (10µM) (Pierce et al., 1997), against 
LPS-induced changes in the blood vessel was also assessed. Unless, indicated 
otherwise, all experiments were conducted on nominally endothelium-intact 
segments of the coronary artery.  In a further set of experiments the effect of 1µM 
quercetin was examined against LPS-induced changes in contractile responses in 
endothelium-denuded segments of the coronary artery, prepared as described by 
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Suri et al., (2010).  In all instances the segments were effectively paired so that 
each experimental condition had a control segment taken from the same animal. 
 
After overnight storage, segments were removed from the incubation solution and 
placed in K-H solution (maintained at 37oC and gassed with 95% O2 and 5% 
CO2) in a 15 ml isolated organ bath, prepared for isometric tension recordings as 
previously described (Qi et al., 2007) and allowed to equilibrate for 60 min. 
Contractions of the segment were measured using a Grass FT03 isometric force 
transducer connected to a MacLab unit coupled to a Macintosh LC4 computer 
running Chart 3.5.  An initial resting tension of 80 mN was slowly applied to each 
segment at the end of the equilibration period and the recorded tension declined to 
40-60 mN over a further 40 min period. Segments were repeatedly exposed to 
60mM KCl for 15 min until reproducible contractions were observed. The 
preparations were exposed to cumulatively increasing concentrations of either 
KCl (6-60mM) or U46619 (a stable thromboxane-mimetic analogue, 9,11-
dideoxy-ĮĮ-methanoepoxyprostaglandin FĮ 1-200 nM). When each 
preparation was exposed to a maximally-effective concentration of U46619, 
10nM substance P was added to assess the integrity of the endothelium. In some 
experiments, the involvement of nitric oxide in the effect of LPS on contractile 
UHVSRQVHV ZDV LQYHVWLJDWHG E\ DGGLQJ ȝ0 : D VHOHFWLYH LQKLELWRU RI
inducible NOS (Garvey et al., 1997a), 30 min before constructing concentration-
response curves to either KCl or U46619. 
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3.2.2 Nitrite Determination 
For the measurement of nitrite ion accumulation, a marker for nitric oxide 
production (Kelm, 1999), two segments were incubated in each vial for 24 hr with 
aerated DMEM (without phenol red) containing 10% FCS, 1mM L-arginine, 
ȝJPO EHQ]\O SHQLFLOOLQ DQG ȝJPO VWUHSWRP\FLQ  The segments were 
H[SRVHG HLWKHU WR ȝJ P/-1 LPS, a flavonoid, or combination of LPS and 
flavonoid, as described above. Some preparations were also exposed to either 
ȝ0 : ȝ0 GH[DPHWKDVRQH RU 0 %D\ -7082 for 24 hr in the 
SUHVHQFH RI ȝJ P/-1 LPS. After the incubation period, the segments were 
removed, briefly blotted on paper towel and weighed.  Nitrite ion accumulation in 
the incubation medium was determined by the Greiss reaction as previously 
described (Ukil et al., 2006). Greiss reagent (500 µl of 1% sulphanilamide and 
0.1% naphthylethylamine diamine in 5% hydrocholoric acid) was added to 500µl 
of the incubation medium and optical density at 550 nm was measured, using a 
UNICAM UV/VIS spectrophotometer. A standard concentration-optical density 
curve was calculated for every assay using sodium nitrite solution against a blank 
(500µl DMEM & 500µl Griess reagent). In a separate experiment I established 
that incubation of DMEM containing either the flavonoid, LPS or a combination 
of both (without the arterial segments) produced an optical density reading similar 
to the blank. The minimum detectable amount of nitrite was 375 nmoles.  
 
3.2.3 Immunohistochemistry 
Sections of the coronary artery incubated under the above conditions were 
prepared on a cryostat (5 µm thick) and stored frozen at -80oC until required.  The 
sections were then warmed to room temperature for 20 min and fixed in cold 
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acetone at -4°C for 20 min. To block endogenous peroxidase activity, sections 
were treated with blocking serum (2 drops of vectastain in 5ml phosphate buffer 
solution (pH 7.4) containing 2% w/v immunohistochemical grade bovine serum 
albumin) for 10 min at room temperature.  The sections were then incubated for 1 
hour with primary mouse antibodies: porcine-PECAM-1 (diluted 1:75), or rabbit 
inducible nitric oxide synthase (iNOS) (diluted 1:100).  The sections were then 
washed in phosphate buffer solution, incubated for 10 min with biotinylated anti-
mouse antibody in 10% NGS (Vectastain ABC Kit), washed in phosphate buffer 
solution, incubated for a further 5 min with ABC (avidin-biotin-peroxidase) 
reagent in phosphate buffer solution and, finally, washed again. Immunoreactive 
CD31 and iNOS were visualized by incubating the sections in Vector Red 
substrate (1 drop of levamisole solution to 5 ml of 200 mM Tris-HCl pH 8.2) for 
30 min. Finally, sections were dehydrated and cover-slipped with DPX mounting 
medium.  The observation and photographs were made using a light microscope 
(Leica DM4000B) and an imaging digital camera.  Images were obtained using 
Openlab (improvision, UK). 
 
3.3 Solutions and drugs 
The composition of K-H solution was (in mM): NaCl, 118; KCl, 4.8; 
MgSO4.7H2O, 1.2; CaCl2.2H2O, 1.3; NaHCO3, 25.0; KH2PO4, 1.2. Benzyl 
penicillin, streptomycin sulphate, ficoll, LPS (Eschericha coli O III: B4), Bay 11-
7082 ((E)-3(4-methylphenylsulfonyl)-2-propenenitrile), sulphanilamide, N-(1-
napthyl)-ethylene-diamine dihydrocholoride and quercetin dehydrate were all 
obtained from Sigma-Aldrich Company Ltd (Poole, Dorset, UK). Substance P 
was obtained from Bachem (UK). U46619 was obtained from Alexis Coporation 
Chapter 3 
 
- 86 - 
 
(Nottingham, UK). 1400W was obtained from Tocris Cookson Ltd (Avonmouth, 
UK). Dexamethasone sodium phosphate was purchased from Organon 
(Cambridge, UK).  Dulbecco,s Modified Eagle,s Medium (DMEM) was 
supplemented with antibiotics (see above) and 2 mM L-glutamine (Gibco). The 
metabolites of quercetin, quercetin-¶-sulphate and quercetin-3-glucuronide, were 
prepared at the Institute of Food Research, Norwich (Needs and Kroon, 2006). 
Antibodies against rabbit iNOS (Santa Cruz Botechology, Santa Cruz, Califonia, 
USA) and mouse anti porcine CD31 (MCA1747, Serotec, Kidlington, UK) were 
also obtained. Quercetin, Bay 11-7082 and quercetin metabolites were dissolved 
in 100% DMSO at a concentration of 10mM (< 0.1% DMSO in final incubation 
medium), whereas dexamethasone was dissolved in absolute ethanol at a 
concentration of 10mM, all other drugs were dissolved in distilled water. 
 
3.4 Data analysis and statistics 
Contractions produced by U46619 and KCl were measured as milliNewtons force 
(mN). Responses were expressed as the maximum contraction (Emax), and potency 
determined as the negative logarithm of the concentration causing 50% of the 
maximum response (-log EC50 or pD2) using a logistic equation (Kaleidagraph, 
version 3.6 Synergy Software). The values are shown as the mean (± sem). The 
content of nitrite ions in the medium was calculated according to the equation 
deduced from the standard curve. The amount of nitrite ions in the medium was 
then divided by the wet weight of tissues to obtain the amount of nitrite ion 
production from each segment in the unit of nmoles per mg wet weight.  In the 
majority of instances differences between mean force developed (mN) in 
segments from the same animal were assessed by a paired Student¶s t-test (two-
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tailed).  When responses were normalised, relative to either the maximum 
contractile response in the corresponding control segment, or pre-existing tone 
(dilator responses), then difference were assessed using a Wilcoxon test.  Where 
there was more than one treatment condition assessed differences were analysed 
by ANOVA followed by post-hoc Dunnett¶s test. A p value < 0.05 was considered 
statistically significant.
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3.5 Results 
3.5.1 Contraction Studies 
OYHUQLJKW LQFXEDWLRQ RI VHJPHQWV ZLWK HLWKHU ȝ0 TXHUFHWLQ DORQH RU 0
myricetin alone (followed by subsequent removal) was associated with a 
significant reduction, 18.6±3.7% (n=21) and 39.3±3.3% (n=7), respectively, in 
the contractions elicited by KCl (see Table 3.1).  Responses to U46619 were also 
significantly reduced by 25.6±5.6% (n=7), following overnight exposure to 10µM 
myricetin alone (Table 3.1).  Although exposure to 10µM quercetin did not 
significantly affect U46619-induced contractions (Table 3.1), substance P-
induced relaxations were significantly reduced.  Similarly, following overnight 
co-incubation of segments with 10µM Bay 11-7082, a selective inhibitor of NFNB 
(and subsequent removal), the maximum response to KCl and U46619 were 
significantly reduced with no alteration in the potency (Table 3.1). Table 3.1 also 
shows that overnight exposure to 1µM quercetin did not affect either KCl or 
U46619-induced contractions or substance P-induced relaxations.  
  
KCl and U46619 elicited concentration-dependent contractions of the porcine 
coronary artery (Figure 3.1a and 3.1b), with a potency (pD2) of 1.59±0.01 (n=11) 
and 7.96±0.05 (n=11), respectively.  Overnight exposure of the porcine coronary 
DUWHU\ WR ȝJPO LPS significantly reduced the maximum response to KCl to 
68.8.±3.1% (n=11) of control without significantly altering the potency (pD2 
1.55±0.02).  Similarly, the maximum response to U46619 was reduced to 
71.4±2.1% (n=11) of control with no alteration in the potency (pD2 ± 7.89±0.07). 
Following overnight co-incubation of segments with LPS and 10µM Bay 11-7082 
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(and subsequent removal), submaximal and maximal responses to both agonists 
were significantly increased (Figure 3.1), with the maximum contractions 
equivalent to 84.9±3.1% (KCl) and 89.8±2.6% (U46619) of the control responses 
(Figure 3.1). The potency of the agonists was not altered (data not shown).  As 
shown in Figures 3.1c and 3.1d, LPS-induced suppression of the maximum 
responses to KCl (31.9±4.5%, n=12) and U46619-induced contractions 
(28.9±12.4%, n=12) were abolished following post-incubation exposure to 10µM 
1400W, a selective inhibitor of inducible nitric oxide synthase.    
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Figure 3-1 The effect of overnight exposure of the porcine coronary artery to ȝJ
mL-1 LPS with or without 10µM Bay 11-7082 on (a) KCl- and (b) U46619-
induced contraction and 10µM 1400W on (c) KCl and (d) U46619-induced 
contraction. The responses shown are as mean ± SEM of 11-12 observations. *- 
(p <0.05) denote a statistically significant difference between the responses for 
the paired LPS-treated preparations. 
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Table 3-1 Effect of Bay 11-7082, quercetin and myricetin on the maximum response 
(mN) and potency (pD2) of KCl and U46619 contractions and SP-induced relaxation 
in isolated porcine coronary arteries incubated for 16 h in modified Krebs-Henseleit 
solution. Values shown are the mean ± SEM of 7-21 observations. 
 
 
KCl U46619 SP 
Max (mN) pD2 Max (mN) pD2 % 
relaxation 
Control 
(n=11) 1015±4.3 1.59±0.01 96.8±2.3 7.96±0.04 Nd 
10µM 
Bay 11-
7082 
83.5±3.3** 1.57±0.02 86.1±2.0** 7.91±0.08 Nd 
Control 
(n=21) 124.6±9.2 1.54±0.02 120.6±9.6 7.67±0.07 37.1±4.9 
10µM 
Quercetin 98.1±6.7** 1.62±0.03 109.8±6.7 7.88±0.06 24.1±3.1** 
Control 
(n=7) 121.6±7.3 1.68±0.04 110.8±6.4 8.11±0.08 16.7±7.6 
10µM 
Myricetin 73.5±5.2** 1.68±0.01 82.6±7.2** 7.97±0.08 7.2±1.4 
Control 
(n=8) 94.4±6.3 1.54±0.02 93.2±4.1 8.01±0.03 38.8±2.0 
1µM 
Quercetin 9.63±0.64 1.52±0.02 9.50±0.42 8.01±0.03 35.2±2.5 
 
*- (p <0.05) and **- (p < 0.01) denote a statistically significant difference from 
the paired control preparation.  
nd ± denotes not done 
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Overnight co-LQFXEDWLRQRISRUFLQHFRURQDU\DUWHU\VHJPHQWVZLWKȝJP/-1 LPS and 
10µM quercetin (and subsequent removal) increased responses to both KCl and 
U46619 compared to that of LPS alone (Figure 3.2).  In contrast, overnight 
incubation with 10µM myricetin did not affect LPS-induced inhibition of KCl and 
U46619-induded contractions (Figure 3.2).  At the end of the U46619 concentration 
responses curve the addition of 10nM substance P produced a transient relaxation 
(25.9±5.6%, n=13) in control preparations (see also Table 3.1) that was significantly 
reduced (p <0.01) following LPS-treatment (9.1±2.0%, n=13).  As shown in Table 
3.2, the inhibitory effect of LPS on substance P-induced relaxations was prevented 
by co-incubation with 1µM and 10µM quercetin. In contrast, substance P-induced 
relaxations were not significantly different between segments incubated overnight 
ZLWKHLWKHUȝJP/-1 /36RUȝJP/-1 LPS and 10µM myricetin (Table 3.2).  
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Table 3-2 Effect of quercetin, myricetin and Bay11-7082 compound on the 
maximum response (mN) and potency (pD2) of KCl and U46619 contractions and 
SP-induced relaxation in isolated porcine coronary arteries incubated for 16 h in 
modified Krebs-+HQVHOHLW VROXWLRQ LQ WKH SUHVHQFH RI ȝJ P/-1 LPS. Values 
shown are the mean ± SEM of 7-26 observations. 
 
 
KCl U46619 SP 
Max 
(% control) pD2 
Max 
(% control) pD2 
% 
Relaxation 
LPS (n=13) 60.1±3.5 1.62±0.03 71.2±3.4 7.72±0.06 9.35±1.9 
LPS 
10µM 
Quercetin 
85.8±4.68* 1.57±0.04 83.5±6.5* 7.87±0.08* 22.5±3.9* 
LPS  (n=7) 58.6±5.9 1.64±0.04 70.3±4.4 7.89±0.06 5.4±0.6 
LPS 
10µM  
Myricetin 
65.9±8.2 1.59±0.04 66.3±7.8 7.97±0.08 9.1±3.0 
LPS (n=26) 62.6±3.0 1.59±0.03 77.6±3.4 7.72±0.03 8.6±1.4 
LPS 
1µM 
Quercetin 
95.0±4.7** 1.60±0.02 110.0±7.4** 7.84±0.03* 23.6±3.4** 
LPS (n=13) 64.0±4.8 1.53±0.04 75.5±3.4 7.73±0.04 7.9±2.0 
LPS 
0.1µM 
Quercetin 
83.7±5.8** 1.57±0.03 90.8±5.6* 7.92±0.05* 12.0±3.4 
LPS (n=10) 
1µM 
Quercetin 
85.3±2.0 1.62±0.02 87.3±3.6 7.99±0.03 32.5.0±5.2 
LPS 
1µM 
Quercetin 
10µM Bay 
11-7082 
79.5±5.3 1.65±0.02 79.5±5.7 7.96±0.04 25.4±4.0 
 
*- (p <0.05) and **- (p < 0.01) denote a statistically significant difference from the 
paired LPS preparation or the paired LPS & 1µM quercetin preparation. 
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Figure 3-2 The effect of overnight exposure of the porcine coronary artery to ȝJ
mL-1 LPS, in the presence or absence of either (a, b) 10µM quercetin or (c, d) 
10µM myricetin, on responses elicited by KCl and U46619. The responses shown 
are as mean ± SEM of 7-13 observations *- (p <0.05) denote a statistically 
significant difference between the responses for the paired LPS-treated 
preparations. 
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Figure 3.3 shows that porcine coronary artery segments exposed overnight to a 
FRPELQDWLRQRI0TXHUFHWLQZLWKȝJP/-1 /36RU0TXHUFHWLQZLWKȝJP/-
1 LPS, elicited larger contractions to both KCl and U46619 compared with segments 
H[SRVHGWRȝJP/-1 /36DORQH3ULRUH[SRVXUHWRȝ0RUȝ0TXHUFHWLQSUHYHQWHG
WKH LQKLELWRU\ HIIHFW RI ȝJ P/-1 LPS on substance P-induced relaxation and was 
associated with a small increase in the potency of U46619 (Table 3.2).   The 
impairment of .&O DQG 8 UHVSRQVHV FDXVHG E\ ȝJ P/-1 LPS was also 
VLJQLILFDQWO\UHGXFHGE\SULRUH[SRVXUHWRHLWKHUȝ0TXHUFHWLQ-¶-sulphate or 10 
ȝ0 TXHUFHWLQ-3-glucuronide (Figure 3.4).  Similarly, substance P-induced 
relaxations following exposure to LPS were significantly larger when preparations 
were co-incubated with the metabolites (LPS 20.3±5.7 vs. quercetin-3`-sulphate 
49.5±4.8, n=8) and (LPS 10.03±4.5 vs. quercetin-3-glucuronide 30.9±8.7, n=10).  
Figure 3.5 shows that while both 1µM quercetin and a combination of 1µM 
quercetin and 10µM Bay K 11-7082 were able to oppose the inhibitory effect of LPS 
on constrictor responses and endothelium-dependent relaxations, there was no 
difference between the two conditions (see Table 3.2). 
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Figure 3-3 The effect of overnight exposure of the porcine coronary artery to ȝJ
mL-1 LPS, in the presence or absence of either (a, b) 0.1µM quercetin or (c, d) 
1µM quercetin, on responses elicited by KCl and U46619. The responses shown 
are as mean ± SEM of 13-26 observations. *- (p <0.05) denote a statistically 
significant difference between responses for the paired LPS-treated preparations. 
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Figure 3-4 The effect of overnight exposure of the porcine coronary artery to ȝJ
mL-1 LPS, in the presence or absence of either (a, b) 10µM quercetin-3`-sulphate 
or (c, d) 10µM quercetin-3-glucuronide, on responses elicited by KCl and 
U46619. The responses shown are as mean ± SEM of 8-10 observations. *- (p 
<0.05) denote a statistically significant difference between responses for the 
paired LPS-treated preparations.  
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Figure 3-5 The effect of overnight exposure of the porcine coronary artery to 
ȝJPO/36LQWKHSUHVHQFHRUDEVHQFHRIHLWKHU0TXHUFHWLQRU0TXHUFHWLQ
and 10µM Bay K 11-7082 on responses to either (a) KCl or (b) U46619. The 
responses are shown as the mean ± SEM of 10 observations and significant 
differences between the maximum responses in preparations treated with LPS are 
shown as * (p < 0.05) or ** (p <0.01) based on ANOVA followed by Dunnett 
post-hoc test. 
 
Chapter 3 
 
- 99 - 
 
3.5.2 Nitrite accumulation 
Following overnight storage in DMEM control segments of the porcine coronary 
artery produced between 3 to 30 nmol nitrate/nitrite per mg wet weight.  Exposure to 
ȝJP/-1 LPS was associated with a 5 to 20-fold increase in the production of nitrite 
ions by the coronary artery (Table 3.3).  Co-incubation of the porcine coronary artery 
with either 10µM 1400W or 1µM Dexamethasone reduced the LPS response by 
77.6±5.3% (n=12) and 70.9±4.8% (n=12), respectively, while 10µM Bay 11-7082 
abolished the response (Table 3.3).  
While prior exposure to 10µM quercetin caused a significant 89.6±4.4% (n-12) 
reduction in LPS-induced nitrite production (Figure 3.7a), exposure to 10µM 
myricetin did not affect LPS-induced increase in nitrite production (Figure 3.7b). 
Table 3.3 shows that prior incubation with either 0.1µM and 1µM quercetin reduced 
LPS-induced nitrite production by 50.0±12.5% (n=9) and 73.1±12.0% (n=16), 
respectively. Similarly, exSRVXUHWR0TXHUFHWLQ¶-sulphate and 10µM quercetin 
3-glucuronide significantly reduced LPS-induced production by 77.0±5.9% (n=11) 
and 91.6±4.8% (n=11), respectively (Figure 3.8). 
 
3.5.3 Immunohistochemistry 
Evidence for the induction of nitric oxide synthase was provided by 
immunohistochemical examination of the porcine coronary artery.  Figure 3.6 shows 
that control preparations express CD31 on endothelial cells but no evidence of 
LQGXFLEOH QLWULF R[LGH V\QWKDVH 6HJPHQWV WUHDWHG RYHUQLJKW ZLWK ȝJ PL-1 LPS 
exhibited increased expression of endothelial CD31 and the appearance of inducible 
nitric oxide synthase in the tunica adventitia (but not the tunica media). Co-
incubation with 10µM quercetin reduced LPS-induced expression of endothelial 
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CD31 and adventitial nitric oxide synthase (Fig 3.6). Similar observations were 
noted in three other preparations of the coronary artery. 
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Figure 3-6 Immunohistochemical localization of (upper panels) PECAM-1 
(CD31) and (lower panels) inducible nitric oxide synthase (iNOS) in the porcine 
isolated coronary artery following incubation in modified Krebs-Henseleit 
solution for 16-18 hours at 37oC without (Control) or with either ȝJP/-1 LPS or 
ȝJP/-1 LPS and 10µM quercetin (quercetin added 60 min before LPS). 
Evidence for the presence of these proteins in either the endothelium or tunica 
adventitia is shown the presence of red staining either 100µm or 50µm. 
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Figure 3-7 7KH HIIHFW RI  KRXU H[SRVXUH WR ȝJPO /36 D ȝJ P/-1 
LPS plus 10µM quercetin and (b) 1µg/ml LPS plus 10µM myricetin on 
nitrite production in porcine coronary artery segments incubated in DMEM. 
The responses shown are the mean ± SEM of 8-12 observations. ** (p 
<0.01) denotes significance difference from control preparations based on 
ANOVA followed by Dunnett post-hoc test. 
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Figure  3-8 Effect of inhibitors of nitric oxide synthase and various flavonoids on 
nitrite production of the porcine isolated coronary artery incubated for 16 h in 
modified Krebs-Henseleit solution in the DEVHQFHRUSUHVHQFHRIȝJ P/-1 LPS. 
Responses shown are the mean ± SEM of 9-16 observations. ** (p <0.01) denotes 
significance difference from control preparations based on ANOVA followed by 
Dunnett post-hoc test. 
 
Q-S quercetin-3`-sulphate 
Q-G quercetin-3-glucuronides 
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Table 3-3 Effect of inhibitors of nitric oxide synthase and various flavonoids on 
nitrite production of the porcine isolated coronary artery incubated for 24 h in 
DMEM in the absence or presence oIȝJP/-1 LPS.  
 
Nitrite 
nmol/mg wet 
wt (n=12) 
Nitrite 
nmol/mg wet 
wt (n=12) 
Nitrite 
nmol/mg wet 
wt (n=9) 
Nitrite 
nmol/mg wet 
wt (n=16) 
Control 7.4±3.2 5.5±0.9 17.8±7.6 21.1±6.7 
LPS 99.8±10.6 32.5±0.5 138±29.1 105±18.8 
LPS & 
Flavonoid or 
Inhibitor 
 
30.8±3.3** 
(10µM 
1400W) 
6.4±0.9** 
(10 µM Bay 
11-7082) 
 
70.6±20.0** 
(0.1µM 
Quercetin) 
37.4±10.2** 
(1µM 
Quercetin) 
LPS & 
Flavonoid or 
Inhibitor 
33.1±5.6** 
(1µM 
'H[DPHWK¶ 
   
 
Values shown are the mean ± SEM of 9-16 observations. *- (p <0.05) and **- (p < 
0.01) denote a statistically significant difference from the LPS preparation (paired 
6WXGHQW¶VW-test) or ANOVA with a post-hoc Dunnett test.  
Dexameth ± Dexamethesone.  
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In light of the observations that quercetin, but not myricetin, reduced LPS-induced 
nitrite production in the coronary artery (Figure 3.7), I also examined the effect of 
prior exposure to 10µM myricetin against the inhibitory effect of 1µM quercetin.  
Figure 3.9 shows that 1µM quercetin alone reduced LPS-induced nitrite production 
by 88.4±2.4% (n=12) but was weakly active (23.6±17.1% reduction) in the 
presence of 10µM myricetin.    
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Figure 3-9 The effect of 24 hour exposure to ȝJ P/-1 LPS, ȝJ P/-1 LPS plus 
1µM quercetin (Quer) and 1µg/ml LPS with a combination of 10µM myricetin 
(Myr) and 1µM quercetin on nitrite production in porcine coronary artery segments 
incubated in DMEM. The values shown are the mean ± SEM of 12 observations. * 
(p<0.05) denotes a significant difference from control by ANOVA followed by 
Dunnette post±hoc test. 
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3.6 Discussion 
The principal observation in this study is that quercetin and its metabolites, 
TXHUFHWLQ ¶-sulphate and quercetin 3-glucoronide, inhibit key inflammatory 
changes in the porcine isolated coronary artery induced by prolonged exposure to 
lipopolysaccharide.  The basis of this potentially beneficial effect of the flavonoid 
can be largely attributed to prevention of the induction of nitric oxide synthase. 
 
3.6.1 LPS-induced changes in the porcine coronary artery 
Prolonged exposure of the coronary artery to LPS induced a significant reduction in 
contractile responses to both KCl and U46619, with a slightly greater effect against 
the former, and an impairment of endothelium-dependent relaxations to substance 
P.  The effect of LPS on contractile responses is qualitatively similar to that noted 
in other studies (Gibreal et al., 2000; Piepot et al., 2000 ), but was not accompanied 
by a reduction in the potency of either agonist. In the case of substance P-induced 
relaxations, suppression of endothelium-dependent responses by LPS has been 
previously reported for the porcine coronary artery (Qi et al., 2007). 
  
The above changes in vascular responsiveness were accompanied by increased 
production of nitrite ions (as determined by the Griess reaction) and 
immunohistochemical evidence for induction of nitric oxide synthase in the blood 
vessel.  The adventitial location for inducible nitric oxide synthase in the coronary 
artery is similar to that reported in the rat aorta (Kleschyov et al., 1998), where 
exposure to LPS caused a 4 to 10-fold greater activity for nitric oxide production in 
the tunica adventitia compared to the tunica media.  Pharmacological evidence for a 
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link between the biochemical and contractile changes detected was provided by the 
finding that post-incubation exposure to 1400W, a selective inhibitor of inducible 
nitric oxide synthase (Garvey et al., 1997b), reversed the impairment of contractile 
responses in the porcine coronary artery by LPS and reduced nitric oxide 
formation.  Since the effect of 1400W on LPS-induced changes in the coronary 
artery were mimicked by inhibition of NFNB (with Bay 11-7082) it would appear 
that activation of this pathway precedes induction of nitric oxide synthase, as 
described in macrophages (Chen et al., 2005).       
 
3.6.2 The effect of quercetin and quercetin metabolites 
4XHUFHWLQ TXHUFHWLQ ¶VXOSKDWH DQG TXHUFHWLQ -glucuronide suppressed LPS-
induced changes in contractile responses and the elevation in nitric oxide 
production in the coronary artery, with the aglycone exhibiting activity at 
concentrations as low as 0.1µM.  The effect on contractile responses is qualitatively 
similar to that reported for eritoran, a Toll-like receptor 4 antagonist, against LPS 
in rat aortic segments (Ehrentraut et al., 2007), which suggests that these 
flavonoids may have therapeutic  potential. In the case of quercetin, 
immunohistochemical evidence was also obtained that this effect was due to 
suppression of the induction of nitric oxide synthase in the tunica adventitia; which 
excludes the possibility of a direct inhibitory effect on the enzyme (cf. 1400W).  
Thus, the effect of quercetin is comparable to that observed for dexamethasone on 
nitric oxide production, which suggests an action primarily on the expression of the 
enzyme (Korhonen, 2002).  Quercetin has been reported to inhibit LPS-induced 
nitric oxide production in various non-vascular cells, including RAW 264.7 
macrophages (Chen et al., 2001), J774.1 macrophages (Hamalainen et al., 2007; 
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Raso et al., 2001) and mouse BV-2 microglia (Chen et al., 2005).  Crucially, 
however, the potency of quercetin in the porcine isolated coronary artery is 
approximately 10-30-fold greater than that noted in cultured cells, where it is 
typically > 3µM.  The efficacy of quercetin and its metabolites in this vascular 
model stands in marked contrast to that of myricetin, which failed to modify LPS-
induced suppression of contractile responses.   
 
Quercetin-induced changes of nitric oxide production superficially mirrors the 
effects observed on LPS-induced suppression of contractile responses.  While this 
point is reinforced by the lack of effect of myricetin on LPS-induced nitrite/nitrate 
production, the precise relationship between biochemical events and functional 
changes is clearly complex.  The highest concentration of quercetin examined 
(10µM) significantly impaired vasoconstrictor responses and substance P-mediated 
relaxations per se (see: Table 3.1). Thus, the overall effect of 10µM quercetin on 
LPS-induced changes in contractile responses is the sum of two opposing actions 
and less than that observed with 1µM quercetin - but comparable to that noted for 
the overall effect of 0.1µM quercetin. Also, it remains a possibility that the overall 
effect of LPS on contractile responses is product of the induction of several 
inflammatory mediators rather than just nitric oxide (see: (Qi et al., 2007).  
 
It is well recognised that a key mediator of inflammatory responses in cells is the 
translocation of nuclear factor-NB (NFNB) from the cytoplasm to the nucleus and 
activation of numerous genes, including those for nitric oxide synthase and pro-
inflammatory cytokines (Liu and Malik, 2006). In the case of endothelial and 
vascular smooth muscle cells NFNB has been linked to increased expression of cell 
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adhesion molecules (Read et al., 1994), the induction of nitric oxide synthase 
(Hattori et al., 2003) and associated with development of early atherosclerotic 
lesions (Hajra et al., 2000). Thus, stabilization of the NF-NB/INB complex in the 
coronary artery could explain the protective effect of quercetin against LPS-
induced changes in contractile responses, nitric oxide production and the 
expression of PECAM-1 (CD31) found in this study.  This possibility is reinforced 
by the observation that a combination of quercetin and Bay K 11-7082, a known 
inhibitor of NFNB (Pierce et al., 1997) was no more effective against LPS-induced 
changes in the coronary artery than quercetin alone (see Figure 3.4), yet neither 
condition completely prevented the inhibitory effect of LPS. While the precise 
molecular target for this beneficial effect of quercetin was not investigated, the 
failure of myricetin to mimic the effect of quercetin on LPS-induced nitric oxide 
SURGXFWLRQ DQG WR DOVR µDQWDJRQLVH¶ WKH HIIHFW RI TXHUFHWLQ VHH )LJure 3.7), 
indicates that these structurally-related flavonoids may prove useful in further 
studies. It is noteworthy that the lack of effect of myricetin on inflammatory 
responses in the coronary artery is not a selective effect for the vasculature.  
Blonska and colleagues (2003) noted that quercetin and kaempferol were capable 
of inhibiting LPS-induced production of IL-1E in RAW 264.7 cells but myricetin 
was inactive (Blonska et al., 2003).   
 
Although the potency of the flavonoids against inflammatory events in the 
coronary artery is greater than that reported in macrophages, suggesting a selective 
action on the vasculature, the physiological relevance remains unclear. Quercetin is 
extensively metabolised in man and the concentrations used in this study exceeded 
the peak plasma levels of the aglycone (0.03µM) and the metabolites (3µM) 
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detected following dietary ingestion (Kroon et al., 2004; Wang and Morris, 2005).  
However, two recent studies raise the possibility that flavanoids can be either 
generated in situ from metabolites accumulated in activated cells (Kawai et al., 
2008a) or even preferentially concentrated in cells (Kawai et al., 2008b), 
potentially reducing the threshold for physiological significance.  Nonetheless, 
further studies on human blood vessels with lower concentrations of quercetin and 
the metabolites are warranted.  In light of the striking difference between the effect 
of quercetin and myricetin on the porcine coronary artery, there is also a need to 
establish whether myricetin can inhibit the effect of quercetin in human vascular 
FHOOVHIIHFWLYHO\EHKDYLQJDVDQµDQWDJRQLVW¶ 
 
The finding that quercetin can oppose the proinflammatory effect of LPS on the 
vasculature may also hold therapeutic significance.  Recently, quercetin has been 
shown to attenuate both the release of pro-inflammatory cytokines in response to 
LPS in mice and the associated lethality (Teng et al., 2009).  Significantly, this 
effect of quercetin was manifest even when administered several hours after 
exposure to LPS, suggesting the possibility that a similar mechanism may occur in 
the vasculature.  
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3.7 Conclusion 
In conclusion I have demonstrated that one of the major dietary flavonoids, 
quercetin, and its principal human metabolites oppose pro-inflammatory events in 
both endothelial cells and vascular smooth muscle cells. These effects of quercetin 
are evident at lower concentrations than previously reported in studies using other 
cell types and suggests a selective action on the vasculature, particularly against the 
induction of nitric oxide synthase.  Further studies on human blood vessels are 
warranted to establish whether these observations are relevant to the well-
documented beneficial effects of dietary flavonoids (Boots et al., 2008; Halliwell, 
2007). 
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4.1 Introduction 
Catechins are present in various species of plant, including the green tea plant, and 
they are known to exhibit potent anti-inflammatory, anti-oxidative and anti-
carcinogenic effects (Beecher et al., 1999; Ishikawa et al., 1997; Junkun et al., 1997; 
Yang et al., 2001). Epidemiological studies have suggested that the intake of 
catechins correlates with risk reduction for coronary heart disease (Arts et al., 2001; 
Knekt et al., 2002). It has been reported that green tea consumption is associated 
with reduced mortality due to all causes and specifically due to cardiovascular 
diseases (Kuriyama et al., 2006; Suzuki et al., 2009). Interestingly, data from a 
population-based cohort study of 1,169 patients linked chocolate consumption with 
decreased mortality after myocardial infarction (MI) (Janszky et al., 2009). 
Furthermore, Ikeda and colleagues showed that habitual  ingestion of green tea 
catechins from an early age prevented the development of spontaneous stroke in rat, 
probably by inhibiting the further development of high blood pressure at late ages 
(Ikeda et al., 2007). A prospective cohort study (Zutphen Elderly study) also 
provided evidence for a primary protective effect of flavanols (Buijsse et al., 2006; 
Hertog et al., 1993; Streppel et al., 2009). 
 
Catechins belong to the flavan-3-ol class of flavonoids. The major tea catechins are 
epigallocathechin-3 gallate (EGCG), epigallocathechin (EGC), and epicathechin-3 
gallate (ECG). Recent research has shown that inflammation plays a key role in 
coronary artery diseases (CAD) and other manifestations of atherosclerosis 
(Hansson, 2005). Epigallocatechin gallate has been particularly well studied and has 
been shown to modulate the secretion of a range of pro-inflammatory mediators 
implicated in the development of cardiovascular conditions. For example, EGCG has 
Chapter 4 
 
- 115 - 
 
been reported to inhibit lipopolysaccharide-induced TNF-Į SURGXFWLRQ LQ PRXVH
macrophages (Yang et al., 1998b), the induction of inducible nitric oxide synthase in 
mouse macrophages (Lin and Lin, 1997) and IL-8 production by human 
keratinocytes (Tang and Meydani, 2001) or endothelial cells, (Chen et al., 2002; 
Tronperzinski et al., 2003). Al-Hanbali and colleagues (2009) reported that 
epicatechin suppresses IL-6, IL-8 and enhances IL-10 production with NF-kappaB 
nuclear translocation in a whole blood stimulated system. 
 
The possible anti-inflammatory activity of the green tea catechins may, in large part, 
be accounted for by their antioxidant actions. EGCG has been found to inhibit the 
activity of the transcription factors AP-1 and NF-kappa B, both of which may 
mediate many inflammatory processes and both of which may be activated by 
reactive oxygen species. These effects are induced by the suppression of 
inflammatory factors including nuclear factor-kappa B (NF-ț% D PXOWLSRWHQWLDO
promoter of inducible nitric oxide synthase (iNOS) and adhesion molecules (Yang et 
al., 2001). Moreover, it has been demonstrated that epigallocatechin-3-gallate blocks 
the induction of nitric oxide synthase by down-regulating lipopolysaccharide-
induced activity of transcription factor nuclear factor-kB (Lin and Lin, 1997 ).  
 
In contrast to the beneficial effects of catechins on vascular homeostasis described 
above,  some studies reported that catechins can exert contractile effects in rat aorta 
and impair endothelium-dependent vasorelaxation (Sanae et al., 2002; Shen et al., 
2003). It was proposed that the inhibition of vasorelaxation by catechins could be 
due to inactivation of endothelium-derived NO (Sanae et al., 2002).  
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While the characteristics of the effects of green tea catechins have been well 
documented in various cell lines (Benelli et al., 2002), there is much less 
information regarding their acute effect on isolated blood vessels and relatively little 
information regarding their ability to modulate inflammatory events in the 
vasculature. Recent studies with flavonoid-containing beverages suggest that 
the benefits of these nutrients may relate, in part, to improved endothelial function. 
For example, Widlansky and colleagues  found that acute epigallocatechin gallate 
supplementation improves endothelial function in humans with coronary heart 
disease (Widlansky et  al., 2007). Additionally, it was reported that epicatechin has 
vasorelaxant effects in rat mesenteric artery (Huang et al., 1998) and in rat aorta 
(Andriambeloson et al., 1998; Benito et al., 2002) through the enhancement of nitric 
oxide production (Huang et al., 1999). Previous work in this lab found that acute 
exposure to quercetin caused endothelium-independent relaxation of porcine 
coronary artery that was associated with a selective enhancement of responses 
involving elevation of cyclic GMP (Suri et al., 2010). Recently we have 
demonstrated that prolonged incubation with quercetin and two of its metabolites, 
quercetin-3`-sulphate and quercetin-3-glucuronide, inhibited the LPS-induced 
changes in endothelial and vascular responses and the elevation of nitrite ion 
production in porcine coronary artery (chapter 3). Therefore, the aim of this chapter 
is to investigate the effects of flavanol type flavonoids (catechins, epicatechin and 
epigallocatechin gallate) on the vascular reactivity and the generation of nitric oxide 
of porcine isolated coronary artery exposed to LPS in vitro.  
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4.2 Material and Methods 
Porcine hearts were obtained from a local abattoir and transported to the laboratory 
in ice-cold Krebs-Henseleit bicarbonate buffer (K-H) solution within one hour. The 
anterior branch of the porcine coronary artery 5 mm length, 2-3 mm internal 
diameter was dissected and cleaned of fat and connective tissues.  
 
4.2.1 Contraction Studies 
For contraction experiments, single segments of the porcine coronary artery were 
incubated in 2ml K-H solution (previously gassed with 95% O2 and 5% CO2 for 5 
PLQ FRQWDLQLQJ  ILFROO DQG D FRPELQDWLRQ RI ȝJPO benzyl penicillin and 
ȝJPOVWUHSWRP\FLQVXOSKDWH and 10% FCS. The inclusion of ficoll in the bathing 
medium was to prevent swelling of the tissue. 7KHVROXWLRQDOVRFRQWDLQHGȝJP/-1 
LPS, various catechins or a combination of LPS and the flavanol (added 60 min 
before LPS) and then sealed in a sterilized glass vial and stored overnight at 37°C 
for 16-18 h.  In some experiments the effect of various concentrations of epicatechin 
in the presence of LPS were examined. Unless, indicated otherwise, all experiments 
were conducted on nominally endothelium-intact segments of the coronary artery. In 
all instances the segments were effectively paired so that each experimental 
condition had a control segment taken from the same animal. 
 
  
On the following day, segments were taken out of the incubation solution and 
prepared for isometric tension recording as described in Chapter 2. After repeated 
exposure to 60mM KCl to establish the reproducibility of responses, each 
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preparation was exposed to cumulative concentrations of potassium chloride (KCl, 
6-60mM), and then to the stable thromboxane mimetic analog,9,11-dideoxy-11a,9a-
epoxymethanoprostaglandin F2Į 8 -200nM) to evaluate the constrictor 
response of the tissue. After attainment of a stable response, the segments were then 
exposed to a single concentration of substance P (10nM). 
 
4.2.2 Nitrite Determination 
For the measurement of nitrite ion accumulation, a marker for nitric oxide 
production (Kelm 1999), two 5mm segments were incubated in each vial for 24 hr 
with aerated DMEM (without phenol red) containing 10% FCS, 1mM L-arginine, 
ȝJPO EHQ]\O SHQLFLOOLQ DQG ȝJPO VWUHSWRP\FLQ 7KH VHJPHQWVZHUH H[SRVHG
HLWKHUWRȝJP/-1 LPS, a flavanol, or combination of LPS and flavanol, as described 
DERYH 6RPH SUHSDUDWLRQV ZHUH DOVR H[SRVHG WR HLWKHU ȝ0 P\ULFHWLQ or 
FRPELQDWLRQ RI  ȝ0 HSLFDWHFKLQ DQG 0 VLPYDVWDWLQ IRU  KU LQ WKH
SUHVHQFHRIȝJP/-1 LPS. After the incubation period, the segments were removed, 
briefly blotted on paper cloth and weighed.  Nitrite ion accumulation in the 
incubation medium was determined by the Greiss reaction as previously described 
(Ukil et al., 2006).  Greiss reagent (500 µl of 1% sulphanilamide and 0.1% 
naphthylethylamine diamine in 5% hydrochloric acid) was added to 500µl of the 
incubation medium and optical density at 550 nm was measured, using a UNICAM 
UV/VIS spectrophotometer. A standard concentration-optical density curve was 
calculated for every assay using sodium nitrite solution against a blank (500µl 
DMEM & 500µl Griess Reagent). In a separate experiment we established that 
incubation of DMEM containing either the flavanol, LPS or a combination of both 
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(without the arterial segments) produced an optical density reading similar to the 
blank. The minimum detectable amount of nitrite was 375 nmoles.  
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4.3 Solutions and drugs  
The composition of Krebs-Henseleit solution is (mM): NaCl 118; KCl, 4.8; 
SO4.7H2O, 1.2; CaCl2 .2H2O, 1.3; NaHCO3, 25.0; KH2PO4, 1.2. Benzyl penicillin 
streptomycin sulphate, ficoll, LPS (Eschericha coli O III :B4) and the catechins were 
obtained from Sigma-Aldrich Company Ltd (Poole, Dorset, UK.). The catechins 
used were as follows; (+)-catechin, (+)-epicatechin and (-)-epigallocatechin gallate. 
Substance P was obtained from Bachem (UK). KCl (potassium chloride) and 
U46619 (9,11-dideoxy-11a,9a-epoxymethanoprostaglandin F2Įwere obtained from 
Alexis Corporation (Nottingham, UK.). DMEM was supplemented with antibiotics 
(see above) and 2 mM L-glutamine (Gibco). All drugs were dissolved in distilled 
water. 
 
4.4 Data analysis and statistics 
Contractions produced by KCl and U46619 were measured as milliNewtons force 
(mN). Responses were expressed as the maximum contraction (Emax), and potency 
determined as the negative logarithm of the concentration causing 50% of the 
maximum response (-log EC50 or pD2) using a logistic equation (Kaleidagraph, 
version 3.6 Synergy Software). The values are shown as the mean (±SEM). The 
content of nitrite ions in the medium was calculated according to the equation 
deduced from the standard curve. The amount of nitrite ions in the medium was then 
divided by the wet weight of tissues to obtain the amount of nitrite ion production 
from each segment, as nmoles/mg wet weight. In the majority of instances 
differences between mean force developed (mN) in segments from the same animal 
ZHUHDVVHVVHGE\DSDLUHG6WXGHQW¶V W-test (two-tailed). Where there was more than 
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one treatment condition assessed differences were analysed by ANOVA followed by 
SRVWKRF'XQQHWW¶VWHVW$S-YDOXHZDVFRQVLGHUHGVWDWLVWLFDOO\VLJQL¿FDnt. 
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4.5 Results 
4.5.1 The effect of catechins alone 
Prior to investigating the effects of the catechins on LPS-induced inflammatory 
changes in the coronary artery, it was necessary to establish the effect on vascular 
responsiveness of prolonged (overnight) exposure of the flavonoids. Table 4.1 shows 
that the overnight exposure of porcine isolated coronary artery to 10µM epicatachin 
(followed by subsequent removal) did not significantly changed the vascular 
response to KCl or U46619. In contrast overnight exposure to its isomer (10µM) 
catechin was associated with a significant reduction in the contractions of KCl and 
U46619 by 22.7±6.5%, (n=8) and 20.6±5.1%, (n=8), respectively without affecting 
the sensitivity to both agonists. Similarly, epigallocatechin gallate (EGCG) 
significantly affected the vascular response of the segments to KCl by 17.2±4.2%, 
(n=11) but its effect on the contractile response of U46619 failed to reach 
significance (p =  0.07), as determined by Student t-test. The three compounds did 
not significantly change the relaxant effect of substance P (Table 4.1). 
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Table 4-1 (IIHFW RI ȝ0 HSLFDWHFKLQ ȝ0 HSLJDOORFDWHFKLQ JDOODWH DQG ȝ0
catechin on the maximum response (mN) and potency (pD2) of KCl and U46619 
contractions and SP-induced relaxation in isolated porcine coronary arteries 
incubated for 16 h in modified Krebs-Henseleit solution.  
 
 KCl U46619 SP 
Max 
(mN) pD2 
Max 
(mN) pD2 % 
   Relaxation 
   Control 
     (n=12) 
 
     10µM 
 Epicatechin 
       111.6±5.9 
 
      104.8±8.8 
      1.58±0.03 
 
       1.57±0.03 
     104.8±6.3 
 
     97.95±8.8 
      7.97±0.1 
 
      7.82±0.1 
   37.5±5.5 
 
   31.6±7.3 
    Control  
      (n=11) 
 
      10µM  
      EGCG 
     130.3±8.8 
 
    108.7±10.2** 
     1.63±0.01 
 
    1.64±0.03 
   118.5±6.8 
 
     93.4±5.8 
      7.67±0.1 
 
      7.61±0.2 
   36.9±4.3 
 
    37.7±7.8 
      Control 
        (n=8) 
 
        10µM 
      Catechin 
    101.8±2.9 
 
      84.2±5.8** 
   1.39±0.09 
 
    1.45±0.06 
 105.3±1.3 
 
  84. 2±4.2** 
       7.8±0.1 
 
       7.8±0.04 
    72.6 ±4.7 
 
     70.9 ±6.1 
 
Values shown are the mean ± SEM of 8-12 observations. 
 **- (p < 0.01) denote a statistically significant difference from the paired control 
preparation.  
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4.5.2 Effect RI WKH FDWHFKLQV RQ ȝJ P/-1 LPS-induced changes in vascular 
responses of porcine coronary artery 
Figure 4.1 shows the cumulative response curves of KCl and U46619 in porcine 
LVRODWHG FRURQDU\ DUWHU\ WUHDWHG ZLWK ȝJ P/-1 LPS, a combination of 10µM 
epicatHFKLQ DQG ȝJ P/-1 LPS (figure 4.1a and 4.1b) or a combination of 10µM 
FDWHFKLQ DQG ȝJ P/-1 LPS (figure 4.1c and 4.1d), or a combination of 10µM 
HSLJDOORFDWHFKLQ JDOODWH DQG ȝJ P/-1 LPS (figure 4.1e and 4.1f). Overnight 
H[SRVXUHWRȝJP/-1 LPS significantly reduced the maximum responses to KCl and 
U46619 (to 71.3±4.9%, n=12 and 74.6±4.3% n=12, respectively, of control). 
Although exposure of the tissue to 10µM epicatechin alone failed to modify 
responses to either agonist (Table 4.1), co-incubation with 10µM epicatechin caused 
a significant increase in the contraction effects of KCl and U46619 (figure 4.1a and 
4.1b).  A significant reduction in the responses to 10nM substance P was noted in 
DUWHULDO VHJPHQWVH[SRVHGRYHUQLJKW WRȝJP/-1 LPS (Control 36.5±5.5% vs. LPS 
23.2±5.9% of U46619-induced tension, n=12). The inhibitory effect of LPS on 
substance P-induced relaxations was not observed if the segments were co-incubated 
with 10µM epicatechin (Table 4.2).  
 
Figure 4.1c and 4.1d shows that overnight exposure of the porcine isolated coronary 
DUWHU\ WR ȝJ P/-1 LPS caused an approximate 40% reduction in the maximum 
response to KCl and a 30% reduction in the maximum response to U46619. The 
addition of the 10µM catechin 60 min before LPS prevented the changes in vascular 
responses.  Substance P (10nM) caused 72.6±4.8%, (n=8) in control tissue, 
RYHUQLJKWH[SRVXUHWRȝJP/-1 LPS caused a significant reduction on the relaxation 
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induced by SP. However, the substance P-induced response was similar to the 
control in segments incubated with LPS and 10µM catechin (Table 4.2). 
 
 Figure 4.1e and 4.1f shows that overnight exposure of the porcine isolated coronary 
DUWHU\ WR ȝJ P/-1 LPS caused a 37±3.8%, (n=11) reduction in the maximum 
response to KCl and a 19±4.4% reduction in the maximum response to U46619. 
Attenuation of the responsiveness to KCl and U46619 in the segments exposed to 
LPS was prevented by co-incubation with 10µM EGCG. In terms of endothelium-
dependent relaxation, substance P caused a 37±4.2% relaxation in control segments; 
this relaxant effect was impaired to 23±3.1% in presence of LPS, however, the 
SUHVHQFHRIȝ0(*&*LQWKH LQFXEDWLRQPHGLXPSUHYHQWHGWKHLQKLELWRU\HIIHFW
of LPS on SP-induced relaxation (Table 4.2). 
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Figure 4-1 The effect of overnight exposure of the porcine coronary artery to 1 
µg·mL-1 LPS, in the presence or absence of either (a, b) 10µM epicatechin or (c, d) 
10µM catechin, or (e, f) 10µM EGCG on responses elicited by KCl and U46619. 
The responses shown are as mean ± SEM of 8±12 observations.  
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Figure 4.2a and 4.2b show that LPS caused a significant 3-10-fold increase in the 
production of nitrite in the porcine isolated coronary artery and this effect was 
reduced by prior exposure to either 10µM catechin or 10µM epicatechin. Although 
neither catechin nor epicatechin alone affected the control segments in nitrite 
content, both flavanols significantly reduced the amount of nitrite induced by LPS 
(catechin 99.1±2.7%, n=11) (epicatechin 87.6±25.2 %, n=16). 
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Figure 4-2  The effect of 24 h exposure to 1 µg·mL-1 LPS (a) 1 µg·mL-1 LPS plus 10 
µM catechin and (b) 1 µg·mL-1 LPS plus 10 µM epicatechin on nitrite ion 
production in porcine coronary artery segments incubated in DMEM. The values 
shown are the mean ± SEM of 11±16 observations. **p VLJQL¿FDQWGLIIHUHQFH
from control by ANOVA.  
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4.5.3 (IIHFW RI WKH HSLFDWHFKLQV RQ ȝJ P/-1 LPS-induced changes on porcine 
coronary artery 
As preliminary results showed that prolonged exposure to 10µM epicatechin alone 
did not change the vascular response to KCl and U46619 or the relaxant response to 
SP (Table 4.1), epicatechin was chosen to study in greater detail. 
 
Figure 4.3 shows that porcine coronary artery segments exposed overnight to a 
FRPELQDWLRQRI0HSLFDWHFKLQZLWKȝJP/-1 LPS, or to a combination of 0.1µM 
HSLFDWHFKLQZLWKȝJP/-1 /36RUWRDFRPELQDWLRQRI0HSLFDWHFKLQZLWKȝJ
mL-1 LPS elicited greater contraction to both KCl and U46619 compared to 
VHJPHQWV WKDWH[SRVHG WRȝJP/-1LPS alone. Additionally, prior exposure to low 
concentrations of epicatechin significantly inhibited the impairment effect of LPS on 
SP-induced relaxation (Table 4.2). 
 
Incubation of segments from porcine coronary artery in DMEM alone for 24 hrs 
produced about 30nmoles/mg wet weight tissue of nitrite ions in the incubation 
medium, wKLOH H[SRVXUH WR ȝJ P/-1 LPS caused a 4-fold increase in nitrite ion 
production. Pre-incubation of the segments with either 1µM epicatechin or 0.1µM 
epicatechin reduced the LPS-induced nitrite by 95.8±4.9%, (n=8) and 98.1±4.5%, 
(n=8) respectively (Figure 4.4). 
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Table 4-2 Effect RI   DQG ȝ0 eSLFDWHFKLQ  ȝ0 FDWHFKLQ DQG  ȝ0
epigallocatechin gallate (EGCG) on the maximum response (mN) and potency (pD2) 
of KCl and U46619 contractions and SP-induced relaxation in isolated porcine 
coronary arteries incubated for 16 h in modified Krebs-Henseleit solution in the 
SUHVHQFHRIȝJP/-1 LPS. 
 KCl U46619 SP 
Max 
(%control) 
 
     pD2 Max 
(% control) 
      pD2 
% 
  Relaxation 
      LPS  
    (n=12) 
      LPS            
     10µM 
Epicatechin 
   71.30±4.9 
109.3±10.55** 
1.52±0.03 
 
1.56±0.02 
       74.6±4.3 
 
      117.3±14.6* 
   7.74±0.07 
 
    7.83±0.05 
   23.17±5.9 
 
   38.7±0.01* 
      LPS  
   (n=14) 
 
LPS          
1µM  
Epicatechin 
        62.7±4.2 
      85.5±5.0** 
    1.58±0.01 
    1.57±0.03 
      55.0±3.9 
      87.6±6.1** 
    7.76±0.03 
   7.80±0.05* 
13.4±6.2 
 34.9±5.9** 
       LPS 
     (n=14) 
LPS          
0.1µM 
Epicatechin 
      62.7±4.2 
    101.4±8.4** 
   1.58±0.01 
   1.57±0.03 
    55.0±3.9 
   109.9±11.8** 
   7.76±0.03 
   7.76±0.06 
  13.4±6.2 
   30.1±5.3* 
     LPS  
      (n=8) 
 
LPS       
0.01µM 
Epicatechin 
    49.3±2.6 
    68.9±3.1** 
1.40±0.06 
1.49±0.03 
  51.0±6.2 
  77.1±15.6** 
  7.62±0.2 
   7.86±0.05 
  18.5±1.6 
  42.2±8.2** 
      LPS 
    (n=11) 
 
LPS        
10µM EGCG 
63.3±3.9 
 
107.2±8.1** 
1.60±0.02 
 
1.63±0.03 
81.0±4.4 
 
115.5±10.8** 
7.73±0.1 
 
7.73±0.08 
23.9±3.1 
 
38.1±4.1** 
LPS 
(n=8) 
LPS          
10µM 
Catechin 
     60.8±3.2 
     94.5±2.5* 
   1.4±0.06 
  1.49±0.03 
    70.0±5.5 
     89.0±2.6** 
    7.6±0.17 
     7.8±0.05 
 15.7±2.9 
76.1±2.5** 
Values shown are the mean ± sem of 8-14 observations.* (p <0.05) and ** (p < 0.01) 
denote a statistically significant difference from the paired control preparation. 
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Figure 4-3  The effect of overnight exposure of the porcine coronary artery to 1 µg 
mL-1 LPS, in the presence or absence of either (a, b) 1µM epicatechin or (c, d) 
0.1µM epicatechin or (e, f) 0.01µM epicatechin on responses elicited by KCl and 
U46619. The responses shown are as mean ± SEM of 8±14 observations. 
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Figure 4-4  The effect of 24h exposure to 1µg·mL-1LPS, 1µg mL-1LPS plus 1µM 
epicatechin and 1µg·mL-1LPS plus 0.1µM epicatechin on nitrite ion production in 
porcine coronary artery segments incubated in DMEM. The values shown are the 
mean±SEM of 8 observations. **p <  VLJQL¿FDQW GLIIHUHQFH IURP FRQWURO E\
ANOVA.  
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In chapter 3, I demonstrated that in contrast to quercetin, myricetin did not modify 
LPS-induced changes in contractile response. More significantly, myricetin failed to 
modify LPS-induced changes in nitrite ion production, but was able to block the 
ability effect of quercetin to do this. This was taken as evidence that myricetin and 
quercetin work at a common site. In the present study I repeated the 
myricetin/quercetin experiment on LPS-induced nitrite ion production, though on 
this occasion the magnitude of the antagonism was less than previously observed 
(see Figure 4.5a, compared with Figure 3.9). While exposure to 1µM quercetin alone 
caused a significant reduction (97.5±2.8%, (n=8) in LPS-induced nitrite ion 
production, prior exposure to 10 µM myricetin significantly reduced the inhibitory 
effects of quercetin (61±12.5%, n=8). To examine whether epicatechin behaves in 
the same way as quercetin, I examined this inhibitory effect of myricetin on flavanol 
type flavonoid (epicatechin). Figure 4.5b shows that 24 hour exposure of the 
segments to LPS was associated with 5-fold increase in nitrite production compared 
to the segment incubated in DMEM alone. In contrast to Figure 4.5a, prior exposure 
of the segment to 10µM myricetin did not affect the inhibitory effect of 1µM 
epicatechin on LPS-induced nitrite production. 
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Figure 4-5 The effect of 24 h exposure to 1µg·mL-1LPS (a) 1µg mL-1LPS plus 1µM 
quercetin and 1 µg mL-1LPS with a combination of 10µM myricetin and 1µM 
quercetin and (b) 1µg mL-1 LPS plus 1µM epicatechin and 1µg·mL-1 LPS with a 
combination of 10µM myricetin and 1 µM epicatechin on nitrite ion production in 
porcine coronary artery segments incubated in DMEM. 
The values shown are the mean ±SEM of 8-12 observations. **p VLJQL¿FDQW
difference from control by ANOVA.  
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4.6 Discussion 
The main finding in this chapter is that epicatechin, its steroisomer catechin and 
epigallocatechin gallate significantly suppressed the changes induced by 1µg mL-1 LPS 
in porcine coronary artery. In keeping with the findings in previous chapters, prolonged 
exposure to LPS was associated with significant reduction in contractions elicited by 
KCl and U46619 and endothelium-dependent relaxation to substance P. Exposure to 
LPS was also associated with an increase in the generation of nitrite ions in the 
incubation medium. The hyporesponsiveness of coronary artery following exposure to 
LPS is generally attributed to the induction of the enzyme nitric oxide synthase, which 
results in a significant production of nitric oxide (Hauser  et al., 2005).  In a previous 
chapter (chapter 3), I have shown that 1400W, a selective inhibitor of inducible nitric 
oxide synthase, abolished the effect of LPS. 
 
In this chapter I have demonstrated that overnight incubation of porcine isolated 
coronary artery with 10µM epicatechin alone did not affect the contractile ability of the 
arteries to both KCl and U46619, However, both 10µM catechin and 10µM 
epigallocatechin gallate significantly reduced the vascular response of the arteries to 
KCl and U46619. In term of endothelium-dependent relaxations, none of the tested 
compounds have any effect on substance P. However, a previous study found that 
catechins prevented a substance P-induced hyperactive bladder in rats via the down 
regulation of ICAM and ROS (Chen et al., 2004). 
 
The results in this chapter showed that a high concentration (10µM) of epicatechin, 
catechin and epigallocatechin gallate suppressed the LPS-induced changes in 
endothelial and vascular responses. These results are in line with a study carried out by 
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Lin & Lin (1997); they examined the effects of EGCG on NO production from murine 
peritoneal macrophages and sought possible reaction mechanisms. Their results 
suggested that EGCG blocks early events of NOS induction, and the blocking could 
occur via inhibition of binding of transcription factor NF-ț% WR WKH L126 SURPRWHU
thereby inhibiting the induction of iNOS transcription (Lin & Lin 1997). Also an in 
vitro study by Guruvayoorappan and Kuttan  (+)-catechin significantly inhibited nitrite 
ion production and TNF-alpha production in LPS-stimulated macrophages 
(Guruvayoorappan and Kuttan, 2008). 
 
While endothelial-derived NO from activation of constitutive NO synthase is important 
for maintaining vascular tone and homeostasis, higher concentrations of NO produced 
by iNOS from immune cells such as macrophages can cause oxidative damage. The 
results of this study showed the ability of epicatechin and its stereoisomer catechin to 
suppress the effect of LPS elevation in nitrite ion production. EGCG dose-dependently 
inhibited the expression of iNOS in lipopolysaccharide-activated macrophages by 
preventing the binding of nuclear transcriptional factor-kB (NF-kB) to the iNOS gene 
promoter and also reduced the activity of iNOS, thereby reducing toxic NO generation 
(Chan et al., 1997; Lin and Lin, 1997). Experimental and clinical studies suggest that 
tea catechins can significantly improve endothelial function, thereby providing an 
additional beneficial effect on patients with CVD. EGCG was shown to improve 
endothelial function and reduce blood pressure in hypertensive rats (Potenza et al., 
2007). (±)-epicatechin reduces blood pressure in hypertensive patients and limits infarct 
size in animal models of myocardial ischemia±reperfusion injury. Recent results 
demonstrate the unique capacity of (±)-epicatechin  to confer cardioprotection in the 
setting of a severe form of myocardial ischemic injury (Yamazaki, et al., 2010). 
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Benito et al (2002) found that endothelium-dependent relaxation and cyclic guanosine-
3',5'-monophosphate (cGMP) accumulation were greater in arterial tissue isolated from 
rats consuming de-alcoholized red wine or a catechin-rich diet compared with  a control 
diet, and these effects were attributable to an increase in the activity, but not the 
expression of endothelial nitric oxide synthase (eNOS) (Benito et al., 2002). Recent 
reports indicate that (±)-epicatechin can exert cardioprotective actions, which may 
involve endothelial nitric oxide synthase (eNOS)-mediated nitric oxide production in 
endothelial cells (Sanchez et al., 2010). Epicatechin had comparable effects on eNOS 
activity in cultured endothelial cells (Huang et al., 1999). Moreover, Lorenz and 
colleagues (2004) specifically examined the effects of EGCG on endothelial function. 
 They observed that EGCG produces eNOS-dependent relaxation of isolated rat aorta 
and increases eNOS activity in cultured endothelial cells. 
 
Myricetin and quercetin are structurly related flavonoids i.e. myricetin is 5-hydroxy 
quercetin. The results indicated that myricetin failed to mimic the effect of quercetin on 
LPS-induced nitric oxide production. It also antagonised the inhibitory effect of 
quercetin on LPS-induced nitrite. On the other hand, epicatechin is chemically different 
from myricetin; however, myricetin did not antagonise or reverse the effect of 
epicatchin on inhibition of nitrite ion induced by LPS. 
 
4.7 Conclusion 
In conclusion I have demonstrated that epicatechin, its steroisomers catechins and 
epigallocatechin gallate oppose pro-inflammatory events in both endothelial cells and 
vascular smooth muscle cells. These effects of catechins are evident at lower 
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concentrations than previously reported in studies using other cell types and suggests a 
selective action on the vasculature.  Further work on human blood vessels is required to 
establish whether these observations are relevant to the well-documented beneficial 
effects of tea catechins  (Arts et al., 2001). 
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5.1 Introduction 
A burgeoning body of evidence, largely derived from retrospective studies, suggests 
that statins may be useful for preventing the development of sepsis in patients or 
treating the fulminate of the condition (Brookes et al., 2009; Gao et al., 2008; 
Terblanche et al., 2006). Liappis and colleagues were amongst the first to report that 
pre-admission use of statins, to lower cholesterol, was associated with a significant 
reduction in mortality rate amongst patients who developed bacteraemia in hospital  
(Liappis et al., 2001). Several other retrospective studies have provided general 
support for the notion that prior use of statins is associated with improved outcomes 
for patients with bacteraemia and suspected sepsis (Almog et al., 2004; Kruger et 
al., 2009; Schmidt et al., 2006). Taken together, these finding are consistent with 
accumulating data indicating that these drugs possess significant `anti-inflammatory` 
activity following cardiac and non-cardiac surgery (Clark et al., 2006; O'Neil-
Callahan et al., 2005; Poldermans et al., 2003; Schouten et al., 2009). 
 
The beneficial effect of statins in these clinical settings is generally through to be a 
function of inhibition of HMG CoA reductase, but to be unrelated to changes in 
plasma cholesterol. Instead, inflammation-associated changes in isoprenoid 
metabolism are thought to be suppressed by statins the so-called  pleiotropic activity 
of this class of drugs (Brookes et al., 2009) that has been largely characterised from 
in vitro studies. For example, fluvastatin has been reported to inhibit 
lipopolysaccharide (LPS)-induced expression of nitric oxide synthase and the 
associated nitrite ion production in both cultured vascular smooth muscle cells and 
intact blood vessels (Wei et al., 2006), while simvastatin reduced LPS-induced 
cyclo-oxygenase-2 expression and postanoid production in a monocyctic cell line 
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U937 (Habib et al., 2007 ). Several studies have reported that statins can reduce 
expression of cell adhesion molecules on cultured human endothelial and vascular 
cells (Landsberger et al., 2007; Mulhaupt et al., 2003). Finally, several studies 
reported the anti-inflammatory cytokines in both smooth muscle cells (Ito et al., 
2002) and cultured monocyes  (Methe et al., 2005). These in vitro observations are 
also supported by findings in man, where simvastatin has been reported to inhibit 
LPS-induced elevation of plasma TNF-ĮDQG QHXWURSKLOR[LGDWLYH EXUVW (Pleiner et 
al., 2004). 
 
Despite the wealth of evidence highlighting the anti-inflammatory activity of statins, 
doubts remain regarding its clinical relevance in septic shock, with a few reports 
indicating either no benefit (Yang et al., 2007) or even worse mortality outcomes 
(Fernandez et al., 2006). Moreover, statins have also been reported to enhance 
cytokine-induced expression of nitric oxide synthase and nitrite ion production in 
vascular smooth muscle cells (Chen et al., 2000; Wei et al., 2006; Yamamoto et al., 
2003). 
 
The impairment of endothelium-dependent relaxations and the development of 
hyporesponsiveness to vasoconstrictor agents are cardinal features of experimental 
and clinical sepsis in man (Pleiner et al., 2004). Since these changes are usually 
accompanied by an elevation in plasma nitrite ions, it is generally assumed that the 
increased expression of nitric oxide synthase in both vascular (Fernanades and 
Assreuy, 2008; Stoclet et al., 1999b) and non-vascular cells (Hollenberg and Cinel, 
2009) makes a significant contribution to the condition. I have demonstrated that 
overnight exposure of the porcine isolated coronary artery to LPS is accompanied by 
                                                                                                                               Chapter 5 
- 142 - 
 
the increased expression of inducible nitric oxide synthase, impairment of 
endothelium-dependent relaxation to substance P and attenuation of vasoconstrictor 
response (Chapters 2, 3and 4). Thus, in the present chapter I have examined the 
effects of simvastatin and pravastatin on LPS-induced changes in vascular 
responses. Since overnight exposure of rat and human blood vessels to lovastatin has 
been reported to enhance vasoconstrictor response and impair endothelium-
dependent relaxation (Roulett et al., 1995), I have also closely examined the effects 
of statins alone on vascular responses. 
 
A recent area of interest that may be fruitful is the study of anti-inflammatory effects 
of tea polyphenols in combination with therapeutic agents (e.g. statins). In a recent 
study carried out by Naruszewicz et al (2007), it was demonstrated that a 
combination therapy of statin and flavonoid rich extract enhanced the reduction in 
cardiovascular risk markers in patients after myocardial infarction (MI) 
(Naruszewiczac et al., 2007). Therefore, I have investigated the combination effects 
of low concentration of epicatechin and simvastatin on LPS-induced inflammatory 
changes on porcine isolated coronary artery. 
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5.2   Material and Methods 
Porcine hearts were obtained from a local abattoir and placed in modified Krebs-
Henseleit (K-H) solution maintained at 4°C before being transported to the 
laboratory. The an interior descending branch of the coronary artery was dissected 
from the hearts, cleaned of connective tissue, and then divided into 4 mm long 
segments. 
 
5.2.1  Contraction Studies 
For contraction experiments, single segments of the porcine coronary artery were 
incubated in 2ml K-H solution (previously gassed with 95% O2 and 5% CO2 for 5 
PLQ FRQWDLQLQJ  ILFROO DQG D FRPELQDWLRQ RI ȝJPO benzyl penicillin and 
ȝJPOVWUHSWRP\FLQVXOSKDWH and 10% FCS7KHVROXWLRQDOVRFRQWDLQHGȝJP/-
1LPS, various concentrations of simvastatin or a combination of LPS and simvastatin 
(added 60 min before LPS) and then sealed in a sterilized glass vial and stored 
overnight at 37°C for 16-18 h.  Similar experiments were also conducted in the 
presence of 10µM pravastatin. In order to better understand the action of simvastatin 
some segments were aOVR LQFXEDWHG RYHUQLJKW LQ WKH SUHVHQFH RI WKH YHKLFOH ȝJ
mL-1LPS, a combination of LPS and 3µM simvastatin and combination of LPS, 
simvastatin and 100µM mevalonate. In this instance, it was also necessary to 
determine the effect of combination with 100µM mevalonate, against LPS-induced 
changes in the blood vessel.  In another experiment, segments were exposed to a 
combination of 0.01µM epicatechin and 0.03µM simvastatin for 1hour followed by 
the addition of ȝJP/-1 LPS to the incubation solution and incubated overnight in a 
pre-gassed modified K-H solution. In all instances the segments were effectively 
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paired so that each experimental condition had a control segment taken from the 
same animal. 
 
 After overnight storage, segments were removed from the incubation solution and 
placed in K-H solution (maintained at 37oC and gassed with 95% O2 and 5% CO2) in 
a 15 ml isolated organ bath, prepared for isometric tension recordings as previously 
described (Qi et al., 2007) and allowed to equilibrate for 60 min. Contractions of the 
segment were measured using a Grass FT03 isometric force transducer connected to 
a MacLab unit coupled to a Macintosh LC4 computer running Chart 3.5.  An initial 
resting tension of 80mN was slowly applied to each segment at the end of the 
equilibration period and the recorded tension declined to 40-60mN over a further 40 
min period. Segments were repeatedly exposed to 60mM KCl for 15 min until 
reproducible contractions were observed. The preparations were exposed to 
cumulatively increasing concentrations of either KCl (6-60mM) or U46619 (a stable 
thromboxane-mimetic analogue, 9,11-dideoxy-ĮĮ-methanoepoxyprostaglandin 
FĮ 1-200 nM). When each preparation was exposed to a maximally-effective 
concentration of U46619, 10nM substance P was added to assess the integrity of the 
endothelium. 
 
In order to establish whether the effects of simvastatin on LPS-induced changes in 
vascular responses can also occur if the drug is presented after the inflammatory 
stimuli, segments of porcine isolated coronary artery were incubated in the presence 
DQGDEVHQFHRIȝJP/-1LPS for 40 hours and 3µM simvastatin was added into the 
medium 16 hours after exposure to LPS (24 hour statin exposure time). After 40 
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hours incubation the segments were then prepared for the isometric tension 
recording as described above. 
 
5.2.2 Nitrite Determination 
For the measurement of nitrite accumulation, a marker for nitric oxide production 
(Kelm, 1999), two 4mm segments were incubated in each vial for 24 hr with aerated 
DMEM (without phenol red) containing 10% FCS, 1mM L-DUJLQLQH ȝJPO
EHQ]\O SHQLFLOOLQ DQG ȝJPO VWUHSWRP\FLQ 7KH VHJPHQWV ZHUH exposed to either 
1µg mL-1LPS, simvastatin, or combination of LPS and simvastatin as described 
above. After the incubation period, the segments were removed, briefly blotted on 
paper cloth and weighed.  The accumulation nitrite ions was determined by taking 
ORIWKHLQFXEDWLRQPHGLXPDGGLQJȝO*ULHVVUHDJHQWDQGan optical density 
at 550nm was measured, using a UNICAM UV/VIS spectrophotometer. A standard 
concentration-optical density curve was calculated for every assay using sodium 
nitrite solution against a blank (500µl DMEM & 500µl Griess Reagent). In a 
separate experiment we established that incubation of DMEM containing either the 
statins, LPS or a combination of both (without the arterial segments) produced an 
optical density reading similar to the blank. The minimum detectable amount of 
nitrite was 375 nmoles.  For comparative purposes, the effect of hydrophilic statin 
(pravastatin) on LPS-induced changes on porcine isolated coronary artery was also 
examined. 
 
5.2.3 Immunohistochemistry 
Sections of the coronary artery incubated under the above conditions were prepared 
on a cryostat (5µm thick) and stored frozen at -80oC until required.  The section 
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were then warmed to room temperature for 20 min and fixed in cold acetone at -4°C 
for 20 min. To block endogenous peroxidase activity, sections were treated with 
blocking serum (2 drops of vectastain in 5ml phosphate buffer solution (pH 7.4) 
containing 2%w/v immunohistochemical grade bovine serum albumin) for 10 min at 
room temperature.  The sections were then incubated for 1 hour with primary mouse 
antibodies: porcine-PECAM-1 (diluted 1:75), or rabbit inducible nitric oxide 
synthase (iNOS) (diluted 1:100).  The sections were then washed in phosphate 
buffer solution, incubated for 10 min with biotinylated anti-mouse antibody in 10% 
NGS (Vectastain ABC Kit), washed in phosphate buffer solution, incubated for a 
further 5 min with ABC (avidin-biotin-peroxidase) reagent in phosphate buffer 
solution and, finally, washed again. Immunoreactive CD31 and iNOS were 
visualized by incubating the sections in Vector Red substrate (1 drop of levamisole 
solution to 5 ml of 200 mM Tris-HCl  pH 8.2) for 30 min. Finally, sections were 
dehydrated and cover-slipped with DPX mounting medium.  The observation and 
photographs were made using a light microscope (Leica DM4000B) and an imaging 
digital camera.  Images were obtained using Openlab (improvision, UK). 
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5.3 Solutions and drugs 
The composition of K-H solution was (in mM): NaCl, 118; KCl, 4.8; MgSO4.7H2O, 
1.2; CaCl2.2H2O, 1.3; NaHCO3, 25.0; KH2PO4, 1.2. Benzyl penicillin, streptomycin 
sulphate, ficoll, LPS, R-(-) mevalonolactone and Pravastatin sodium were all 
obtained from Sigma-Aldrich Company Ltd (Poole, Dorset, UK). Substance P was 
obtained from Bachem (UK). U46619 was obtained from Alexis Coporation 
(Nottingham, UK).  Dulbeccos Modified Eagle`s Medium (DMEM) was 
supplemented with antibiotics (see above) and 2 mM L-glutamine (Gibco). Statins, 
and mevalonolactone were dissolved in distilled water. 
 
5.4 Data analysis and statistics 
Contractions produced by U46619 and KCl were measured as mN force. Responses 
were expressed as the maximum contraction (Emax), and potency determined as the 
negative logarithm of the concentration causing 50% of the maximum response (-log 
EC50 or pD2) using a logistic equation (Kaleidagraph, version 3.6 Synergy 
Software). The values are shown as the mean (± SEM). The content of nitrite in the 
medium was calculated according to the equation deduced from the standard curve. 
The amount on nitrite in the medium was then divided by the wet weight of tissues 
to obtain the amount of nitrite production from each segment in the units of nmoles 
per mg wet weight.  In the majority of instances differences between mean values 
were assessed by a Student¶s t-test (two-tailed). However, where there was more 
than one treatment condition assessed differences were analysed by ANOVA 
followed by post-hoc Dunnett¶s test. A p value < 0.05 was considered statistically 
significant.
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5.5 Results 
5.5.1  The effect of simvastatin 
Following overnight incubation of the isolated segments of porcine coronary artery 
at 37ºC in modified Krebs-Henseleit solution, KCl and U46619 produced 
concentration-dependent contractions of comparable sizes (Table 5.1) in the 
presence of maximally effective concentrations of U46619, 10nM  substance P (SP) 
produced transient, endothelium-dependant relaxations (Table 5.1). Table 5.1 also 
shows that overnight exposure to 0.3- 30µM simvastatin (and subsequent removal) 
did not significantly alter either KCl-induced contraction or substance P-induced 
relaxations. However, overnight incubation of segments with 0.3-3µM simvastatin 
was associated with an increase in the potency of U46619 and an increase in the 
magnitude of the maximum contraction. In the case of 3µM simvastatin the increase 
in the maximum contraction to U46619 (36.4±8.3%, n=8) was statiscally significant 
(p<0.05). In a separate series of experiments, acute exposure of coronary artery 
segments to 3µM simvastatin (1 hour) did not affect either the potency or the 
magnitude of the maximum contractions to KCl and U46619. In addition, relaxation 
induced by substance P was unaffected by acute exposure to 3µM simvastatin (data 
not shown).    
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Table 5-1 Effect of 30µM, 3µM and 0.3µM simvastatin on the maximum response 
(mN) and potency (pD2) of KCl and U46619 contractions and SP-induced relaxation 
in isolated porcine coronary arteries incubated for 16 h in modified Krebs-Henseleit 
solution. 
 
       KCl 
 
      U46619       SP 
Max 
(mN) 
pD2 Max 
(mN) 
pD2 % 
  Relaxation 
Control 
(n=8) 
 
30µM 
Simvastatin
 
 
3µM 
Simvastatin
 
 
0.3µM 
Simvastatin
115.5±9.7 
 
 
115.6±8.1 
 
 
129.1±10.3 
 
 
112.5±10.3 
1.45±0.04 
 
 
1.4±0.05 
 
 
1.48±0.04 
 
 
1.5±0.03 
102.1±8.3 
 
 
127.4±7.5 
 
 
160.6±8.3** 
 
 
135.2±7.6* 
7.6±0.06 
 
 
7.8±0.03** 
 
 
7.8±0.06** 
 
 
7.9±0.04** 
44.6±4.2 
 
 
42.9±7.0 
 
 
44.1±5.1 
 
 
35.5±4.6 
 
Values shown are the mean ± SEM of 8 observations. * (p <0.05) and ** (p < 0.01) 
denote a statistically significant difference from control by ANOVA.  
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Figure 5.1 shows that KCl and U46619-induced contractions of the porcine isolated 
coronary artery were significantly reduced to 73.9±3.4% (n=18) and 74.5±3.3% 
(n=18) of control, respectively, following overnight exposure to 1µg mL-1LPS, with 
a small (1.8-fold), non-significant reduction in the potency of both agents. Following 
overnight co-incubation of segments with a combination of LPS and 3µM 
simvastatin (and subsequent removal), responses to both KCl and U46619 were 
significantly increased compared with that of LPS alone (Figure 5.1a and 5.1b); the 
maximum contraction to KCl and U46619 after exposure to LPS and 3µM 
simvastatin were 101.2±5.1% (n=18) and 105.9±4.5% (n=18) respectively. At the 
end of the U46619 contraction response curve, the addition of 10nM SP caused a 
transient relaxation (16.3±2.3%, n=18) in control preparations that was significantly 
impaired (10.9±3.2%, p<0.05) following 1µg mL-1LPS treatment. The inhibitory 
effect of LPS on SP-induced relaxation was prevented by co-incubation with 3µM 
simvastatin (17.2±3.4%, n=18). 
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Figure 5-1  7KHHIIHFWRIRYHUQLJKWH[SRVXUHRIWKHSRUFLQHFRURQDU\DUWHU\WRȝJ
mL-1 LPS, in the presence or absence of 3µM simvastatin on responses elicited by 
KCl (a) and U46619 (b). The responses shown are as mean ± SEM of 18 
observations. 
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Table 5.2 shows the results from a further experiment to investigate the effect of lower 
concentration of simvastatin on LPS-induced changes in vascular responses. Overnight 
exposure of porcine isolated coronary artery to 1µg mL-1LPS was associated with 
approximately 35% reduction in the maximum contractions to KCl and U46619 and a 
statistically significant 2-fold reduction in the potency of U46619. The combination of 
VLPYDVWDWLQ ȝ0 DQG ȝ0 DQG ȝJ P/-1 LPS was associated with a smaller 
impairment of maximum contractions (approximately 25%) to KCl and U46619 but this 
did not reach statistical significance. Interestingly, the 2-fold reduction in the potency 
RI8 IROORZLQJH[SRVXUH WRȝJP/-1 LPS was not observed in the presence of 
LPS and simvastatin (Table 5.2). Also, the inhibitory effect of LPS on substance P-
induced relaxation was prevented by co-incubation with either 0.3µM or 0.03µM 
simvastatin (Table 5.2). 
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Table 5-2 (IIHFWRIDQGȝ0 simvastatin, on the maximum response (mN) 
and potency (pD2) of KCl and U46619 contractions and SP-induced relaxation in 
isolated porcine coronary arteries incubated for 16 h in modified Krebs-Henseleit 
solution in the presence of 1µg mL-1 LPS. 
 
 
       KCl 
 
    U46619      SP 
       Max 
(% control) 
      pD2       Max 
  (% control) 
      pD2         % 
Relaxation 
 
     Control 
 
 
  ȝJPO/36 
 
 
      0.3µM 
Simvastatin 
 ȝJPO/36 
 
    0.03µM 
Simvastatin 
 ȝJPO/36 
 
        100 
 
 
 64.9±5.6** 
 
 
 73.9±3.6** 
 
 
 
 76.2±3.4** 
 
    1.6±0.01 
 
 
  1.57±0.01 
 
 
  1.56±0.02 
 
 
 
  1.64±0.01 
 
      100 
 
 
 64.7±5.3** 
 
 
 76.2±5.2** 
 
 
 
  73.5±3.1** 
 
  7.8±0.06 
 
 
 7.4±0.09** 
 
 
 7.7±0.07 
 
 
 
 7.8±0.06 
 
 42.3±4.9 
 
 
 20.6±4.4** 
 
 
  37.6±3.9 
 
 
 
  38.2±3.4 
 
Values shown are the mean ± SEM of 11 observations. ** p < 0.01 denote a statistically 
significant difference from control by ANOVA. 
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Following 24 hours incubation of porcine coronary artery segments in DMEM, the 
nitric oxide content of the media was 15-20nmoles/mg wet weight tissue (Figure 5.2a). 
The inclusion of ȝJP/-1 LPS in the media was associated with 7-10fold increase in 
the production of nitrite ions by coronary artery segments, while the inclusion of 
simvastatin (3µM) did not affect basal nitrite production. However, the addition of 
3µM simvastatin prior to exposure to LPS was associated with a 94.7±5.7% (n=8) 
reduction in LPS-induced nitrite production. As shown in Figure 5.2b, co-incubation of 
the porcine coronary artery segments with either 0.3µM or 0.03µM simvastatin reduced 
the LPS-induced nitrite ions production by 92.4±6.6% (n=12) and 93.4±7.8% (n=12), 
respectively. 
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Figure 5-2  7KHHIIHFWRIKRXUH[SRVXUHWRȝJP/-1 /36DȝJP/-1 LPS plus 
0VLPYDVWDWLQDQGEȝJP/-1 LPS plus either 0.3µM or 0.03 µM simvastatin 
on nitrite production in porcine coronary artery segments incubated in DMEM. The 
values shown are the mean ± SEM of 8-12 observations. ** p<0.01 significant 
difference from control by ANOVA. 
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Immunohistochemical study showed strong evidence for the induction of nitric oxide 
synthase by LPS. As shown in Figure 5.3 which is representative of 4 experiments, 
immunohistochemical analysis showed that control preparations express CD31 on 
endothelial cells but provide no evidence of inducible nitric oxide synthase in the 
vessel. Treatment of segments of porcine coronary artery for 18 h with 1µg mL-1 
LPS exhibited increased expression of endothelial CD31 and the appearance of 
inducible nitric oxide synthase in the tunica adventitia (rather than the tunica media). 
Interestingly, in arterial segments co-incubation with 3µM simvastatin and LPS 
there was no evidence of adventitial nitric oxide synthase, while the intensity of 
endothelial CD31 detected by anti-CD31 antibody was comparable to that in control 
preparations (Figure 5.3).  
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Figure 5-3 Immunohistochemical localization of (upper panels) PECAM-1 (CD31) 
and (lower panels) inducible nitric oxide synthase (iNOS) in the porcine isolated 
coronary artery following incubation in modified Krebs-Henseleit solution for 16-18 
hours at 37o&ZLWKRXW&RQWURORUZLWKHLWKHUȝJP/-1 /36RUȝJP/-1 LPS and 
3µM simvastatin. 
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5.5.2 Effects of pravastatin 
In light of the effect of simvastatin, a lipophilic statin, on LPS-induced changes in 
vascular responses, I also examined the effect of water-soluble statin, pravastatin. 
2YHUQLJKW H[SRVXUH WR ȝ0 SUDYDVWDWLQ DORQH DQG VXEVHTXHQW UHPRYDO
significantly altered the maximum contraction elicited by KCl and U46619. 
Pravastatin caused a significant increase in the contractile responses to KCl (Control 
P1YVȝ0SUDYDVWDWLQP1Q p=0.02), but the response 
WR 8 &RQWURO P1 YV ȝ0 SUDYDVWatin 169.5±7.5mN, n=8) just 
failed to reach statistical significance (p=0.06). The potency of KCl was unchanged; 
KRZHYHUȝ0SUDYDVWDWLQVLJQLILFDQWO\HQKDQFHGWKHSRWHQF\RI8&RQWURO
YVȝ0SUDYDVWDWLQQ p<0.05). 
 
Figure 5.4 shows the cumulative concentration response curves to KCl and U46619 
in porcine isolated coronary artery segments. Exposure to 1µg mL-1LPS caused a 
significant reduction to the maximum response to KCl (34.5±5.6%, n=8) and to 
U46619 (31.2±5.4%, n=8) and these effects were significantly reduced by prior 
exposure to 10µM pravastatin without any alteration in the potency of either agent. 
Furthermore, exposure of coronary artery segments to 1µg mL-1LPS was associated 
with a significant reduction in endothelium-dependent relaxations to substance P 
(control: 33.5±1.7% n=8; LPS: 13.1±0.6%, n=8) (p <0.001) and prior exposure to 
10µM pravastatin prevented this inhibitory effect on substance P-induced relaxation 
34.5±1.4%, n=8) (p <0.001).   
 
Twenty-four hours incubation with 1µg mL-1LPS significantly increased by 10-fold 
the production of nitrite ion in the incubation medium (Control, 26.6±2.4 nmoles mg 
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wet weight; LPS: 297±27.4 nmoles mg wet weight, n=8) and the presence of 10µM 
pravastatin reduced (91.5±3.0%, n=8; P<0.0001) nitrite accumulation in the 
presence of LPS (Figure 5.5). 
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Figure 5-4 7KHHIIHFWRIRYHUQLJKWH[SRVXUHRI WKHSRUFLQHFRURQDU\DUWHU\WRȝJ
mL-1 LPS, in the presence or absence of 10µM pravastatin on responses elicited by 
KCl (a) and U46619 (b).  The responses shown are as mean ± SEM of 8 
observations. 
 
 
 
 
                                                                                                                               Chapter 5 
- 161 - 
 
 
 
 
 
 
 
 
 
 
Figure 5-5 7KH HIIHFW RI  KRXU H[SRVXUH WR ȝJ P/-1 /36 ȝJ P/-1 LPS plus 
10µM pravastatin on nitrite production in porcine coronary artery segments 
incubated in DMEM.  The values shown are the mean ±SEM of 8 observations. ** 
p<0.01 significant difference from control by ANOVA. 
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Immunohistochemical study showed strong evidence for the induction of nitric oxide 
synthase. As shown in Figure 5.6 immunohistochemical analysis showed that control 
preparations (n=4) express CD31 on endothelial cells but with no evidence of 
inducible nitric oxide synthase. Treatment of segments of porcine coronary artery for 
18 h with 1µg mL-1LPS increased expression of endothelial CD31 and the 
appearance of inducible nitric oxide synthase in the tunica adventitia (but not the 
tunica media). Co-incubation with 10µM pravastatin reduced LPS-induced 
expression of endothelial CD31 and adventitial nitric oxide synthase (Figure 5.6).  
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Figure 5-6 Immunohistochemical localization of (upper panels) PECAM-1 (CD31) and 
(lower panels) inducible nitric oxide synthase (iNOS) in the porcine isolated coronary 
artery following incubation in modified Krebs-Henseleit solution for 16-18 hours at 
37o& ZLWKRXW &RQWURO RU ZLWK HLWKHU ȝJ P/-1 /36 RU ȝJ P/-1 LPS and 10µM 
pravastatin. 
 
 
 
 
 
 
 
 
                                                                                                                               Chapter 5 
- 164 - 
 
5.5.3  Effect of mevalonate 
In order to assess the effect of mevalonate on the ability of statins to modulate LPS-
induced changes in vascular responses, I established that overnight exposure to 
100µM mevalonate alone did not affect either the potency or the maximum 
contraction eliciated by KCl and U46619 (Figure 5.7a and 5.7b). However, while 
overnight incubation of isolated coronary artery segments with 1µg mL-1LPS was 
associated with a reduction in the maximum contractions to KCl by 62.8±2.5%., 
(n=7), the Emax to U46619 was also decreased by 65.6±5.3%, (n=7) with no effect on 
the potency of KCl or U46619. Overnight incubation of isolated coronary artery 
segments with a combination of 100µM mevalonate and 1µg mL-1LPS significantly 
enhanced the contractile response to KCl (Figure 5.8a), however, the effect of 
mevalonate failed to reach significance as determined by Student t-test on the 
response of U46619 (Figure 5.8b); 100µM mevalonate failed to affect the potency of 
KCl and U46619. 
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Figure 5-7  The effect of overnight exposure of the porcine coronary artery to 
100µM mevalonate (with subsequent removal) on responses elicited by KC (a) and 
U46619 (b). The responses shown are as mean ± SEM of 7 observations. 
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Figure 5-8  7KHHIIHFWRIRYHUQLJKWH[SRVXUHRIWKHSRUFLQHFRURQDU\DUWHU\WRȝJ
mL-1 LPS with or without 100µM mevalonate (with subsequent removal) on on 
responses elicited by KC (a) and U46619 (b).   The responses shown are as mean ± 
SEM of 7 observations. . *- (p <0.05) denote a statistically significant difference 
between responses for the paired LPS-treated preparations.  
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To assess whether the effects of simvastatin described above were associated with 
inhibition of HMG-CoA reductase and subsequently reduced mevalonate levels in 
porcine coronary artery, the segments were exposed to LPS and simvastatin in the 
presence of mevalonate (100µM). As shown in figure 5.9a and 5.9b, mevalonate 
reversed the effect of simvastatin on KCl and U46619. Moreover, 10nM SP 
produced transient relaxation in control segments (39.8±6.1%, n=12). This 
relaxation effect was significantly reduced to (7.5±1.5%, n=12), in segments 
exposed to LPS alone. The inhibitory effect of LPS on SP-induced relaxation was 
significantly reversed when segments were treated with simvastatin (47.8±4.7%, 
n=12) and relaxation was impaired (8.1±1.5%, n=12) when 100µM mevalonate was 
incorporated in the incubation medium. 
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Figure 5-9 7KHHIIHFWRIRYHUQLJKWH[SRVXUHRI WKHSRUFLQHFRURQDU\DUWHU\WRȝJ
mL-1 LPS in the presence or absence of either 3µM simvastatin, or 3µM simvastatin 
and 100µM mevalonate on responses to either (a) KCl or (b) U46619.  The 
responses are shown as the mean ± SEM of 12 observations. *- (p <0.05) denote a 
statistically significant difference between responses for the paired LPS-treated 
preparations.  
. 
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Incubation of segments in DMEM for 24 hrs produced 8-20nmoles per mg wet 
weight nitrite ions. Stimulation of WKH DUWHULHV ZLWK ȝJ P/-1 LPS caused a 
significant increase of 24-hr nitrite accumulation in the incubation medium. 
Addition of the 3µM simvastain or 0.3µM simvastain 60 min prior to LPS 
significantly inhibited the nitrite produced by LPS by 92.9±7.9%, (n=16) and 
96.4±12.8%, (n=11) respectively. However addition of the combination of either 
100µM mevalonate and 3µM simvastain or 100µM mevalonate and 0.3µM 
simvastain 60 min prior to LPS significantly inhibited the inhibitory effect of 
simvastatin on nitrite production by 31.5±12.8%, (n=16), and 51.3±17.2%, (n=11), 
respectively (Figure 5.10).  
                                                                                                                               Chapter 5 
- 170 - 
 
 
 
 
Figure 5-10 7KHHIIHFWRIKRXUH[SRVXUHWRȝJP/-1 /36DȝJP/-1 LPS plus 
3µM simvastatin and 1µg mL-1 LPS with a combination of 100µM mevalonate and 
3µM simvastatin DQG E ȝJ P/-1 LPS plus 0.3µM and 1µg mL-1 LPS with a 
combination of 100µM mevalonate and 0.3µM simvastatin on nitrite production in 
porcine coronary artery segments incubated in DMEM. The values shown are the 
mean ± SEM of 11-16 observations. ** p<0.01 significant difference from control 
by ANOVA. 
 
                                                                                                                               Chapter 5 
- 171 - 
 
5.5.4 The effect of post-LPS exposure to simvastatin on vascular responses  
All of the previous experiments have established that statins exert an anti-
inflammatory effect on the porcine coronary artery if added prior to exposure to the 
inflammatory insult (LPS).  In order to establish whether similar activity for 
simvastatin was manifest if added after exposure to LPS, the effect of 40hr exposure 
of porcine isolated coronary artery to 1µg mL-1 LPS was determined. The segments 
were incubated in presence or absence of 1µg mL-1 LPS for 40 hr in K-H solution at 
37ºC (with an exchange of medium after 16 hr. In some experiments 3µM 
simvastatin was added after 16 hr and then the segments incubated for further 24 hr 
in the continued presence of LPS.  
Following prolonged exposure (40hr) to 1µg mL-1 LPS, KCl and U46619 produced 
concentration-dependent contractions that were significantly reduced in magnitude 
and potency. The maximum contractions to KCl and U46619 were reduced to 
57.4±3.4% (n=8) and 59.7±3.9% (n=8), respectively, of responses in control 
preparations.  In addition, the magnitude of substance P-induced relaxations was 
reduced from 36.1±4.1% (n=8) of U46619-induced tone to 15.1±3.6% (n=8) 
following exposure to LPS.  The addition of 3µM simvastatin to the incubation 
medium for the last 24 hours significantly reversed the inhibitory effect of LPS on 
KCl and U46619 produced contraction (figure 5.11a and 5.11b).  Furthermore, 
substance P-induced relaxations (43.1±3.5%, n=8) were comparable to control 
preparations. 
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Figure 5-11 The effect of (40hr) H[SRVXUHRIWKHSRUFLQHFRURQDU\DUWHU\WRȝJP/-
1
 LPS, in the presence or absence of 3µM simvastatin on responses elicited by KCl 
(a) and U46619 (b). The responses shown are as mean ± SEM of 12 observations. 
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5.5.5 The effect of a combination of simvastatin and epicatechin on LPS-
induced changes in contractile response. 
In another experiment, segments were exposed to a combination of 0.01µM 
epicatechin and 0.03µM simvastatin for 1hour followed by the addition of ȝJP/-1 
LPS to the incubation solution and incubated overnight in pre-gassed modified K-H 
solution. 
Figure 5.12 shows that KCl and U46619 elicited concentration-dependent 
contraction in segments of porcine coronary artery incubated overnight in Krebs-
Henseleit solution. These contractions were impaired by overnight exposure of the 
VHJPHQWVWRȝJP/-1 LPS. LPS reduced the maximum response to KCl (60.1±3.4% 
of Control, n=12) and to U46619 (57.7±4.2% of Control, n=12). Pre-treatment of the 
segments with 0.01µM epicatechin alone did not significantly affect the maximum 
responses to KCl and to U46619 in LPS-treated segments. Interestingly, combined 
incubation with epicatechin and simvastatin significantly prevented the inhibitory 
effect of LPS on contractions of KCl (83.5±3.6%, n=12, p=0.001) and U46619 
(83.4±4.3%, n=12, p=0.001), as determined by ANOVA. Following attainment of 
maximal contractions to U46619, the addition of 10nM substance P was associated 
with a relaxation (49.8±6.4%, n=8) that was significantly reduced in preparations 
previously exposed to 1ȝJ P/-1LPS (10.5±2.5%, n=8).  Pre-treatment of the 
segments with 0.01µM epicatechin alone or the combination incubation with 
epicatechin and simvastatin significantly prevented the inhibitory effect of LPS on 
substance P by (32.7±5.2%, n=12) and (37.0±6.0%, n=12) respectively. 
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Figure 5-12 The effect of overnight exposure of the porcine coronary artery to 1 µg 
mL-1 LPS in the presence or absence of either 0.01µM epicatechin or 0.01µM 
epicatechin and 0.03 µM simvastatin on responses to either (a) KCl or (b) U46619. 
The responses are shown as the mean ± SEM of 12 observations. *p < 0.05 
VLJQL¿FDQWGLIIHUHQFHVEHWZHHQWKHPD[LPXPUHVSRQVHVLQSUHSDUDWLRQVWUHDWHGZLWK
LPS. 
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5.6 Discussion 
As outlined in the Introduction, the evidence for an anti-inflammatory effect of 
statins is extensive and convincing, but is largely based on observations on cells 
maintained in cultured (see: Habib et al., 2006; Methe  et al., 2005).  While these 
findings also extend to cultured endothelial and vascular smooth cells, particularly in 
terms of the expression of cell adhesion molecules and other inflammatory markers 
(Landsberger et al. 2007; Wei  et al., 2006; Mulhapht  et al., 2006), there is little 
information regarding the impact of these drugs on the contractile properties of 
intact blood vessels.  The results in this chapter represent one of the few studies that 
show the ability of statins to oppose inflammatory changes induced by LPS in a 
blood vessel.   
 
5.6.1 Statins & LPS-induced changes in the coronary artery  
In agreement with the observation in Chapter 3 & 4 that prolonged exposure to 1µg 
mL-1 LPS was associated with a significant reduction in contractions to both KCl 
and U46619, and impairment of substance P-induced, endothelium-dependent 
relaxations.  These effects were still evident 4-6 hours after removal of LPS.  In 
addition, LPS caused an increase in both nitrite ion production (3-10-fold) and the 
expression of CD31 (an endothelial cell adhesion molecule) and also induced NOS 
in the adventitia of the vessels.  In order to interpret the effect of statins on LPS-
induced changes in the blood vessel, it was first necessary to examine the effect of 
prolonged exposure to the statin alone. While neither simvastatin nor pravastatin 
affected contractile responses to KCl or substance P-induced relaxations, 
contractions to U46619 were significantly increased (see Table 5.1).  Interestingly, 
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the latter effect is qualitatively similar to that previously reported in both rat and 
human mesenteric arteries, where overnight incubation with lovastatin, and 
subsequent removal, was associated with increased potency of noradrenaline 
(Roulett et al., 1995).  Thus, the effect of prolonged exposure to a statin on receptor-
mediated contractile responses makes changes in KCl-induced contractions and SP-
induced relaxations more reliable indicators of the modulation of inflammatory 
responses.    
 
The mechanism underlying the selective effect of simvastatin and pravastatin on 
U46619-induced contractions is unclear. Even though prolonged inhibition of HMG 
CoA reductase by statins is associated with an increase in mRNA HMG CoA 
reductase and enzyme activity on removal of the drug (Puccetti et al., 2004; Laufs et 
al., 2005), it is unlikely that this factor is implicated.  Specifically, after prolonged 
exposure to simvastatin there was no difference in the U46619-induced contractions 
between segments subsequently examined in simvastatin-free medium and those 
examined in the presence of simvastatin. 
 
The key observation in this study is that high concentrations of simvastatin and 
pravastatin prevented the pro-inflammatory effect of LPS on the porcine isolated 
coronary artery.  In the presence of the statin, LPS failed to reduce the maximum 
response to KCl, endothelium-dependent relaxations to substance P were not 
impaired and both nitrite ion production and the expression of CD31 were 
comparable to control preparations.  The fact that simvastatin, a lipophilic agent, and 
pravastatin, a hydrophilic agent, were active in this model indicates that the anti-
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inflammatory activity is a property of all statins and, therefore, similar to that 
reported in endotoxaemic human volunteers (Pleiner et al., 2004).  Surprisingly, low 
concentrations of simvastatin (0.03-0.3µM), also inhibited LPS-induced nitrite ion 
production and prevented the impairment of substance P-induced relaxations, yet 
failed to prevent the reduction in KCl-induced contractions. Although I have 
previously demonstrated a close association between LPS-induced nitrite formation 
and suppression of contractile responses (Chapter 3), previous studies have 
highlighted that exposure of vascular smooth muscle to LPS also involves up-
regulation in other vasoactive agents including production of both endothelin-1 and 
prostanoids (Bishop-Bailey  et al., 1999; Wood  et al., 1998).   Indeed, earlier work 
in this laboratory has suggested a role for LPS-induced prostanoids, generated 
following the induction of COX-2, in supporting contractile responses in the porcine 
isolated coronary artery (Qi et al., 2007).  Thus, it seems likely that the anti-
inflammatory effect of statins involves a mechanism different from that of either 
quercetin or epicatechin. Taken together, since the anti-inflammatory effects of 
statins in the porcine isolated coronary artery was evident with concentrations lower 
than those known to occur with therapeutic doses of simvastatin (1µM;  Lilja  et al., 
2004), the findings may have clinical significance. 
 
5.6.2 Mechanism of action. 
The principal target for the action of statins is inhibition of HMG CoA reductase 
(Ness and Chambers, 2000) and, interestingly, the activity of the enzyme has been 
reported to be elevated following exposure to LPS (Feingold  et al., 1995; Memon  
et al., 1997).  Although there is no direct evidence for the presence of the enzyme in 
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the porcine isolated coronary artery, it is possible to provide indirect support for the 
involvement of HMG CoA reductase by adding mevalonate to overcome the 
functional effect of the statin.   As was the case for investigating the effect of the 
statins on LPS-induced changes in the blood vessel, it was necessary to first 
establish the effect of mevalonate alone on control preparations and LPS-exposed 
preparation.  Overnight exposure to mevalonate alone did not affect KCl and 
U46619 responses in control preparations, but in LPS-treated segments caused a 
small, statistically significant increase in the maximum contraction to KCl (see 
Figure 5.8a).   Nonetheless, the presence of mevalonate opposed the effect of 
simvastatin on LPS-induced changes to contractions induced by KCl and U46619 
and also substance P-induced relaxations.  These findings provide convincing 
evidence for a role of inhibition of HMG CoA reductase in the action of simvastatin. 
 
A key observation in this chapter is that the anti-inflammatory action of simvastatin 
is also manifest if the drug is added after the inflammatory insult (Figure 5.11). 
Thus, changes in responses to KCl, U46619 and substance P produced by LPS could 
be reversed by exposure to simvastatin 16 hours after the onset of inflammation, 
which clearly makes these findings more clinically relevant.  The vast majority of 
studies highlighting the anti-inflammatory actions of statins have tended to involve 
treatment prior to the inflammatory insult (see: Pleiner  et al.,  2004), but these 
findings provide support for the idea that statins could be used therapeutically in 
septic shock to improve outcomes (Brookes  et al., 2009; Gao  et al., 2008).  This 
possibility raises the question as to mechanism underlying the effect of statins, since 
inhibition of the initiation of the inflammation is no longer an adequate explanation.  
It is noteworthy, therefore, that Reis and colleagues (2008) have suggested that 
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statins (and quercetin) may exert their primary anti-inflammatory effect by 
influencing protein breakdown at the level of the proteosome.  
The final observation in this chapter is the finding that low, sub-therapeutic 
concentrations of simvastatin may synergise with dietary flavonoids (eg. 
epicatechin) to produce an anti-inflammatory effect on the vasculature. Qualitatively 
similar effects have been reported in isolated platelets (Franiak-Pietyga et al., 2009) 
and in patients (Naruszewicz et al., 2007).  Thus, further experiments are warranted 
to establish whether this effect is also observed against other inflammatory markers 
(eg. LPS-induced cytokine production) and whether key flavonoid metabolites also 
possess the ability to interact with low concentrations of statins.  
 
5.7 Conclusion 
In summary, both simvastatin and pravastatin exhibit anti-inflammatory activity in 
intact blood vessels in manner comparable to that previously described for the 
flavonoids quercetin (Chapter 3) and epicatechin (Chapter 4).  LPS-induced changes 
in vasoconstrictor and vasodilator responses, and the induction of inflammatory 
enzyme are suppressed by statins and, in the case of simvastatin, is manifest at 
concentrations lower than those currently used therapeutically to treat 
atherosclerosis.  This effect appears to involve inhibition of HMG CoA reductase 
and, significantly is still apparent when administered after the onset of inflammatory 
processes.  Taken together, the observations provide strong support for statins 
exerting important cholesterol-independent effects on the vasculature. 
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The principal findings in this thesis are that quercetin and its metabolites, quercetin 
¶-sulphate and quercetin 3-glucoronide, catechins and statins inhibit key 
inflammatory changes in the porcine isolated coronary artery induced by prolonged 
exposure to lipopolysaccharide. 
 
6.1 LPS-induced changes in the porcine coronary artery 
I have demonstrated that in vitro overnight incubation of porcine isolated coronary 
artery in Krebs-Henseleit solution with 1µg mL-1LPS reproducibly induces 
substantial vascular hyporeactivity to KCl and to the thromboxane mimetic, 
U46619. Similar findings have also been reported in rat mesenteric artery (O'Brien 
et al., 2001), and in rat aorta (Wylam et al., 2001). While the LPS concentrations I 
used are similar to most other in vitro studies (Glembot et al., 1995; Muller et al., 
1998; Scott et al., 1996), they still exceed those generally found in the plasma 
(mean peak 0.5 ng mLí1) of septic humans (Danner et al., 1991). although 
concentrations as high as 10 ng mlí1 have been reported in septic patients with 
meningitis (Brandizaeg et al., 1992), There has been one study of concentration-
dependent depression of vascular contractility at much lower concentrations of LPS 
(1 ± 100 ng mLí1) in rat aorta rings incubated for 16 h in DMEM containing 1% 
FCS (Mckenna, 1990). 
  
The addition of serum to the incubation medium enhanced and prolonged the 
effects of LPS. Serum contains LPS binding protein and soluble CD14 which have 
key roles in LPS-induced cellular activation and production of pro-inflammatory 
cytokines (Schiletter et al., 1995).  LPS binding protein transfers LPS to soluble 
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CD14 and the newly formed LPS-CD14 complex can, in turn, activate endothelial 
and vascular smooth muscle cells to release transcription factors responsible for the 
induction of various proteins (Arditi et al., 1993; Loppnow et al., 1995). The 
situation is somewhat different in macrophages and monocytes which already 
contain membrane bound CD14 receptors that can be activated directly by LPS 
(Schiletter et al., 1995). However, CD14-independent mechanisms also contribute 
to LPS induction of iNOS expression and NO production in macrophages  
(Matsuno et al., 1998).   
 
The continued presence of LPS within the incubation medium increased the 
reduction of vascular reactivity.  The results indicated statistically significant 
reduction in the maximum response of KCl and U46619 of the segments exposed to 
ȝJP/-1LPS for 42 hours in the presence of 10%FCS. A previous study, using an in 
vitro organ culture model of in rat aorta,  reported that the expression of iNOS and 
COX-2 remained elevated over the entire 10-day duration in the presence of 
LPS (Bishop-Bailey et al., 1997). 
 
Vascular hyporeactivity did not depend upon the presence of an intact endothelial 
layer, since denuding vessels of endothelium did not affect the level of vascular 
hyporeactivity following overnight exposure to LPS. This finding suggests that the 
medial and/or adventitial layers are principally responsible for continued 
hyporeactivity once the vessel has been transferred to the organ bath; an observation 
consistent with previous studies showing that an intact endothelium is not necessary 
for endotoxin-mediated vascular suppression (Hall et al., 1996; Julou-Schaeffer et 
al., 1990; Mckenna, 1990).  
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6.2 The effect of flavonoids and metabolites 
6WLPXODWLRQ RI LQÀDPPDWRU\ FHOOV VXFK DV PDFURSKDJHV E\ EDFWHULDO HQGRWR[LQV RU
LQÀDPPDWRU\ F\WRNLQHV UHVXOWV LQ LQFUHDVHG H[SUHVVLRQ RI LQGXFLEOH QLWULF R[LGH
synthase (iNOS) and subsequent production of large amount of nitric oxide that is 
able to produce oxidative injury. The inhibition of this enzyme reduces the 
production of arachidonic acid, prostaglandins, leukeotrienes, and NO, which are 
FUXFLDO PHGLDWRUV RI LQÀDPPDWLRQ 7KXV WKH LQKLELWLRQ RI WKHVH HQ]\PHV E\
Àavonoids may be one of the most important mechanisms of their anti-LQÀDPPDWRU\
activity. Therefore, in this thesis I have investigate the major dietary flavonoids, 
quercetin and its main metabolites, quercetin-3`-sulphate and quercetin-3-glucurnide, 
and the catechins namely epicatechin, its isomer catechin and epigallocatechin 
gallate on LPS-induced inflammatory changes on porcine isolated coronary artery. 
The results indicated that, with the exception of myricetin, all tested flavonoids are 
able to suppress LPS-induced hyporesponsiveness in contractility and the elevation 
in nitric oxide production in the coronary artery, with the aglycone exhibiting activity 
at concentrations as low as 0.01µM.  These results are in agreement with previous 
studies which found that flavonoids can inhibit lipopolysaccharide-induced iNOS 
gene expression, iNOS activity and nitric ion production in cultured macrophages 
(Chan et al., 1997; Sarkar and Bhaduri, 2001) and subsequently prevent oxidative 
damage. Moreover, the results indicated that quercetin suppressed the induction of 
nitric oxide synthase in the tunica adventitia, as demonstrated by an 
immunohistochemical approach. Interestingly, published data in rat aorta suggest that 
the adventitia is responsible for the majority of iNOS expression, NO production and 
medial hyporeactivity following exposure to LPS (Kleschyov et al., 1998; Zhangh et 
al., 1999). The results of this thesis suggest that quercetin, and its human metabolites 
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and the catechins may be considered as possible therapeutic agents for a variety of 
LQÀDPPDWRU\GLVHDVHVVXFKDVDWKHURVFOHURVLV 
 
6.3 The effect of statins  
Simvastatin and pravastatin suppressed the LPS-induced changes in endothelial and 
vascular responses, and suppressed the induction of nitric oxide synthase caused by 
LPS and the associated increase in nitrite ion production. These effects of simvastatin 
and pravaststin are similar to those noted in other studies. Simvastatin has been 
shown to decrease plasma levels of nitrate in vivo, in association with decreased 
iNOS activity (Giusti-Pavia et al., 2004). More recently, McGown et al 2010, 
reported that pravastatin reduced the increase in nitrite concentration induced by LPS 
in rat mesentry (McGown et al., 2010). Using immunohistochemistry I also reported 
that LPS caused increased expression of inducible nitric oxide synthase in the tunica 
advententia, however, co-incubation with either 3µM simvastatin or 10µM 
pravastatin significantly reduced LPS-induced expression of endothelial CD31 and 
adventitial nitric oxide synthase. Our results are in agreement with other studies, in 
that chronic administration of simvastatin has been shown to reduce production of 
NO via iNOS during inflammation induced by LPS (Alvarez de Sotomayer et al., 
2008; Kang et al., 2004). Others have demonstrated that expression of iNOS in 
response to TNF-ĮDQG,/-1 is also reduced by statins (Madonna et al., 2005). 
 
The observed vasculoprotective effects of statins are not related to their hydrophilic 
versus lipophilic properties, because both lipophilic statins (simvastatin) and 
hydrophilic statins (pravastain) exhibited similar effects. 
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HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonate. 
Mevalonate metabolism yields a series of isoprenoid compounds including farnesyl 
pyrophosphate, geranyl geranylpyrophosphate, and squalene. The mevalonate 
pathway plays an important role in cell growth and signal transduction (Goldstein 
and Brown, 1990). Previous studies demonstrated that exogenous mevalonate 
completely prevented the inhibition of proliferation and migration of VSMCs 
induced by fluvastatin and the inhibition of the inhibition of preproendothin-1 
transcription induced by simvastatin or atrovastatin (Herandez-Perera et al., 1998).  
It has been demonstrated that co-treatment with mevalonate completely reverses 
eNOS upregulation induced by simvastatin or atrovastatin (Laufs et al., 1997; Laufs 
et al., 1998). In this study, I observed that addition of mevalonate reversed the effect 
of simvastatin on LPS-induced changes in KCl and U46619-induced contractions, 
SP-induced relaxations and nitrite ion production. These effects of statins on LPS-
induced changes appear to be mediated through specific inhibition of HMG-CoA 
reductase, since they were reversibly blocked by excess amounts of mevalonate. 
Recent studies suggest that, by blocking the mevalonate pathway, statins exerts 
pleriotropic effects on vascular cell function which may not be related directly to 
cholesterol synthesis (Laufs et al., 2001; Wassmann et al., 2001). 
 
Several studies have investigated whether statins are most effective as a prophylactic 
treatment during sepsis (Merx et al 2004, Merx et al 2005). Our results indicate that 
addition of simvastatin to the incubation medium 16 hours after exposure to LPS 
reversed the inhibitory effect of LPS on KCl and U46619 produced contraction. 
Ando and colleagues (2000) found that cervistatin was ineffective when administered 
after LPS injection; however, in the same study, pre-treatment with cervistatin 
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reduced mortality rate. This effect of simvastatin was manifest even when 
administered several hours after exposure to LPS. 
 
 
6.4 Further Possible Studies 
The experiments of this thesis examined the vascular responses of the porcine 
isolated coronary artery only.  Although a 30-40% reduction in the response to 
norepinephrine has been reported in an in vivo model of endotoxemia (Datta and 
Magder 1999), there is no literature that has directly compared the effects of LPS on 
vascular function of pigs ex vivo with that in vitro.  Thus, it is hard to directly 
compare my results with other in vivo reports.  Also, it is not clear whether other 
types of vascular bed, for example, the mesenteric artery or small resistant artery 
respond similarly to the stimulation by lipopolysaccharides. Nevertheless, the 
establishment of the inflammation in vascular model in this thesis provides the 
potential for investigating other type of vascular beds, for example, resistance 
arteries or veins, following exposure to the different inflammatory stimuli.  
Moreover, the induction of inducible nitric oxide synthase can be detected by using 
an immunohistochemical technique on this vascular model.  
 
The concentrations of quercetin used in this study exceeded the peak plasma levels of 
the aglycone (0.03µM) and the metabolites (3µM) detected following dietary 
ingestion (Kroon et al., 2004; Wang and Morris, 2005).  Nonetheless, further studies 
on human blood vessels with lower concentrations of quercetin and its metabolites 
are warranted.  In light of the striking difference between the effects of quercetin and 
myricetin on the porcine coronary artery, there is also a need to establish whether 
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myricetin can inhibit the effect of quercetin in human vascular cells, effectively 
EHKDYLQJDVDQµDQWDJRQLVW¶ 
 
Further studies will be needed to determine the relative merits of flavonoid 
consumption as supplements or whether consumption of these compounds in whole 
foods and beverages is preferable, as is currently recommended by the American 
Heart Association (Kris-Etherton et al., 2004). 
 
Many large clinical studies conducted over the last two decades have shown that 
flavonoids exert positive influences on health and a diet rich in flavonoids alleviate 
and prevent many serious diseases. Flavonoids as antioxidants are ideal 
nutraceuticals for neutralizing stress-induced free radicals. Many other actions of 
flavonoids like in cancer prevention have been reported in the recent literature, but 
large clinical trials are necessary before these effects are proved. 
  
The continual efforts will provide new insight into the anti-inflammatory activity of 
flavonoids, and might eventually lead to the development of a new class of anti-
inflammatory agents based on the flavonoid molecule. 
 
6.5 General Conclusion 
In conclusion, I have established an impaired vascular reactivity model by exposing  
porcine coronary artery segments to ȝJPO /36 RYHUQLJKW LQ .UHEV-Henseleit 
solution at 37ºC in presence of 10% foetal calf serum. The responses of porcine 
isolated coronary artery to low concentrations of LPS is enhanced by serum, possibly 
due to the participation of sCD14 and LBP. I also have demonstrated that dietary 
Chapter 6: General Discussion 
- 188 - 
 
flavonoids, quercetin, and its principal human metabolites and catechins oppose pro-
inflammatory events in both endothelial cells and vascular smooth muscle cells. 
Since pre-treatment of the porcine coronary artery with statin reduced LPS-induced 
changes in vasoconstrictor responses, suppressed the induction of nitric oxidec 
synthase caused by LPS and the associated increase in nitrite production. It is 
unlikely that the effect of the statin involves direct inhibition of NOS. These findings 
are consistent with clinical studies suggesting that prior use of statins may afford 
protection against bacterial sepsis. 
 
When Hippocrates, the Father of MHGLFLQHVDLGWKDW³/HWIRRGEHWK\PHGLFLQHDQG
OHWWK\PHGLFLQHEHIRRG´KHZDVSUREDEO\UHIHUULQJWRIRRGVOLNHflavonoids. 
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